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resumo 
 
 
As nanopartículas de prata (AgNPs) estão entre as nanopartículas mais 
utilizadas devido às suas propriedades fisico-químicas e biológicas (como por 
exemplo a sua eficiente actividade antimicrobiana). Contudo, existe uma 
crescente preocupação relativamente ao seu potencial impacto no ambiente e 
na saúde humana. Mais especificamente, ainda não está explicada a influência 
dos revestimentos das nanopartículas na citotoxicidade, inflamação e potencial 
genotóxico em células humanas. Neste estudo, as AgNPs revestidas com 
citrato ou poli(etilenoglicol) (PEG) foram utilizadas para determinar in vitro a 
influência do revestimento nos perfis de toxicidade das AgNPs em células da 
pele, fígado e sangue. 
A linha celular de queratinócitos humanos (HaCaT) foi exposta a AgNPs de 30 
nm revestidas com citrato ou PEG (Cit30 ou PEG30) onde foram determinados 
a viabilidade, stress oxidativo, produção de citoquinas, apoptose e efeito 
citostático. No geral, as Cit30 foram mais citotóxicas do que as PEG30 
demonstrando a influência do revestimento relativamente ao modo da morte 
celular e à progressão do ciclo celular para as concentrações testadas (IC50 e 
IC20 para as Cit30, correspondendo a 40 µg/mL e 10 µg/mL, 
respectivamente). Enquanto que as Cit30 induzem morte por apoptose, as 
células expostas a PEG30 aparentemente estão numa fase precoce dos 
mecanismos de apoptose, tal como sugere a análise da expressão génica. As 
Cit30 foram posteriormente utilizadas para determinar o potencial genotóxico 
na mesma linha celular, através da determinação do dano no DNA e a indução 
de micronúcleos (MNi). Foi demonstrado que Cit30 induzem dano no DNA e 
provocam a ocorrência de MNi, bem como, a redução do Índice de Divisão 
Nuclear (NDI). Finalmente, e considerando que nesta linha de células a 
modulação do processo inflamatório é particularmente importante, as células 
foram expostas a AgNPs de 10 nm com revestimento de citrato ou PEG (Cit10 
e PEG10). Os resultados mostraram que Cit10 e PEG10 modularam a 
resposta inflamatória de forma diferente, onde apenas PEG10 estimulou a 
indução do Factor Nuclear (NF)- κB. Contudo, ambas as AgNPs não 
estimularam a produção de citoquinas, mas antes, diminuiram a proteina 
quimio-atrativa de monócitos -1 (MCP1).  
A linha celular humana de hepatoma (HepG2) também foi exposta a Cit30 e 
PEG30 para determinar a influência dos revestimento nos efeitos das AgNPs 
na viabilidade, apoptose, genes relacionados com a apoptose, ciclo celular e 
expressão génica de ciclinas. Estas células apresentaram uma sensibilidade 
similar às AgNPs com ambos os revestimentos, ocorrendo redução de 
viabilidade e comprometimento do ciclo celular para as concentrações testadas 
(IC50 e IC20 para as Cit30 que corresponde a 11 µg/mL e 5 µg/mL, 
respectivamente). 
 
 
 
 
  
 
resumo (cont.) 
 
A linha celular de macrofágos de ratinho (murganho) (RAW 264.7) foi utilizada 
para avaliar a citotoxicidade das Cit30, onde a viabilidade, stress oxidativo e as 
dinamicas do ciclo celular foram determinados. A proliferação e viabilidade das 
RAW 264.7 apenas decresceu após exposição a concentrações superiores a 
75 µg/mL de Cit30, sugerindo uma baixa sensibilidade destas células a baixas 
concentrações de Cit30. Após exposição de 24 h o conteúdo de ROS 
(espécies reactivas de oxigénio) diminuiu nas células expostas a 60 µg/mL de 
Cit30 (IC20) o que pode ter contribuído para a tolerância destas células às 
AgNPs revestidas de citrato. Contudo, estas células apresentaram o ciclo 
celular comprometido e foi ainda observado um aumento de células na fase 
Sub-G1. Este aumento da população Sub-G1 está correlacionado com um 
aumento da fragmentação do DNA o que sugere um aumento de apoptose 
nestas células. 
Assim, e comparando a resposta dos diferentes tipos celulares às AgNPs em 
termos de viabilidade celular, podemos concluir que os hepatócitos são os 
mais sensiveis às AgNPs e que os macrófagos parecem ser os mais tolerantes 
(das mais sensíveis para as mais tolerentes: HepG2>HaCaT>RAW 264.7). 
Este estudo sugere que o revestimento com PEG pode ser considerado como 
uma boa alternativa à estabilização das AgNPs com o citrato para a utilização 
ao nível da indústria e nas aplicações médicas em relação às células da pele 
humana. Contudo, para os hepatócitos, o potencial citotóxico das AgNPs foi 
independente dos revestimentos. Para além disso, e considerando que as 
AgNPs estão presentes num vasto número de produtos de consumo e a sua 
utilização tem sido provada como útil ao nível industrial e da engenharia 
biomédica, embora os nossos dados sugiram que no geral PEG-AgNP são 
menos tóxicas, mais investigação é necessária para determinar as 
propriedades que conferem menor toxicidade das AgNPs para as diferentes 
linhas celulares.   
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abstract 
 
 
Silver nanoparticles (AgNPs) are among the most commonly used engineered 
NPs due to their physicochemical and biological properties (e.g. efficient 
antimicrobial activity). There is, however, a growing concern about their 
putative impact on the environment and on human health. In particular, there is 
no complete understanding of the influence of the coating on the cytotoxic, 
inflammatory and genotoxic potential of AgNPs to human cells. In this study, 
AgNPs coated with citrate or poly(ethylene glycol) (PEG) were used to assess 
in vitro the influence of coating on the AgNPs toxicity profiles on skin, liver and 
blood cells.  
Human Keratinocyte cell line (HaCaT) was exposed to 30 nm AgNPs coated 
with citrate or PEG (Cit30 or PEG30) and assessed for viability, oxidative 
stress, cytokine production, apoptosis and cytostaticity. Overall Cit30 was more 
toxic than PEG30 demonstrating the influence of coating regarding the mode of 
cell death and cell cycle progression for the concentrations tested (IC50 and 
IC20 for citrate- AgNPs corresponding to 40 µg/mL and 10 µg/mL, 
respectively). While Cit30 AgNPs clearly induced apoptotic death, cells 
exposed to PEG30 AgNPs appeared to be at an earlier phase of apoptosis 
mechanisms, as supported by gene expression analysis. Later these Cit30 
were used to assess genotoxic potential on the same cell line, by measuring 
DNA damage and micronuclei (MNi) induction. It was demonstrated that Cit30 
induced DNA damage, and MNi occurrence as well as a reduction of NDI 
(Nuclear division index). Finally, and considering that in these cell lines the 
inflammatory modulation is particularly important, cells were exposed to 10 nm 
(citrate vs. PEG) AgNPs. Data showed that Cit10 and PEG10 differently 
modulate the inflammatory response, with only PEG10 stimulating the Nuclear 
factor (NF)-κB induction. However, both AgNPs did not stimulate the release of 
cytokines but decreased MCP1 (Monocyte chemoattractant protein-1).  
Human Hepatoma cell line (HepG2) was also exposed to Cit30 and PEG30 to 
assess the influence of coating on the AgNPs effects on viability, apoptosis, 
apoptotic related genes, cell cycle and cyclins gene expression. These cells 
had similar sensitivity to both coatings, and suffered a decrease of viability as 
well as an impairment of the cells cycle for the concentrations tested (IC50 and 
IC20 for citrate- AgNPs corresponding to 11 µg/mL and 5 µg/mL, respectively). 
Mouse macrophage cell line (RAW 264.7) was used to evaluate the cytotoxicity 
of Cit30, where viability, oxidative stress and cell cycle dynamics were 
assessed. The proliferation and viability of RAW 264.7 cells only decreased 
upon exposure to Cit30 at concentrations above 75 µg/mL, suggesting a low 
sensitivity of RAW cells to lower doses of these AgNPs.  
 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
abstract (cont.) 
 
After 24 h exposure, ROS content decreased in cells exposed to 60 µg/mL 
AgNPs (IC20 value) which can have contributed to the high tolerance of these 
cells to citrate-AgNPs. However, these cells suffered an impairment of the cell 
cycle and an increase of cells at Sub-G1 phase was observed. This increase of 
the subG1 population is correlated with an increase of DNA fragmentation 
which suggests an increase of apoptosis in these cells. 
Therefore, and taking together the different decreases on cells viability, we 
conclude that hepatocytes are more sensitive to AgNPs than keratinocytes and 
that macrophages seem the more tolerant (from the most sensitive for more 
tolerant: HepG2>HaCaT>RAW 264.7). This study suggests that PEG-coating 
can be regarded as a good alternative to citrate stabilization of AgNPs used in 
industrial and medical applications towards human skin cells. However, for 
hepatocyte cells, AgNPs cytotoxic potential was coating independent  
Ultimately, and considering that AgNPs are present in a vast number of 
consumer products and their use has been proved to be helpful in industrial 
and biomedical engineering, despite our data suggest that overall PEG-AgNP 
are less toxic, more research is needed to determine the properties that confer 
less toxicity of AgNPs to different cell lines. 
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1. Introduction 
The concept of nanotechnology was introduced by the American physicist and Nobel laureate, 
Richard Feynman, in 1959. In his lecture “There’s plenty room at the bottom”, Feynman draw 
the attention to the potential of small matter (near atomic scales) at the production of enhanced 
materials, products and devices (Feynman, 1960). However, the term Nanotechnology was first 
coined only several years later by the Japanese researcher Prof. Norio Taniguchi, in 1974. 
Nowadays, nanotechnology is an emerging science, with wide-ranging applications. In fact, the 
potential of nanomaterials (NMs) and their beneficial features are so vast that we are constantly 
witnessing the rise of applications/consumer products relaying on nanotechnology.  
Nanoparticles (NPs), the building blocks of nanotechnology (Stern and McNeil, 2008), are 
particles with at least one dimension at 100 nm or less, with a high surface/volume ratio (Aitken 
et al., 2006; Buzea et al., 2007; Farre et al., 2011; Handy et al., 2008a; Handy et al., 2008b; 
Nowack and Bucheli, 2007; Stern and McNeil, 2008; Walker and Bucher, 2009), which confers 
specific physico-chemical properties as strength, electrical and optical features. In figure 1.1 it is 
represented the size of NPs and their location between particles only seen by electron 
microscopy to objects seen at unaided eye. 
 
 
 
 
 
 
 
 
 
Figure 1.1: Size comparison from electron microscope to unaided eye (adapted form © 
http://wichlab.com/research/) 
 
 
NPs can derive from natural and anthropic sources, particularly as engineered and/or as 
unwanted/incidental release (Biswas and Wu, 2005; Liden, 2011; Nowack and Bucheli, 2007; 
Tervonen et al., 2009). The natural sources of NPs are photochemical reactions, volcanic 
eruptions, forest ﬁres, simple erosion, and plants and animals (shedding of skin and hair) (Buzea 
et al., 2007). Anthropic generation of NPs may be both engineered or incidental. Engineered 
NPs are classified as carbon NPs, metal oxide NPs, zero-valence metal NPs, quantum dots 
Nanoparticles 
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(QDs) and dendrimers (Farre et al., 2011). Incidental generation of NPs may occur by the by-
products of simple combustion, food cooking, and chemical manufacturing; welding or refining 
and smelting; combustion in vehicles and airplane engines; combustion of treated pulverized 
sewage sludge and combustion of coal and fuel oil for power generation.  
With respect to NPs classification, they can be classified regarding their dimension, 
morphology, composition, uniformity and agglomeration (Buzea et al., 2007). From their 
multiple conformation, composition and nature, NPs present multiple functions and almost 
infinite applications. Indeed, what distinguishes them from the other particles is their small size 
and high surface/volume ratio, which confers specific properties to the NPs.  
Silver-based nano-products show a wide range of applications, which justifies the increasing 
interest demonstrated by industry on these products. In particular, silver nanoparticles (AgNPs) 
present unusually enhanced physicochemical and biological properties and activities (including 
antimicrobial properties), which support the exponential use of these NPs (Behra et al., 2013; 
Eckhardt et al., 2013). The antimicrobial activity attributed to AgNPs is due to the release of Ag 
ions from these NPs (Chook et al., 2012) and despite Ag ions are known for long to be cytotoxic 
to a broad range of microorganisms, the conventional sources of Ag - as salt or metal, which 
may release the Ag ions respectively too rapidly or too inefficiently - have not been applied with 
success in e.g., biomedical applications. On other hand, Ag has already been considered by the 
U.S. Environmental Protection Agency (USEPA) as an environmental hazard and pollutant in 
natural waters and an environmental hazard, partly due to its persistence in the environment, 
bioaccumulative features and its high toxicity to life forms (Luoma, 2008). This author claims 
that nearly one-third of Ag-nanoproducts on the market in september 2007 might have the 
potential to disperse Ag or AgNP into the environment (Luoma, 2008). Therefore, risk 
assessments for some of those Ag-based nanoproducts, as well as estimations of mass 
discharges urge. 
 
1.1.Characteristics and properties of AgNPs 
 
The most fundamental entity of silver is the Ag cation (Ag
+
), which makes it highly reactive. 
Indeed, Ag ion (~0.1 nm of ionic radius) is persistent, cannot be destroyed and can associate 
with other ions. In contrast, a AgNP is made of metallic silver ions in clusters (size 1-100 nm) 
and/or of silver compounds engineered into a particle of nanoscale size (Balogh et al., 2001) 
which is not necessarily persistent, since particles can dissolve or disaggregate. It is important to 
note that silver nanoparticles are usually engineered to release silver ions (the source of 
antibacterial activity as referred before) (Luoma, 2008). 
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AgNPs, once released into the environment, start to transform chemically and biochemically, 
modifying their properties, influencing their bioavailability, uptake and potential toxicity. 
Depending on their characteristics (figure 1.2) as the size, shape, coating, charge and structure 
and on the environmental conditions, AgNPs can aggregate or oxidize, releasing Ag
+
 (Behra et 
al., 2013).  
 
 
 
 
 
 
 
 
 
 
Figure 1.2: The variety of nanoparticles properties. (adapted from Nanocomposix® - “Nanotoxicology: 
Particle Section” ) 
 
The dissolution of AgNPs depends on the presence of oxygen or ligands, which increase the 
dissolution rate, forming Ag
+
 or Ag
+
 complexes (Xiu et al., 2011). Therefore, in order to control 
the colloidal stability, capping agents are usually used, since it influences the size, morphologies 
and interactions of AgNPs. The most frequently used capping agents are: citrate (Lee and 
Meisel, 1982); 3-(aminopropyl)trimethoxysilane (APS) (Pastoriza-Santos and Liz-Marzán, 
1999); poly(vinylpyrrolidone) (PVP) (Nair and Laurencin, 2007); and polyethylene glycol 
(PEG). Beyond these, other polymers may be used as capping agents including polyacrylates, 
poly(vinyl)alcohol (PVA), polyacrylamide, poly(oxyethylene)-segmented imide (POEM), 
poly(styrene-co-maleic anhydride)-grafting poly(oxyalkylene) (SMA), silica, among others 
(Asharani et al., 2009a; Haase et al., 2011; Kim and Choi, 2012; Love and Haynes, 2010; 
Monteiro-Riviere et al., 2013; Nair and Laurencin, 2007; Wang et al., 2012). 
Considering that AgNPs are present in a vast number of consumer products from industrial to 
biomedical contexts, it is important to determine if or which NPs are more cytotoxic, identifying 
the properties that confer AgNPs a lower toxicity. On other hand, while citrate is the most 
commonly reducing agent used to stabilize AgNPs (Gutierrez et al., 2015; Pillai and Kamat, 
2004; Sharma et al., 2009), PEG coating has been increasingly used in nanomedical applications 
(Ginn et al., 2014; Jain and Jain, 2008; Ryan et al., 2008). Therefore, and as comparative studies 
on these coating formulations' cytotoxicity are scarce, in this work, citrate and PEG coated- 
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AgNPs were used to further characterize their cytotoxic and genotoxic potential. 
 
Citrate 
 
Citrate is a derivate of citric acid. The formula of the citrate ion is C6H5O7
3− 
or C3H5O(COO)3
3−
 
and the figure 1.3 represents their structure form. 
 
 
 
 
 
 
Figure 1.3: Structure form of citrate. 
 
Citrate- coating is one of the most popular silver colloids (Pillai and Kamat, 2004; Tolaymat et 
al., 2010; Zhang et al., 2011). It is used as both reducing agent and stabilizer of the particles by 
decorating them with negative charges (Henglein and Giersig, 1999; Wiley et al., 2005; Wiley 
et al., 2007). The citrate- AgNPs structure is exemplified in figure 1.4.  
 
 
 
 
 
 
 
 
 
Figure 1.4: Example of Citrate-coated AgNPs structure. © 
http://cnsi.ctrl.ucla.edu/nanoscience/pages/biotoxicity 
 
 
Polyethylene glycol (PEG) 
 
PEG is a polyether compound, a synthetic biodegradable polymer and it has been applied to 
numerous biomedical applications (Jegatheeswaran and Sundrarajan, 2015). The structure of 
PEG is represented in figure 1.5. 
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Figure 1.5: Structure form of poly(ethylene) glicol (PEG). 
 
PEG- coating is also used as a reducing agent and stabilizer (Luo et al., 2005; Popa et al., 2007), 
with many applications from industrial manufacturing to medicine (Thorley et al 2013). Coating 
particles with low molecular weight PEG renders particles with a neutral charge, significantly 
improving transport of particles across the mucus layer (Lai et al., 2009; Suk et al., 2011). The 
PEG- AgNPs structure is exemplified in figure 1.6. 
 
 
 
 
 
 
 
 
 
Figure 1.6: Chemical structure of AgNPs coated with PEG (from Jazayeri et al., (2013)) 
 
The advent of nanotechnology has prompted the characterization of many NMs and the 
development of new nanotechnology-based products, but nanoscale silver is not a new finding 
and it has been known and used over the last 100 years (Nowack et al., 2011).  
Currently, AgNPs are explored in a wide range of applications, from medicine and industry to 
the most common consumer products. As mentioned before this nanomaterial exhibits a broad 
spectrum of antibacterial activity, against both Gram-negative and Gram-positive bacteria 
(Panacek et al., 2006). Furthermore, AgNPs are reported to exert an efficient bactericidal 
activity on drug-resistant strains (Prakash et al., 2013) and to enhance the activity of several 
antibiotics (Shahverdi et al., 2007). Although the mechanisms of action of AgNPs against fungi 
are not so clear, its antifungal activity has been confirmed in various genera (Kim et al., 2009a; 
Qian et al., 2013; Xu et al., 2013). Similarly, it was suggested that AgNPs should be considered 
as a potential antiviral agent (Galdiero et al., 2011), as studies have demonstrated AgNPs 
activity against HIV-1 (Elechiguerra et al., 2005), Monkeypox virus (Rogers et al., 2008), and 
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herpes simplex virus (Baram-Pinto et al., 2009), among others. The ability to destroy an 
extensive variety of microorganisms gave rise to the widespread use of nanosilver in 
disinfectant products for virtually all situations, such as groundwater (Mpenyana-Monyatsi et 
al., 2012), wastewater treatment (Sheng and Liu, 2011) and air filters improvement 
(Miaśkiewicz-Peska and Łebkowska, 2011). AgNPs are vastly used in medical applications that 
include antibacterial coatings, diagnosis, cancer therapy and/or drug delivery. To reduce 
nosocomial infections, AgNPs has been incorporated in antibacterial coatings on medical 
devices and tools and it can be found in catheters (Bayston et al., 2007), face masks (Li et al., 
2006), wound dressings (Li et al., 2013a) and gel formulations for topical use (Jain et al., 2009). 
Materials used in orthopedics including bone cements (Alt et al., 2004), dentistry (García-
Contreras et al., 2011) and ophthalmic (Weisbarth et al., 2007) can contain nanosilver, as well.  
Moreover, nanosilver is a potential candidate for cancer treatment. Gurunathan and colleagues 
(2009) have reported that AgNPs (40 nm) inhibited in vitro cell proliferation and migration in 
vascular endothelial growth factor (VEGF)-induced angiogenesis in bovine retinal epithelial 
cells (BREC) and formation of new blood vessels, demonstrating its anti-angiogenic effects. 
Furthermore, the surface size of AgNPs was found to enhance the thermal sensitivity of glioma 
cells (Liu et al., 2011a). The possibility of using AgNPs to achieve scar-less wound healing has 
been also suggested, as several studies highlight the anti-inflammatory properties of these NPs 
(Bhol and Schechter, 2005; Nadworny et al., 2010).  
The unique physico-chemical properties of AgNPs confer them great interest for scientific 
applications. Upon irradiation with light, metallic NPs exhibit surface plasmon resonance (SPR) 
– electron charge density waves proportional to their mass -  and, as result, SPR peaks in the 
UV-Vis wavelength range are produced. The characteristics of the SPR peaks depend on various 
properties of NMs (Ju-Nam and Lead, 2008). Such features make AgNMs valuable tools for 
enhanced infrared (IR) absorption spectroscopy (Huo et al., 2006), colorimetric sensors (Dubas 
and Pimpan, 2008; Xiong et al., 2008), among others. The association of nanosilver and surface 
enhanced Raman scattering (SERS) shows potential in genetic analysis, biomedical diagnostics, 
and cellular imaging (Vo-Dinh et al., 2010). Another characteristic of metallic nanoparticles, 
including AgNPs, is the alteration of the intrinsic spectral properties of fluorophores, which 
enables its use for metal enhanced fluorescence applications (Yang et al., 2013). 
The industrial sector has profited with the advances in nanotechnology, too. Silver 
nanocomposites have been used to catalyse many reactions in industrial processes (Yan et al., 
2006). The high electrical conductivity associated with other properties of nanosilver makes this 
a versatile material to explore in electronics (Roldán et al., 2007).  
According to the “living” inventory of nanotechnology-based consumer products compiled by 
the Project on Emerging Nanotechnologies (http://www.nanotechproject.org/cpi), from the 
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estimated 1,814 “nano” products that were introduced in the market (revised inventory released 
in October 2013), 24% are nanosilver-containing products. A wide range of AgNPs applications 
has emerged in consumer products ranging from household products and electronics to personal 
care products, including sanitation products (air sanitizer sprays, water filters, swimming pool 
disinfectants), paints, household appliances (refrigerators, vacuum cleaners, washing machines), 
consumer electronics (cellular phones, hair straighteners), detergents and fabric softeners, 
surface cleaners, food supplements, and food contact materials (food storage containers, food 
packaging materials, water taps, tableware) (EPA, 2010). This AgNPs property has also been 
explored in textiles, with the production of fabrics (cotton, wool, etc.) that contain AgNPs. 
These fabrics are widely used in socks to destroy bacteria associated with foot odour (Benn and 
Westerhoff, 2008), but can also be found in clothing and textiles as shoe insoles, sportswear, 
underwear, towels, sheets, pillows, and mattress covers. Other examples of consumer products 
that contain nanosilver include toys, baby carriages, pacifiers, watch chains, cosmetics and 
personal care products (lotions, soap, shampoo, toothpaste, toothbrush, mouthwash, female-
hygiene products, sunscreen), and even spermicidal foam (EPA, 2010). 
As the applications of NPs (in particular of AgNPs) and consequent release into the 
environment have exponentially increased in the last years, their putative risks associated to 
human exposure have also raised up. It is therefore urgent to know whether the presence of 
nanosilver in these products is essential or not, as well as to fully investigate all the aspects 
concerning the impact on human health and environment prior an extensive use (Nowack and 
Bucheli, 2007). 
 
 
1.2.Fate, distribution and bioaccumulation of AgNPs 
 
Once metal NPs are released into the environment, it is almost impossible to predict their fate 
and distribution in soil and water ecosystems, since they can change according to local 
environmental conditions depending on multiple variables (El Badawy et al., 2010; Simonet and 
Valcárcel, 2009). The fate and distribution of metal NPs also depend on their transport ability 
through the ecosystem. This is conditioned by the physico-chemical properties of these metal 
NPs that may change as result of their interaction with medium and by their retention in smaller 
pore spaces (Lecoanet and Wiesner, 2004; McDowell-Boyer et al., 1986; Sagee et al., 2012; 
Sirivithayapakorn and Keller, 2003). Regarding AgNPs, its bioavailability is influenced by their 
interaction with soil components and transportation through soil and also by the activity of soil 
organisms (Liang et al., 2013). Sagee, Dror et al., (2012) demonstrated that AgNP transport is 
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sensitive to the NP surface, porous material and also to the chemical composition of the 
solution. Soils with small aggregates present a large surface area, thus decreasing the transport 
of AgNPs as there is a higher surface available for AgNP interaction. Other studies showed that 
the transport, aging and transformation of AgNPs depend on the presence of organic matter 
(OM) such as surfactants or humic acids. OM tends to enhance the mobility of AgNPs, while 
higher ionic strength and divalent cations promote aggregation and retention (Benn and 
Westerhoff, 2008; Cornelis et al., 2013; Coutris et al., 2012; Geranio et al., 2009; Levard et al., 
2012; Lin et al., 2012; Nowack and Bucheli, 2007; Tourinho et al., 2012). Regarding soil 
organisms, Shoults-Wilson et al (2011a) studied AgNPs effects on earthworms demonstrating 
significant decrease in Eisenia fetida reproduction. Other study determined the role of particle 
size and soil type on the toxicity of AgNPs to the earthworm Eisenia fetida, suggesting that soil 
type is a more important determinant of Ag accumulation from AgNPs than particle size 
(Shoults-Wilson et al., 2011b). Also Coleman and collaborators (Coleman, Kennedy et al 2013) 
used the sediment-dwelling invertebrate, Lumbriculus variegatus to assess the impact, 
bioaccumulation, tissue distribution, uptake, and depuration of AgNPs on ecosystem. 
In respect to plants, Stampoulis et al (2009) studied the effects of AgNPs on Cucurbita pepo 
(zucchini). The researchers, during a 15-day hydroponic trial growing the plants in hydroponic 
solutions amended with 1000mg/L of AgNPs, demonstrate a reduction by 75% of plants 
biomass. These studies on earthworms and plants help to elucidate the possible fate and 
bioavailability of these particles, but more information on higher-level organisms and possible 
bioaccumulation is also needed (Remédios et al., 2012). 
AgNPs in the soil appear to end up in ground and surface water and watercourses. Water natural 
colloids interact with AgNPs affecting their behavior, bioavailability and toxicity. Previous 
studies on the environmental and physiological implications of Ag ions and AgNPs exposure in 
seawater and freshwater organisms support the need for further assessment studies and support 
the increasing concern on the impacts of AgNPs on ecosystems (Fabrega et al., 2011; Matranga 
and Corsi, 2012; Joo et al., 2013; Zuykov et al., 2011).  
NPs interaction with natural colloids present on aquatic system, will be dependent on their 
surface coating. Studies on coated AgNPs showed that usually they present more threat to water 
column organisms, opposite to uncoated AgNPs that present higher toxicity to sediment and 
filter organisms (Navarro et al., 2008). NPs coating disfavor their medium removal, but prevents 
NPs aggregation, increasing their bioavailability, mobility and their contact with organisms. In 
contrast, uncoated NPs tend to aggregate and to be removed from water columns by 
sedimentation, which make sediment organisms more exposed, specially via ingestion and 
filtration (Fabrega et al., 2009; Fabrega et al., 2011; Navarro et al., 2008; Ward and Kach, 
2009). In water systems the most threatening toxicity may be provided by AgNP itself and not 
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from the Ag
+
 ion dissolution, since in oxidative conditions it may take from 6 days to several 
months for complete dissolution of a 5 nm AgNP (Fabrega et al., 2011). Temperature, pH and 
salinity may also influence the aggregation behavior. For instance high concentrations of NaCl 
in seawater, decrease electrostatic colloidal stabilization due to charge screening, increasing the 
probability to sedimentation (Chinnapongse et al., 2011). It was demonstrated that uncoated 
AgNPs can be more bioaccessible than other particles and even, than AgNO3, since uncoated 
AgNPs can act as constant source of relatively stable and bioaccessible Ag, while AgNO3 is 
rapidly immobilized in soil (Coutris et al., 2012). However, in another study Bastos et al (2012) 
demonstrated that Ag and Ti uncoated NPs showed high heterogeneous effects on cells 
behavior, and suggested that uncoated NPs may present different agglomeration states which 
could have considerable impact on final effect on the cell.  
The degree of bioaccumulation is also an important aspect to consider when evaluating hazards 
and risks of AgNPs. It is determined by a balance between the rate of uptake of AgNPs and the 
rate of loss and dilution by growth; which varies with time exposure, concentration, nature of 
the environment, route of exposure and biology and ecology of the organism (Fabrega, Luoma, 
Tyler, Galloway, & Lead, 2011). 
 
 
1.3.Effects of AgNPs in tissue/organs 
 
There are three principal routes of xenobiotic entrance from environment into human body: 
percutaneous, respiratory and oral. After a compound enters the body penetrating the initial 
cellular barrier (such as skin, intestinal mucosa or the lining of the respiratory tract), it enters 
interstitial fluid, penetrates the capillaries and enters the bloodstream, which distributes it 
throughout the body (Zakrzewski, 2002). For NPs, several uptake and translocation pathways 
have already been deciphered while other routes remain hypothetical (Fig 1.7., see Oberdörster 
et al., (2005) for review). According to these authors, investigation mostly focuses routes 
involving translocation, accumulation and retention in critical target sites. However, potential 
toxicity and its relation with NPs physicochemical characteristics remains little explored.  
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Figure 1.7: Biokinetics of Nano-sized Particles. While many uptake and translocation routes have been 
demonstrated, others still are hypothetical and need to be investigated (From Oberdorster et al (2005)). 
 
AgNPs may enter in human and animal bodies by several routes of exposure, such as, ingestion, 
inhalation, dermal contact, or by injection. The main target organs are the skin, lungs, liver, 
spleen, brain, kidneys, adrenals and testes. AgNPs could also pass through blood vessels walls 
and lymphatic system which allows them to be transported all over the body (Kruszewski et al., 
2011). Loeschner and coworkers (2011) studied an oral exposure of AgNPs to rats, during 28 
days, and found that the largest silver concentrations were detected in intestinal system, liver 
and kidneys, although was also found in lungs and brain. 
 
 
Skin 
 
The skin forms a protective barrier, separating the body from the environment. 
However, three routes of percutaneous absorption are possible: diffusion 
through the epidermis into the dermis, entry through the sweat adducts and 
entry along the hair-follicle orifices. Due to their large surface area, it is believed that absorption 
through the epidermal cells is the major route of entry of toxins. The main obstacle to 
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percutaneous penetration of water and xenobiotics is the stratum corneum (outermost 
membrane). The entry of substances through the stratum corneum occurs by passive diffusion 
across several cell layers, depending on the chemical properties of the xenobiotic. Polar 
substances are believed to penetrate cell membranes trough the protein filaments, while 
nonpolar substances enter through the lipid matrix. In general, gases penetrate skin more readily 
than liquids and solutes, while solids do not penetrate much, but they may be dissolved into the 
skin’s secretions and subsequently absorbed as solutes (Zakrzewski, 2002).  
Skin can be exposed to AgNPs present in the air and sprays, clothing and wound dressings. 
Dermal penetration by AgNPs is controversial, since some studies show that NPs are able to 
penetrate the stratum corneum (strongly keratinized – 10µm) (Borm et al., 2006; Monteiro-
Riviere et al., 2005), while others show that NPs enter the skin through hair follicles, sweat 
glands, broken and flexed skin (Buzea et al., 2007; Oberdörster et al., 2005; Teow et al., 2011; 
Tinkle et al., 2003; Toll et al., 2004). Dermal application of AgNP-coated wound dressing in 
human burns patient showed reversible silver toxicity and transient discoloration of skin 
(argyria-like) (Trop et al., 2006; Vlachou et al., 2007). In the Trop et al., (2006) study, one week 
after treatments, high levels of silver were found in urine and plasma in a young patient. 
Additionally, inhalation and dermal absorption of AgNPs could lead to the uptake of these 
particles via nervous system (brain, spinal cord and nerves). Tang et al., (2009; 2010) showed 
blood brain barrier (BBB) destruction and neuronal degeneration in rats after AgNP exposure 
with subcutaneous injection. 
Ahlberg et al (2014) highlighted that PVP-coated AgNPs when topically applied mostly 
remained in the superficial horny layers of skin. However, in skin regions with eg, hair follicles, 
inflamed skin and wounds, contact to viable epidermis and cellular uptake inevitably occur 
leading to putative cytotoxic effects and free radical production by AgNPs per se and/or due to 
secondary Ag
+
 ion release (Fig 1.8). 
 
 
 
 
 
 
 
 
 
 
Chapter 1 
 
 
 
38 
 
 
 
 
 
 
 
 
 
Figure 1.8: Proposed mechanism of cytotoxic effects and free radical production by AgNPs per se versus 
the effects due to secondary Ag
+
 ion release (from Ahlberg et al 2014). 
 
 
Respiratory system 
 
Respiratory system consists of: nasopharyngeal, tracheobronchial and pulmonary. 
Nasopharyngeal remove large inhaled particles and increase humidity and 
temperature of inhaled air. Tracheobronchial region propels foreign particles from 
the deep parts of the lungs to the oral cavity, where they can be expelled or swallowed. 
Pulmonary region consists of bronchioles, alveolar ducts and clusters of alveoli. Inhaled 
xenobiotics can exert their harmful action either by damaging respiratory tissue or by entering 
the circulation through diffusion across the alveolar membranes. The size of particles influences 
the absorption rate through the alveolar epithelium: particles between 1 to 5 µm sediment within 
the bronchiolar region of lung; and those less than 1 µm can diffuse within the alveoli. Smaller 
sized particles are absorbed in the circulation causing systemic toxicity (Zakrzewski, 2002).  
The lungs have a large surface area and are the primary entry for inhaled AgNPs and other 
nanoparticles. After their entrance, they could deposit into the entire respiratory tract, first at the 
nose then the pharynx, and finally at the lungs (Buzea et al., 2007; Teow et al., 2011). Particle 
size and shape will influence the particle deposition and distribution. Smaller particles (< 10 
nm), may reach gas exchange surfaces but reliable prediction it is not possible. Larger particles 
(<100nm) seem to deposit further in the respiratory tract, before transportation into the deep 
lungs (Wijnhoven and Peijnenburg, 2009). The adverse effect of the inhaled particles depends 
on the residence time and on the lung burden (rate of particle deposition and clearance by 
macrophages). Takenaka et al., (2001) observed AgNPs in lung and blood immediately after 
mice exposure of 10 nm AgNP by inhalation, indicating absorption through systemic 
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circulation. In Ji, Jung et al. (2007) study, after rat inhalation of AgNPs of different sizes, these 
nanoparticles were found in liver, kidney and brain, despite no alterations in body weight nor 
hematological changes were detected. 
 
 
Gastrointestinal Tract 
 
The absorption of compounds taken orally begins in the mouth and esophagus. 
Most of the ingested compounds move to the stomach, where other parameters 
influence the rate of absorption, such as the degree of ionization of an ionizable 
compound upon the acid pH present there. When an acid encounters an acidic environment, 
readily diffuse out of the stomach through the lipid bilayer of the cell membrane. However, 
when these compound encounter the blood (pH 7.4), the degree of ionization increases, and in 
ionized form, very little will diffuse back across the membrane. Thus, the rate at which a 
xenobiotic is absorbed by the stomach is affected by the pH. Xenobiotic not absorbed from the 
stomach lumen, passes into the intestine where secretions raises the pH (Roberts et al., 2014). 
Thus, a percentage of xenobiotics absorbed in the gastrointestinal cells may be biotransformed 
before entering the circulatory system. Absorbed compounds may enter circulation either via the 
lymphatic system, which eventually drains into the bloodstream, or via the portal circulation, 
which carries them to the liver (Zakrzewski, 2002).  
Concerning the gastro-intestinal (GI) tract, many food supplements/products and drugs 
containing AgNPs are available in the market. In addition, inhaled particles cleared by 
mucociliary escalator can be ingested into the GI tract (Buzea et al., 2007; Teow et al., 2011). 
Size, surface charge or coating and attachments to ligands are some of the characteristics that 
control the site-specific target of different regions of the GI tract (Hillyer and Albrecht, 2001). 
Once in the GI, AgNPs could undergo chemical changes (e.g. pH) which may trigger 
agglomeration. Agglomeration may lead to fast transit, followed by excretion through feces and 
urine, however the bigger agglomerates may obstruct GI tract, which could lead to death (Buzea 
et al., 2007; Teow et al., 2011). Mwilu et al., (2013) showed changes in stomach fluid of human 
exposed to synthetic silver nanoparticles. Also in their review Buzea et al., (2007) identified 
some diseases such as Crohn´s disease and colon cancer as putatively related with NPs toxicity 
in the gastrointestinal system. 
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Blood 
 
Once the first barrier is passed (skin, lung epithelia or intestinal lining) 
nanoparticles may then enter the systemic circulation. Indeed, in Pang et al 
(2015) study, PEG-AgNPs showed a long blood circulation in mice. As 
reaching the blood, AgNPs could affect blood cells. Chen and coworkers 
(2015) found that AgNPs induced oxidative stress, membrane injury and subsequently 
hemolysis in red blood cells, in a dose dependent manner. Otherwise, AgNPs could increase 
neutrophil cell size, interact with the cell membrane, penetrate neutrophils, localize in vacuole-
like structures, and be randomly distributed in the cytosol after 24 h of exposure. In addition 
treatment with 100 µg/ml of AgNPs for 24 h increased the neutrophil apoptotic rate (Poirier et 
al., 2014). Other study, using human monocytic cell line THP-1, obtained an apoptosis and 
necrosis induction after AgNPs exposure, depending on dose and exposure time (Foldbjerg et 
al., 2009b). Orlowski et al (2013) obtained dose-dependent toxicity and a decreased 
proliferation of RAW 264.7 monocyte cells after 24h exposure to AgNPs. 
After reaching the systemic circulation, distribution through the entire body followed by uptake 
by the organs could be expected. 
 
Liver 
 
 Together with the systemic circulation that translocate NPs to the whole body, 
the liver also plays a crucial role as it is able to remove compounds from the 
blood and transform them into chemicals easier excreted. The liver is, 
quantitatively, the most important organ for xenobiotic metabolism especially because of its 
high expression levels of many xenobiotic-metabolizing enzymes (Williams et al., 2015). 
Biotransformation of a xenobiotic (generating a more water-soluble product) can decrease the 
body burden, time of exposure and consequent toxic manifestations, although similar enzymes 
can bioactivate some of them to reactive intermediates that bind with the cellular 
macromolecules inducing cytotoxicity and/or carcinogenicity (Rana and Taketa, 1997). 
Biotransformation reactions can be classified in Phase I and Phase II. Phase I involves 
oxidative, reductive, and/or hydrolytic react reactions, which cleaves substract molecules to 
produce a more polar ones. The reaction products generated at Phase I could produce toxic 
manifestations before entering Phase II reactions. Phase II involve conjugation or addition of 
endogenous molecules to the Phase I transformed xenobiotic to make them more polar and 
highly water soluble (Rana and Taketa, 1997). Among the most important xenobiotic 
metabolizing enzymes are cytochrome P450s and Flavin monooxygenases (FMOs), 
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carboxylesterases, and glucoronosyltransferases (Williams et al., 2015). 
Many studies showed deposition of AgNP in liver, kidneys, blood, brain and tests after whether 
oral, inhaled or intravenous exposure (Cha et al., 2008; Ebabe Elle et al., 2013; Ji et al., 2007; 
Kim et al., 2011a; Kim et al., 2008; Park et al., 2011c; Takenaka et al., 2001). Moreover, more 
research is required in order to determine the effects of long-term deposition of AgNPs in 
various organs.  
 
 
1.4.In vitro assays and cell lines 
 
As the exposure route to AgNPs may occur through the dermatologic, inhalation or ingestion 
pathway (reaching blood stream), as such the use of medical devices (Oberdörster et al., 2005), 
it is crucial to study the toxicity of AgNPs in cells/tissues with those pathways.  
In vitro methods are increasingly replacing in vivo assays in assessing the toxicity of 
environmental and occupational health risks (eg, Dechsakulthorn et al., 2007). These in vitro 
methods have shown a significant robustness and fiability, while easier and ethically more 
adequate. As stated by Cho et al., (2013) “The rapidly increasing number and functionalizations 
of NPs makes in vivo toxicity tests undesirable on both ethical and financial grounds, creating 
an urgent need for development of in vitro cell-based assays that accurately predict in vivo 
toxicity and facilitate safe nanotechnology”. Thus, and knowing that liver is the primary site for 
NPs accumulation (Sonavane et al., 2008), our study intends to determine the cytotoxic 
potential of AgNPs on a skin cell line (HaCaT), a liver cell line (HepG2) and a macrophage cell 
line (RAW 264.7). 
 
 
Human Keratinocyte cell line – HaCaT 
 
The human skin keratinocyte HaCaT cell line (Fig. 1.9) was obtained from a histologically 
normal male skin specimen, from distant periphery of a melanoma (second excision). The cells 
were plated in low Ca
2+
 medium since makes it favorable to long-term growth in primary 
culture probably due to a marked reduction in terminal differentiation; and were propagated 
with elevation of culture temperature (38,5ºC) as this increase proliferative activity and prolong 
the average life span. Thus, “The resulting cell line was designated HaCaT to denote its origin 
from human adult skin keratinocytes propagated under low Ca
2+
 conditions and elevated 
temperature.” (Boukamp et al., 1988b).  
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The spontaneously immortalized HaCaT cell line is closely approximated to normal 
keratinocytes, and can be considered immortal (>140 passages), highly differentiated and not 
tumorigenic. HaCaT cells, even after multiple passages have remarkable capacity for normal 
differentiation offering a suitable model to study regulatory mechanisms in the process of 
differentiation of human epidermal cells. Despite the alterations related to long-term 
propagation as in vitro growth parameters, differentiation and karyotypic constitution; HaCaT 
chromosomal content is largely maintained sustaining their nontumorigenic phenotype 
(Boukamp et al., 1997). 
 
 
 
 
 
 
 
 
 
Figure 1.9: Light microscopy image of HaCaT cells: a) 100x; b) 400x. Bar corresponds to 100 μm. 
 
 
HaCaT cell line has been widely used in in vitro studies: to define the protective effects against 
UVB of non-calcemic secosteroids on human keratinocytes (Slominski et al., 2015); providing 
evidence for the human relevance of gene signature, where molecular processes of these genes 
are similar between the HaCaT cell line and freshly isolated skin (Veen et al., 2015); on tests of  
topical corticosteroids on cell proliferation, cell cycle progression and apoptosis (Alexandre et 
al., 2015); studying the cytotoxicity potential of bismuth oxychloride nanosheets (Gao et al., 
2015), among others. 
HaCaT cells have also been used in AgNPs cytotoxic studies. Ahlberg and co-workers (2014a) 
compared the cytotoxicity of AgNPs after different storage conditions; 70nm AgNPs stored in 
argon induced a much smaller intracellular ROS production than AgNPs stored in air, 
suggesting the possibility of reduction of AgNPs toxic effects by storing them under an inert gas 
atmosphere.  
Comfort and colleagues (2014a), evaluated the impact, mechanism of action and continual 
effects of 50 nm AgNPs on epidermal growth factor (EGF) signal transduction on HaCaT cells, 
and found that EGF signaling was initially obstructed due to the dissolution of particles into 
silver ions and at longer durations, the internalized AgNPs increased EGF signaling activity 
a 
b 
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correlating to sustained HaCaT stress. The researchers hypothesized that retained nanomaterials 
are capable of acting as a slow-release mechanism for metallic ions, continually stressing and 
modifying normal cellular functionality. Braroo and co-workers (2014), synthesized colloidal 
AgNPs from leaf extracts of medicinal herb Ocimum sanctum (Tulsi) which also showed in 
vitro cytotoxic effect on human keratinocyte (HaCaT) cell line.  
However there are studies reporting advantages of the AgNPs on HaCaT cells. Arora and 
coworkers (2015), suggested a potential utility of AgNPs as chemopreventive agents against 
UVB-induced DNA damage and apoptosis in immortalized human epidermal keratinocytes 
(HaCaT). In David and colleagues (2014) study, AgNPs biosynthesized fast and eco-friendly 
using European black elderberry (Sambucus nigra – SN, Adoxaceae family) fruit extracts, 
showed anti-inflammatory properties on HaCaT cells exposed to UVB radiation by the decrease 
of cytokines production. Taken together all these data support the need to evaluate altogether 
the putative positive vs negative effects of AgNPs on cells metabolic pathways, and ultimately 
on animals and human health. 
 
 
Human hepatocellular carcinoma cell line - HepG2 
 
Human hepatoma cell line, HepG2 (Fig. 1.10), was primarily isolated by Aden et al (1980) from 
primary hepatoblastoma of a 15-year-old Argentine boy. Hepatoblastoma (HB) is an embryonal 
malignancy of hepatocellular origin and the most common type of liver primary malignant 
tumors of childhood, although accounting 1% of all childhood cancer (Finegold, 2004). 
HepG2 cells have an epithelial like morphology, synthesizing and secreting many of the plasma 
proteins characteristic of normal human liver cells (Faedmaleki et al., 2014; Knowles et al., 
1980). Additionally, HepG2 cells express wide range of phase I and phase II drug metabolizing 
enzymes (Knasmüller et al., 1998). Therefore, liver cell lines are commonly used in biomedical 
research involving xenobiotic metabolism. 
HepG2 cells have been used in liver disease studies (Cederbaum et al., 2001), mechanism of 
action of drugs (Kim et al., 2003), gene expression and transcription (Carruba et al., 1999; Iyoda 
et al., 2003), genotoxicity studies (Knasmüller et al., 1998). 
There are already some studies determining the potential cytotoxicity of AgNPs on HepG2 cell 
line. Faedmaleki and co-workers (2014), reported that AgNPs had cytotoxic effects on HepG2 
cell line, decreasing cell viability, IC50 value of 2.764 µg/mL. Xin and colleagues (2015), 
studied the potential cytotoxic of AgNPs on HepG2 cells and found dose-dependent cytotoxicity 
(significantly decreasing viability from 25 to 200 µg/mL) resulted from an interaction of 
oxidative stress, DNA damage and mitochondrial injury. Ávalos and co-workers (2015), 
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assessed the genotoxic potential of AgNPs in cell lines and observed DNA damage in HepG2 in 
a dose- and size-dependent manner following 24h treatment, which damage could be related to 
oxidative stress. 
 
 
Figure 1.10: Light microscopy image of HepG2 cells: a) 100x; b) 400x. Bar corresponds to 100 μm. 
 
 
Murine macrophage-like cell line – RAW 264.7 
 
RAW 264.7 cells (Fig. 1.11) are adherent macrophage-like cells derived from a tumor, 
inoculated with Abelson murine leukemia virus (MuLV) (Raschke et al., 1978). These cells are 
immortalized, relatively stable and mature and have been used for models of macrophage 
activation in numerous studies (Bailey et al., 2005; Bailey et al., 2004; Naureckiene et al., 2007; 
Wu et al., 2006).  
Furthermore, there are many studies using murine cell as putative analogs to human 
macrophages (Gutting et al., 2005; Naureckiene et al., 2007; Vigo et al., 2005).  
Macrophage is a highly differentiated phagocyte and a part of the innate protective immune 
response, which an exposure to a xenobiotic could trigger a chain reaction of inflammatory 
responses (Giovanni et al., 2015). Thus, on Giovanni and co-workers study (2015), 
concentrations of AgNPs (considered non-cytotoxic) could induce mild pro-inflammatory 
responses by RAW 246.7 starting from 10
-7
 µg/mL (lower that the levels found in the 
environment and in consumer products), while a reduction on macrophages viability was only 
observed for the highest concentration tested, 10 µg/mL. Also, Munusamy and colleagues 
(2015) observed cytotoxicity effects on RAW 264.7 cells following 24h exposure of AgNPs at 
50 µg/ml. 
 
 
 
 
b 
a 
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Figure 1.11: Light microscopy image of RAW 246.7 cells: a) 100x; b) 400x. Bar corresponds to 100 μm. 
 
 
1.5.Cellular uptake of AgNPs 
 
An important issue related to AgNPs toxicity is their capacity to enter cells, since they are able 
to cross cell membranes and reach organelles. The effects of AgNPs in cells are highly 
dependent on the effective amount of NP internalized and their location. The uptake and 
intracellular trafficking of AgNPs is mostly determined by NP physico-chemical properties, 
concentration, exposure period and specific transport mechanisms. The main physico-chemical 
properties of AgNPs affecting NP cellular uptake include NP surface charge and chemistry, 
shape, size and aggregation state. 
In in vitro studies, AgNP uptake and transport has been analyzed in systems that rely on 
exposure to uncoated AgNPs (Yen et al., 2009a) or NPs stabilized by coating (exemplified 
before). Furthermore, cell exposure to AgNPs in vitro represents a very complex system, since 
the culture media have high protein content, ligands and chelators for Ag
+
 in the solution. 
Indeed, the chemical composition of cell culture media is a complex mixture (consisting of 
inorganic salts, carbohydrates, amino acids, various supplements (i.e. vitamins, fatty acids, 
lipids) and fetal bovine serum (FBS), which may result in transformations of AgNPs and, 
consequently, the complexation of Ag
+
 (Behra et al., 2013). Thus, the conjugation of charged 
AgNPs with different types of ligand molecules available in the extracellular milieu can coat 
NPs with proteins and other biomolecules (protein corona), resulting in different outcomes for 
cellular uptake rates and transport routes (Fig. 1.12). 
In Human Embryonic Kidney, HEK cells, incubation of citrate- or silica-coated AgNPs pre-
treated with albumin or IgG showed different uptake rates as measured by ICP-OES 
quantification of Ag, as well as different dispersion degree in the cell, observed by TEM 
(Monteiro-Riviere et al., 2013). Such differences according to charge and protein coating may 
b 
a 
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be explained by different interactions between the surface coating and surrounding proteins, e.g. 
as observed in studies by Treuel and colleagues (Treuel et al., 2010). The shape of NPs may 
also influence their internalization, although the effect has not been dissected yet. In a study by 
Zhang and coworkers (Zhang et al., 2012) polystyrene nanospheres were readily taken up by 
Human epithelioid cervix carcinoma, HeLa cells, whereas nanodisks of approximately identical 
diameter were not internalized. However, in another study, when keratinocytes were exposed to 
30 nm PVP- coated silver nanomaterials in the form of nanospheres or nanoprisms, the uptake 
rates were found similar as determined by high-resolution ICP-OES and ICP-MS (Lu et al., 
2010a). Moreover, both Ag nanospheres and nanoprisms reached the cell nucleus as assessed by 
TEM. 
Cellular uptake may also be affected by NP size. In murine adrenal medullary chromaffin cells, 
cellular uptake of citrate-coated AgNPs as determined by ICP-OES showed that exposure to 
smallest NPs resulted in the highest number of internalized NPs (Love et al., 2012). Direct 
penetration of AgNP has also been reported in THP-1 monocytic leukemia cells exposed to 20 
nm citrate-coated AgNPs, as observed by TEM (Haase et al., 2011). 
Multiple internalization mechanisms have been proposed to mediate AgNP cellular uptake. 
Various complementing techniques can be used to characterize the mechanisms of AgNP 
internalization and intracellular transport, e.g. incubation with transport inhibitors followed by 
ICP-OES, plasmon coupling microscopy, Laser-SNMS/TOF-SIMS, confocal Raman 
microscopy or surface-enhanced Raman scattering (SERS) spectroscopy. Apart from direct 
penetration (passive uptake), AgNPs can be internalized by active uptake (endocytosis): 
macropinocytosis, pinocytosis, phagocytosis clathrin-dependent endocytosis, and clathrin-
independent endocytosis, which includes caveolae/lipid raft-mediated endocytosis (Fig. 1.12). 
In macropinocytosis, actin-dependent membrane protrusions also called ruffles are developed, 
which upon fusion with each other or with the cell membrane engulf large suspended particles, 
typically up to 1 μm or in the specific case of phagocytosis up to 5 μm. Past studies suggest that 
in some systems, macropinocytosis is the dominant mechanism of AgNP internalization. Unlike 
other endocytic processes, macropinocytosis is largely inhibited by the presence of inhibitors of 
Na
+
/H
+
 exchange, such as amiloride. Luther et al. reported in astrocytes exposed to PVP-coated 
AgNPs a 30% uptake decrease after incubation with amiloride (Luther et al., 2011). In human 
mesenchymal stem cells, Greulich and coworkers observed that internalization of PVP-coated 
AgNPs was significantly inhibited by wortmannin, an inhibitor of phosphoinositide 3-phosphate 
kinases (Greulich et al., 2011b). Moreover, in different cell lines exposed to citrate-coated 
AgNPs, the two non-specific inhibitors of phagocytic/macropinocytic pathways sodium azide 
and staurosporine significantly reduced cellular uptake (Singh and Ramarao, 2012).  
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Figure 1.12: Nanoparticle uptake – in the extracellular fluid NPs are coated by proteins and other 
biomolecules determining how NPs interacts with cells; cellular internalization may involve active 
(receptor mediated) or passive transport across the membrane (adapted from Shang et al. (2014)). 
 
 
In addition to sensitivity to inhibitors of macropinocytosis, in some systems depending on the 
AgNP characteristics and cell line, large intracellular clusters of AgNPs have been observed 
(e.g. Haase et al., 2011; Wang et al., 2012). In macrophages, different types of AgNPs were 
shown to interact with the cell membrane by binding to scavenger receptors, as AgNP 
internalization was inhibited by incubation with polyinosinic acid (Wang et al., 2012) or dextran 
sulfate (Singh and Ramarao, 2012). 
Endocytosis mediated by clathrin-coated vesicles is the most well-studied endocytic pathway 
and shows preference for particles up to ca. 200 nm, whereas larger particles up to 500 nm are 
more often internalized by clathrin-independent mechanisms (Rejman et al., 2004). Inhibition of 
clathrin-dependent endocytosis is most commonly achieved by potassium depletion or 
incubation with chlorpromazine. In human glioblastoma U251 cells exposed to potato starch 
coated AgNPs, potassium depletion resulted in decreased AgNP uptake, confirming clathrin-
dependent endocytosis of the studied AgNPs (Asharani et al., 2009a). Moreover, in human 
mesenchymal stem cells exposed to PVP-coated AgNPs, a significant inhibition by 
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chlorpromazine was observed, also suggesting clathrin-dependent endocytosis (Greulich et al., 
2011b). 
Internalization of AgNPs by clathrin-independent endocytosis compared to macropinocytosis 
and clathrin-dependent endocytosis has so far been considered a marginal event in AgNP 
uptake, since it shows preference for the internalization of particles larger than 200 nn and up to 
500 nm (Asharani et al., 2009a; Greulich et al., 2011b; Haase et al., 2012b; Wang et al., 2012). 
Cellular uptake via clathrin-independent endocytosis is commonly investigated by use of 
polyene antibiotics such as nystatin and filipin, or the use of methyl-β-cyclodextrin, a less 
specific inhibitor of clathrin-independent endocytosis (Luther et al., 2011). 
Different routes of intracellular transport have been suggested for AgNPs, with the final 
location depending mainly on the properties of AgNPs, concentration, time and cell type. A 
cytoplasmic location has been observed either in the form of clusters, e.g. up to 800 μm, in J774 
A1 murine macrophages (Yen et al., 2009a). In RAW 264.7 macrophages, cytoplasmic location 
was confirmed by TEM, close to the cell periphery (Singh and Ramarao, 2012). AgNP clusters 
of variable sizes were also found in endolysosomal compartments (Asharani et al., 2009a; 
Greulich et al., 2011b; Haase et al., 2012b; Wang et al., 2012) and in the nucleus (Asharani et 
al., 2009a; Greulich et al., 2011a; Lu et al., 2010a). 
In parallel with active internalization, exocytosis of AgNPs was also shown to occur. Through 
CFMA (Carbon-fiber microelectrode amperometry), Love and Haynes (2010) demonstrated that 
citrate-coated AgNPs (~60 nm) perturbed exocytosis in murine adrenal medullary chromaffin 
cells. Moreover, exposure to potato starch-coated AgNPs in human glioblastoma cells (U251 
cells) showed that exocytosis rate increased with time but was slower than endocytosis, 
suggesting AgNP accumulation (Asharani et al., 2009). 
 
 
1.6.Cytotoxicity 
 
Once AgNPs enter the cell it is important to determine their putative cytotoxicity and 
genotoxicity. NPs could trigger the production of reactive oxygen species (ROS), leading to 
activation of cellular stress-dependent signaling pathways, direct damage of subcellular 
organelles such as mitochondria, and DNA fragmentation in the nucleus, resulting in cell cycle 
arrest, apoptosis, and inflammatory response (Fig. 1.13). 
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Figure 1.13: Cytotoxic and genotoxic potential effects of NPs (adapted from Shang et al. (2014)). 
 
 Most of the in vitro studies in the literature report decreases on cell viability upon exposure to 
AgNPs. For instance, Suliman and co-workers (2013a) found that AgNPs (nanopowder < 
100nm) at concentrations higher than 50 µg/ml for 24h, cell viability of human epithelial cells 
was significantly decreased. Also, Song and co-workers (2012) found a decrease in the viability 
of normal human liver cell line, HL-7702 cells, after exposure to α-Methoxy-poly (ethylene 
glycol)-ω-mercapto (mPEG-SH)-coated AgNPs of 40 nm at concentrations of 6.25 µg/ml for 
24h. The IC50 values were also found to depend on the cell line, the size of the NP and the type 
of coating. Park and co-workers (2011d) found that the viability of RAW 264.7 cells was 
significantly reduced by 20% after 24h exposure to 68.9 nm AgNPs dispersed in FBS at 1.6 
µg/ml. Foldbjerg et al., (2009a) found an EC50 value of 2.4 µg/ml for PVP-coated AgNPs (30-
50 nm) compared to 0.6 µg/ml for Ag
+
 in THP-1 cells estimated by the annexin V/PI assay. 
Also, in A549 lung adenocarcinoma cells, PVP-coated AgNPs induced a decrease in 
mitochondrial activity and cell viability (Foldbjerg et al., 2011). The degree of contribution of 
Ag ion to the toxicity of AgNPs has also been discussed in literature. Using human Chang liver 
cells, Piao et al., (2011a) found an IC50 of 4 µg/ml after 24h of exposure, while for the AgNO3 
the IC50 was 8 µg/ml. Lui and co-workers (2010) compared the cytotoxicity of PVP coated 
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AgNPs of 5, 20 and 50 nm and ionic silver in four human cell models (A549, SGC-7901, 
HepG2 and MCF-7) in a series of dilutions and found that the order of toxicity was AgNP 5 nm 
> Ag
+
 > AgNP 20 nm > AgNP 50 nm for all four cell lines, as detected by the MTT assay, while 
the LDH test revealed the following order of toxicity Ag
+ 
> AgNP 5nm > AgNP 20nm > AgNP 
50 nm. Kim, Choi et al (2009b) compared the toxicity of ionic Ag and AgNPs in human 
hepatoma cells and found that AgNPs treated cells have limited exposure to ionic Ag, despite 
the potential release of Ag ion from nanoparticles in the cell culture. For AgNPs these authors 
found an IC50 of 3.38 µg/ml, while for AgNO3 the IC50 was estimated to be 1.37 µg/ml of Ag. 
Oxidative stress is an important mechanism of cytotoxicity related to NPs exposure. Previous 
studies demonstrated that AgNPs could induce oxidative stress in different cell models. Kim 
and Ryu (2013) revised the oxidative stress related effects of AgNPs both in vitro and in vivo. 
However, in spite of a strong evidence of ROS induction, the mechanisms underlying AgNPs 
induced oxidative stress are still poorly understood. Evidences for increased ROS generation 
were shown for AgNP doses as low as 0.2 µg/ml for 1 h in HepG2 cells (Kim et al., 2009b). 
Studies from Piao et al., (2011a) in human Chang liver cells exposed to 4 µg/ml of AgNP 
showed increase in ROS levels after 0.5h of exposure and the levels were kept significantly high 
up to 12h. Foldbjerg et al., (2009a) found that both PVP-coated AgNPs and ionic silver 
increased the levels of ROS in the human monocytic cell line THP-1. Furthermore, in A549 
lung adenocarcinoma cell line the same effect was observed, but when cells were treated with 
N- acetylcysteine (NAC) the levels of ROS were reduced, suggesting antioxidant scavenging 
(Foldbjerg et al., 2011). Also, PVP stabilized AgNPs of 5, 20 and 50 nm increased the levels of 
ROS in HepG2 cells; for the smallest (5 nm) this effect was observed at levels of 1 µg/ml, 
which was the same as for Ag ion, while for the largest (20 and 50 nm) this effect was observed 
at doses of 10 µg/ml (Liu et al., 2010). In order to evaluate the contribution of ionic silver 
present in the nanoparticle suspension to the increase in ROS levels, Beer and co-workers 
(2012) compared the effect of both AgNP suspension and supernatant and found that AgNP 
supernatant induces between 2.6- and 6- fold more ROS than AgNP suspension, suggesting that 
ROS production is mainly due to the presence of silver ions (Beer et al., 2012). 
As the oxidative stress is originated by the imbalance between the generation of ROS and the 
antioxidative capacity of the cell, it is important to evaluate also the effect of AgNPs on the 
levels and activity of the ROS scavengers. For instance, Piao and co-workers (2011a) found that 
the increase in ROS levels for 4 µg/ml of AgNP in human Chang liver cells were accompanied 
by decrease in GSH levels after 0.5h and this profile was kept for the following 24h. A decrease 
in GSH levels and increase in SOD and catalase activities was also found by Sulliman and co-
workers (2013a) in A549 lung adenocarcinoma cells exposed to 25 µg/ml after 48h. Otherwise, 
the studies of Song and co-workers (2012) with mPEG-SH-coated AgNPs in HL-7702 cells 
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revealed a decrease in the activities of SOD and GPX. A decrease in both GSH and SOD levels 
was also detected in fibrosarcoma cells HT-1080 and human skin carcinoma cells A431 treated 
with 6.25 µg/ml AgNPs for 24h (Arora et al., 2008). Depletion in SOD activity was also 
observed in HepG2 cells exposed to PVP stabilized AgNps of 5 and 20 nm (Liu et al., 2010). 
However, in this study a size depend effect was observed for the levels of GSH, a decrease for 
the lowest sizes (5 nm) and an increase in the largest NP sizes (20 and 50 nm) (Liu et al., 2010). 
Kang and co-workers (2012) highlighted the protective role of nuclear factor-erythroid 2-related 
factor-2 (Nrf2) against AgNPs toxicity by demonstrating that in Nrf2 knockdown human renal 
epithelial cells, AgNPs reduced GSH levels and increased ROS contributing to the increase of 
DNA damage and cell cycle arrest.  
However, it has also been reported, in human liver and colon cells, that AgNPs could cause 
cytotoxicity without oxidative stress (Sahu et al., 2014). Furthermore, Chairuangkittia et al., 
(2013) described that the toxicity of AgNPs to A549 lung adenocarcinoma was due both to ROS 
dependent and independent pathways, the latter related with cell cycle arrest.  
The level of lipid peroxidation is an important indicator of oxidative stress in the cell. Several 
studies show that AgNP induced lipid peroxidation in several cells types, as for instance, studies 
from Sulliman and co-workers (2013a) in A549 lung adenocarcinoma cells and in HL-7702 
liver cells exposed to mPEG-SH-coated AgNps (Song et al., 2012), in human skin carcinoma 
and ﬁbrosarcoma cells (Arora et al., 2008), as well as in Chang liver cells (Piao et al., 2011a). 
 
 
1.7.Genotoxicity (clastogenicity, DNA breaks and gene expression) 
 
AgNPs have induced genotoxicity in several cell models. For instance, Piao et al., (2011a), 
working with human Chang liver cells exposed to AgNPs found an increase in DNA damage, 
detected by the comet assay. DNA damage detected by ɣ-H2AX phosphorilation was observed 
in HepG2 cells exposed to AgNPs (Kim et al., 2009b). In another study, Kruszewski et al., 
(2013) compared the potential of AgNPs of 20 nm and 200 nm to induce DNA damage in 
HepG2, HT29 colorectal adenocarcinoma and A549 lung adenocarcinoma cells and found that 
in A549 cell line a shorter exposure (2h) induced the same level of DNA damage as more 
prolonged exposure (24h), while in HepG2 cells a shorter exposure showed high levels of DNA 
damage. These different profiles of response may indicate either an effective repair of the 
damage or the induction of an antioxidant defense (Kruszewski et al., 2013). In human 
mesenchymal stem cells (hMSCs) AgNPs at 0.1 µg/ml induced DNA damage after 1h assessed 
by the comet assay and chromosomal aberration test (Hackenberg et al., 2011). The formation 
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of micronuclei was also detected upon exposure to AgNps in HepG2 cells at relatively low 
AgNP doses (<1.0 µg/ml) (Kawata et al., 2009) and also in IMR-90 lung fibroblasts and U251 
glioblastoma cells exposed to starch coated AgNPs (AshaRani et al., 2009b). 
Regarding the role of AgNPs in apoptosis induction, literature still remains conflicting. 
AshaRani and co-workers (2009b) showed only a small increase in the percentage of IMR-90 
fibroblast cells undergoing apoptosis or necrosis after starch coated AgNP exposure, in spite of 
a significant increase in DNA damage detected by the comet assay. In Jurkat leukaemic T cells, 
was observed an increase in the apoptotic and necrotic cell populations after exposure to both 
AgNPs and Ag ions, but more intensely in NP exposed cells. In this cell model AgNPs induced 
cell death in the following order:  late apoptosis > necrosis > early apoptosis (Eom and Choi, 
2010a). An increase in apoptosis was also observed in 5 and 20 nm AgNPs after 24h in HepG2 
cells (Liu et al., 2010). 
AgNP exposure also affects cell cycle dynamics. For instance, a G2 arrest in U251 glioblastoma 
and IMR-90 lung cell lines was found for AgNP concentrations higher than 25 µg/ml (AshaRani 
et al. 2009). By other hand, a decrease in relative amounts of cells in G1 and increase in those in 
S phase was found in HepG2 cells (Liu et al., 2010) and in A549 lung adenocarcinoma cells 
(Beer et al., 2012). In mPEG-SH-coated AgNPs exposed HL-7702 liver cells, Song and co-
workers (2012) found a decrease in the percentage of cells in G0/G1 together with an increase in 
percentage of cells in G2. In HepG2 cells, DNA microarray analysis showed signiﬁcant 
induction of genes associated with cell cycle progression (Kawata et al., 2009).  
The presence or persistence of AgNPs has also been reported to induce inflammatory response. 
Studies reporting the effects of AgNPs on inflammatory response are summarized in table 1.1. 
Moreover, activation of the transcription factor NF-κB has been shown to play central roles in 
the enhanced expression and regulation of cytokine genes (Kelso, 1998).  
 
 
Table 1.1: Resume of the studies found reporting inflammatory response of AgNPs.  
Cytokines NPs Cell type Conditions Reference 
   IL-8 
 
AgNPs, 
TiO2NPs, 
ZnONPs 
Caco-2; SW480 10 and 100 
µg/mL; 48h 
 (ELISA kit) 
Abbott Chalew 
and Schwab, 
2013 
   IL-6,      IL1β,     NFKb,    TNFα 
   IL-6,      IL1β,     NFKb,    TNFα 
   IL-6,      IL1β,     NFKb,    TNFα 
AgNPs 
TiO2NPs, 
ZnONPs 
RAW 264.7 
 
10 µg/mL, 6h Giovanni et al., 
2015 
   TNFα, no dif IL1β,     MCP1 (1u) 
   TNFα, no dif IL1β, 
 
    MCP1 
    MCP1 
 
AgNPs 
(tannic-acid) 
 
AgNPs 
(Unmodified) 
RAW 264.7 
THP1 
 
RAW264.7 
THP1 
 
1 and 10 µg/mL 
12h 
Orlowski et al., 
2013 
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Cytokines NPs Cell type Conditions Reference 
No significant production of IL-6, 
IFN-α, IL-10 and IL-12p70 by 
 monocytes exposed or not to AgNPs 
was detected. 
RAW264.7 
  Il-1,   IL-6,   TNFα 
 
No significant differences 
AuNPs 
 
AgNPs 
J774 A1 
macrophages 
1 µg/mL; 3 and 
6h 
3, 6, 24, 48, 72h 
Yen et al., 2009  
   IL-6 (1.25 to 10 nM),     IL-8 (2.5 
to 10 nM) 
QD621 
(quantum 
dots) 
HEK 24 and 48h Zhang et al., 
2008 
   IL-6,    IL-8. 
Below detectable levels: Il1β, IL-10, 
TNFα. 
IL-6,    TNFα,    MCP1. 
Below detectable levels: INFγ, IL12. 
Iron oxide 
NPs 
 
Iron oxide 
NPs 
HEK 
 
 
JB6 P+ (mouse 
epidermal) 
26 µg/cm2; 24h 
(BD cytometric 
bead array) 
Murray et al., 
2013 
   IL-1β, IL-6, IL-8, and TNF-α 
Below detectable level: IL-10 
0.34 µg/mL 
unwashed 20, 
50, 80 nm 
AgNPs 
HEK 24h Samberg et al., 
2010 
   TNF-α and IFN-γ AgPs Mice 48h Xu et al., 2013 
   IL-1, TNF-α, and IL-6 and Th0 
cytokine (IL-2)  
AgNPs Mice 28 days after a 
single 
instillation 
Park, 2011 
   IL1β, IL-6 AgNPs A549 50 µg/mL Suliman et al., 
2013 
Progressive release of IL-8 AgNPs LoVo cells 1 or 10 µg/ml; 
24 or 48h   
Miethling-Graff 
et al., 2014 
   TNFα,    INFγ 
    TNFα on LPS stimulated RAW 
Evidence of the Anti-inflammatory 
Effects 
AgNPs  abdominal   
perito- 
 neal tissues 
(mice) 
 Wong et al., 
2009 
    IL-6; IL-8; MCP1 
Add NAC       IL6, IL8, MCP-1 
(=abnormal expression levels related 
to oxidative stress) 
AgNPs 65nm; 
sodium citrate 
HUVECs 24h;  
1, 1.5, 2 µg/ml 
Shi et al., 2014 
No significant change in gene 
expression of IL1, IL6, TNFα 
AgNPs: 2-4 
nm; 5-7nm; 
20-40nm 
J774 A1 
macrophages 
1 ppm; 
3, 6, 24 and 72h 
Yen et al., 2009 
   TNFα; no alterations on IL2 and 
IL6 
 
no alterations on IL2, IL6 and TNFα 
AgNPs 
sodium 
citrate+PVP 
10-50nm 
T-lymphocytic 
Jurkat 
 
Monocytic U937 
0-7.5ppm; 24h Parnsamut and 
Brimson, 2015 
    IL1β AgNPs Human 
monocytes 
 Yang, 2012 
The symbol    means increase and     means decrease. 
 
1.8.Effects of AgNPs on cell metabolome 
 
As reported above conventional toxicity assessments show high variability in biological 
responses to AgNPs, therefore it is important to complement this information with other, 
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including the cell metabolic profiling. Studies on the effects of AgNPs in the cell metabolome 
are scarce. Carrola et al (2016) demonstrated by Nuclear Magnetic Resonance (NMR) 
metabolomics that AgNPs-exposed HaCaT cells displayed upregulated glutathione-based 
antioxidant protection, increased glutaminolysis, downregulated tricarboxylic acid (TCA) cycle 
activity, energy depletion and cell membrane modification. In a study by Kim and colleagues 
(2011b), AgNPs increased intracellular pyruvate, oxidized glutathione (GSSG) and decreased 
lactate, taurine, glycine, reduced glutathione (GSH). The AgNPs also increased the levels of 
choline, o-phospho-choline, and sn-glycerol-3-phosphocholine, which are involved in 
phospholipid pathways. In another study, Szmyd and colleagues reported that in NHEK 
keratinocytes ATP content decreased (Szmyd et al., 2013). Cells exposed to 6.25 μg/ml AgNPs 
showed a 40 % decrease in ATP content, whereas cells exposed to 50 μg/ml AgNPs, the ATP 
content decreased by almost 80 %. The changes were even more pronounced after 48h exposure 
(Szmyd et al., 2013). 
 
 
1.9.Aims and outline of this work 
 
The general aim of this thesis was to evaluate AgNPs cytotoxic and genotoxic potential in skin, 
liver and blood, using cell lines: human keratinocyte (HaCaT), human hepatocellular carcinoma 
(HepG2) and mouse leukemic monocyte/macrophage (RAW 264.7), respectively. 
In this line, the specific aims were: 
- To evaluate the effects of AgNPs on cell morphology, cell viability, cell cycle unbalances and 
clastogenicity; 
- To characterize if and how AgNPs induce oxidative stress, apoptosis/necrosis and 
inflammatory responses; 
- To evaluate genotoxic potential of AgNPs measuring DNA damage, chromosome breakage, 
cytostasis and cytotoxicity; 
- To determine the potential effects of AgNPs on gene expression (cell-cycle and apoptosis 
related genes); 
- To compare the toxicity of AgNPs with different surface coatings: citrate- and PEG- AgNPs. 
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Panáček, A., Kvitek, L., Prucek, R., Kolar, M., Vecerova, R., Pizurova, N., Sharma, V., 
Nevecna, T. and Zboril, R. (2006). Silver colloid nanoparticles: synthesis, 
characterization, and their antibacterial activity. J Phys Chem B, 110(33), 16248-16253.  
Pang, C., Brunelli, A., Zhu, C., Hristozov, D., Liu, Y., Semenzin, E., Wang, W., Tao, W., 
Liang, J., Marcomini, A., Chen, C. and Bin Zhao. (2015). Demonstrating approaches to 
chemically modify the surface of Ag nanoparticles in order to influence their cytotoxicity 
and biodistribution after single dose acute intravenous administration. Nanotoxicology, 
1-11.  
Parnsamut, C., and Brimson, S. (2015). Effects of silver nanoparticles and gold nanoparticles on 
IL-2, IL-6, and TNF-α production via MAPK pathway in leukemic cell lines. Genet Mol 
Res, 14(2), 3650. 
Park, E.J.J., Choi, K., and Park, K. (2011). Induction of inflammatory responses and gene 
expression by intratracheal instillation of silver nanoparticles in mice. Arch Pharm Res 
34, 299-307. 
Park, K., Park, E. J., Chun, I. K., Choi, K., Lee, S. H., Yoon, J. and Lee, B. C. (2011). 
Bioavailability and toxicokinetics of citrate-coated silver nanoparticles in rats. Arch 
Pharm Res, 34(1), 153-158. 
Park, M.V., Neigh, A.M., Vermeulen, J.P., de la Fonteyne, L.J., Verharen, H.W., Briedé, J.J., 
Loveren, H. and Jong, W. (2011). The effect of particle size on the cytotoxicity, 
inflammation, developmental toxicity and genotoxicity of silver nanoparticles. 
Biomaterials, 32(36), 9810-9817. 
Pastoriza-Santos, I. and Liz-Marzán, L. M. (1999). Formation and stabilization of silver 
nanoparticles through reduction by N, N-dimethylformamide. Langmuir, 15(4), 948-951. 
Piao, M.J., Kang, K.A., Lee, I.K., Kim, H.S., Kim, S., Choi, J.Y., Choi, J. and Hyun, J. (2011). 
Silver nanoparticles induce oxidative cell damage in human liver cells through inhibition 
of reduced glutathione and induction of mitochondria-involved apoptosis. Toxicol Lett, 
Chapter 1 
 
 
 
63 
201(1), 92-100.  
Pillai, Z.S. and Kamat, P.V. (2004). What factors control the size and shape of silver 
nanoparticles in the citrate ion reduction method?. J Phys Chem B, 108(3), 945-951. 
Poirier, M., Simard, J. C., Antoine, F., and Girard, D. (2014). Interaction between silver 
nanoparticles of 20 nm (AgNP20) and human neutrophils: induction of apoptosis and 
inhibition of de novo protein synthesis by AgNP20 aggregates. J Appl Toxicol, 34(4), 
404-412.  
Popa, M., Pradell, T., Crespo, D., & Calderón-Moreno, J. M. (2007). Stable silver colloidal 
dispersions using short chain polyethylene glycol. Colloids Surf A Physicochem Eng 
Asp, 303(3), 184-190. 
Prakash, P., Gnanaprakasam, P., Emmanuel, R., Arokiyaraj, S., and Saravanan, M. (2013). 
Green synthesis of silver nanoparticles from leaf extract of Mimusops elengi, Linn. for 
enhanced antibacterial activity against multi drug resistant clinical isolates. Colloids Surf 
B Biointerfaces, 108, 255-259. 
Prakash, Y.S. and Matalon, S. (2014). Nanoparticles in the lung: friend or foe?. Am J Physiol 
Lung Cell Mol Physiol, 306 (4), L393-L396. 
Qian, Y., Yu, H., He, D., Yang, H., Wang, W., Wan, X., & Wang, L. (2013). Biosynthesis of 
silver nanoparticles by the endophytic fungus Epicoccum nigrum and their activity 
against pathogenic fungi. Bioprocess Biosyst Eng, 36(11), 1613-1619.  
Rana, S.V.S. and Taketa, K. (1997). Liver and Environmental Xenobiotics. Berlin Heidelberg 
New York: Springer-Verlag. 
Raschke, W.C., Baird, S., Ralph, P. and Nakoinz, I. (1978). Functional macrophage cell lines 
transformed by Abelson leukemia virus. Cell, 15(1), 261-267. 
Rejman, J., Oberle, V., Zuhorn, I. S., & Hoekstra, D. (2004). Size-dependent internalization of 
particles via the pathways of clathrin-and caveolae-mediated endocytosis. Biochem 
J, 377(1), 159-169.  
Remédios, C., Rosário, F. and Bastos, V. (2012). Environmental Nanoparticles Interactions with 
Plants: Morphological, Physiological, and Genotoxic Aspects. J Botany, 2012. 
Roberts, S. M., James, R. C., & Williams, P. L. (2014). Principles of toxicology: environmental 
and industrial applications. John Wiley & Sons 
Rogers, J.V., Parkinson, C.V., Choi, Y.W., Speshock, J.L. and Hussain, S.M. (2008). A 
preliminary assessment of silver nanoparticle inhibition of monkeypox virus plaque 
formation. Nanoscale Res Lett, 3(4), 129-133. 
Roldan, M.V., Frattini, A., de Sanctis, O., Troiani, H. and Pellegri, N. (2007). Characterization 
and applications of Ag nanoparticles in waveguides. Appl Surf Sci, 254(1), 281-285.  
Ryan, S.M.M., Mantovani, G., Wang, X., Haddleton, D.M., and Brayden, D.J. (2008). 
Advances in PEGylation of important biotech molecules: delivery aspects. Expert Opin 
Drug Deliv 5(4), 371-383. 
Sagee, O., Dror, I., and Berkowitz, B. (2012). Transport of silver nanoparticles (AgNPs) in 
soil. Chemosphere, 88(5), 670-675.  
Sahu, S.C., Zheng, J., Graham, L., Chen, L., Ihrie, J., Yourick, J.J. and Sprando, R.L. (2014). 
Comparative cytotoxicity of nanosilver in human liver HepG2 and colon Caco2 cells in 
culture. J Appl Toxicol, 34:1155-1166. 
Samberg, M.E., Oldenburg, S.J., and Monteiro-Riviere, N.A. (2010). Evaluation of Silver 
Nanoparticle Toxicity in Skin in Vivo and Keratinocytes in Vitro. Environ Health 
Perspect, 118, 407-413. 
Shahverdi, A. R., Fakhimi, A., Shahverdi, H. R., & Minaian, S. (2007). Synthesis and effect of 
silver nanoparticles on the antibacterial activity of different antibiotics against 
Staphylococcus aureus and Escherichia coli. Nanomedicine, 3(2), 168-171.  
Shang, L., Nienhaus, K. and Nienhaus, G.U. (2014). Engineered nanoparticles interacting with 
cells: size matters. J Nanobiotechnol, 12(5), b67. 
Sharma, V., Yngard, R., and Lin, Y. (2009). Silver nanoparticles: green synthesis and their 
antimicrobial activities. Adv Colloid Interface Sci 145(1), 83-96. 
Chapter 1 
 
 
 
64 
Sheng, Z. and Liu, Y. (2011). Effects of silver nanoparticles on wastewater biofilms. Water Res, 
45(18), 6039-6050.  
Shi, J., Sun, X., Lin, Y., Zou, X., Li, Z., Liao, Y., Du, M., and Zhang, H. (2014). Endothelial 
cell injury and dysfunction induced by silver nanoparticles through oxidative stress via 
IKK/NF-κB pathways. Biomaterials, 35(24), 6657-6666. 
Shoults-Wilson, W. A., Reinsch, B.C., Tsyusko, O. V., Bertsch, P. M., Lowry, G. V., and 
Unrine, J. M. (2011). Role of particle size and soil type in toxicity of silver nanoparticles 
to earthworms. Soil Sci Soc Am J, 75(2), 365-377.  
Shoults-Wilson, W. A., Reinsch, B. C., Tsyusko, O. V., Bertsch, P. M., Lowry, G. V. and 
Unrine, J. M. (2011). Effect of silver nanoparticle surface coating on bioaccumulation 
and reproductive toxicity in earthworms (Eisenia fetida). Nanotoxicology, 5(3), 432-444. 
Simonet, B., and Valcárcel, M. (2009). Monitoring nanoparticles in the environment. Anal 
Bioanal Chem, 393(1), 17-21.  
Singh, N.P. 1998. "A rapid method for the preparation of single-cell suspensions from solid 
tissues." Cytometry, 31(3), 229-232. 
Singh, R.P. and Ramarao, P. (2012). Cellular uptake, intracellular trafficking and cytotoxicity of 
silver nanoparticles. Toxicol Lett, 213(2), 249-259.  
Sirivithayapakorn, S. and Keller, A. (2003). Transport of colloids in saturated porous media: A 
pore‐ scale observation of the size exclusion effect and colloid acceleration. Water 
Resour Res, 39(4).  
Slominski, A. T., Janjetovic, Z., Kim, T. K., Wasilewski, P., Rosas, S., Hanna, S., Sayre, R., 
Dowdy, J.C., Li, W. and Tuckey, R.C. (2015). Novel non-calcemic secosteroids that are 
produced by human epidermal keratinocytes protect against solar radiation. J Steroid 
Biochem Mol Biol, 148, 52-63.  
Sonavane, G., Tomoda, K. and Makino, K. (2008). Biodistribution of colloidal gold 
nanoparticles after intravenous administration: effect of particle size. Colloids Surf B 
Biointerfaces, 66(2), 274-280.  
Song, X.L., Li, B., Xu, K., Liu, J., Ju, W., Wang, J., Liu, X., Li, J. and Qi, Y. (2012). 
Cytotoxicity of water-soluble mPEG-SH-coated silver nanoparticles in HL-7702 cells. 
Cell Biol Toxicol, 28(4), 225-237.  
Stampoulis, D., Sinha, S.K. and White, J.C. (2009). Assay-dependent phytotoxicity of 
nanoparticles to plants. Environ Sci Technol, 43(24), 9473-9479.  
Stern, S.T. and McNeil, S.E. (2008). Nanotechnology safety concerns revisited. Toxicol Sci, 
101 (1), 4-21. 
Suliman, Y., Omar, A., Ali, D., Alarifi, S., Harrath, A. H., Mansour, L. and Alwasel, S.H. 
(2015). Evaluation of cytotoxic, oxidative stress, proinflammatory and genotoxic effect 
of silver nanoparticles in human lung epithelial cells. Environ Toxicol, 30(2), 149-160.  
Suk, J.S., Lai, S.K., Boylan, N.J., Dawson, M.R., Boyle, M.P. and Hanes, J. (2011). Rapid 
transport of muco-inert nanoparticles in cystic fibrosis sputum treated with N-acetyl 
cysteine. Nanomedicine, 6(2), 365-375.  
Szmyd, R., Goralczyk, A. G., Skalniak, L., Cierniak, A., Lipert, B., Filon, F. L., Crosera, M., 
Borowczyk, J., Laczna, E., Drukala, J., Klein, A. and Jura, J. (2013). Effect of silver 
nanoparticles on human primary keratinocytes. Biol Chem, 394 (1):113-123.  
Takenaka, S., Karg, E., Roth, C., Schulz, H., Ziesenis, A., Heinzmann, U., Schramel, P. and 
Heyder, J. (2001). Pulmonary and systemic distribution of inhaled ultrafine silver 
particles in rats. Environ Health Perspect, 109 Suppl 4:547-551. 
Tang, J., Xiong, L., Wang, S., Wang, J., Liu, L., Li, J., Yuan, F. and Xi, T. (2009). Distribution, 
translocation and accumulation of silver nanoparticles in rats. J Nanosci Nanotechnol, 9 
(8):4924-4932. 
Tang, J., Xiong, L., Zhou, G., Wang, S., Wang, J., Liu, L, Li, J., Yuan, F., Lu, S., Wan, Z., 
Chou, L. and Xi, T. (2010). Silver nanoparticles crossing through and distribution in the 
blood-brain barrier in vitro. J Nanosci Nanotechnol no. 10 (10):6313-6317. 
Teow, Y., Asharani, P.V., Hande, M.P. and Valiyaveettil, S. (2011). Health impact and safety of 
Chapter 1 
 
 
 
65 
engineered nanomaterials. Chem Commun, 47(25), 7025-7038. 
Tervonen, T., Linkov, I., Figueira, J.R., Steevens, J., Chappell, M. and Merad, M. (2009). Risk-
based classification system of nanomaterials. J Nanopart Res, 11(4), 757-766.  
Tice, R. R., Agurell, E., Anderson, D., Burlinson, B., Hartmann, A., Kobayashi, H., Miyamae, 
Y., Rojas, E., Ryu, J.C. and Sasaki Y.F. (2000). Single cell gel/comet assay: Guidelines 
for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen, 35(3), 206-
221. 
Tinkle, S.S., Antonini, J.M., Rich, B.A., Roberts, J.R., Salmen, R., DePree, K. and Adkins, E.J. 
(2003). Skin as a route of exposure and sensitization in chronic beryllium disease. 
Environ Health Perspect, 111(9), 1202.  
Toll, R., Jacobi, U., Richter, H., Lademann, J., Schaefer, H. and Blume-Peytavi, U. (2004). 
Penetration profile of microspheres in follicular targeting of terminal hair follicles. J 
Investig Dermatol, 123(1), 168-176.  
Tolaymat, T.M., El Badawy, A.M., Genaidy, A., Scheckel, K.G., Luxton, T.P. and Suidan, M. 
(2010). An evidence-based environmental perspective of manufactured silver 
nanoparticle in syntheses and applications: a systematic review and critical appraisal of 
peer-reviewed scientific papers. Sci Total Environ, 408(5), 999-1006. 
Tomankova, K., Horakova, J., Harvanova, M., Malina, L., Soukupova, J., Hradilova, S, 
Kejlova, K., Malohlava, J., Licman, L., Dvorakova, M., Jirova, D. and Kolarova, H. 
(2015). Cytotoxicity, cell uptake and microscopic analysis of titanium dioxide and silver 
nanoparticles in vitro. Food Chem Toxicol, 82, 106-115. 
Tourinho, P. S., Van Gestel, C. A., Lofts, S., Svendsen, C., Soares, A. M. and Loureiro, S. 
(2012). Metal-based nanoparticles in soil: fate, behavior, and effects on soil 
invertebrates." Environ Toxicol Chem 31(8), 1679-1692. 
Treuel, L., Malissek, M., Gebauer, J. S. and Zellner, R. (2010). The influence of surface 
composition of nanoparticles on their interactions with serum albumin.ChemPhysChem, 
11(14), 3093-3099. 
Trop, M., Novak, M., Rodl, S., Hellbom, B., Kroell, W. and Goessler, W. (2006). Silver-coated 
dressing acticoat caused raised liver enzymes and argyria-like symptoms in burn patient. 
J Trauma Acute Care Surg, 60(3), 648-652.  
Van der Veen, J.W., Hodemaekers, H., Reus, A.A., Maas, W.J., van Loveren, H. and Ezendam, 
J. (2015). Human relevance of an in vitro gene signature in HaCaT for skin sensitization. 
Toxicol In Vitro, 29(1), 81-84. 
Vigo, E., Cepeda, A. and Gualillo, O. (2005). In-vitro anti-inflammatory activity of Pinus 
sylvestris and Plantago lanceolata extracts: effect on inducible NOS, COX-1, COX-2 and 
their products in J774A.1 murine macrophages. J Pharm Pharmacol, 57(3), 383-391. 
Vlachou, E., Chipp, E., Shale, E., Wilson, Y. T., Papini, R. and Moiemen, N. S. (2007). The 
safety of nanocrystalline silver dressings on burns: a study of systemic silver absorption. 
Burns, 33(8), 979-985. 
Vo-Dinh, T., Wang, H.N. and Scaffidi, J. (2010). Plasmonic nanoprobes for SERS biosensing 
and bioimaging. J Biophotonics, 3(1-2), 89-102. 
Walker, N.J. and Bucher, J.R. (2009). A 21st century paradigm for evaluating the health hazards 
of nanoscale materials?. Toxicol Sci, 110(2), 251-254. 
Wang, H., Wu, L. and Reinhard, B. M. (2012). Scavenger receptor mediated endocytosis of 
silver nanoparticles into J774A. 1 macrophages is heterogeneous. Acs Nano, 6(8), 7122-
7132. 
Ward, J., and Kach, D.J. (2009). Marine aggregates facilitate ingestion of nanoparticles by 
suspension-feeding bivalves. Mar Environ Res, 68 (3):137-142. 
Weisbarth, R.E., Gabriel, M.M., George, M., Rappon, J., Miller, M., Chalmers, R. and 
Winterton, L. (2007). Creating antimicrobial surfaces and materials for contact lenses 
and lens cases. Eye Contact Lens, 33(6, Part 2 of 2), 426-429. 
Wiley, B., Sun, Y., Mayers, B. and Xia, Y. (2005). Shape-controlled synthesis of metal 
nanostructures: the case of silver. Chem A Eur J, 11(2), 454-463. 
Chapter 1 
 
 
 
66 
Wiley, B., Sun, Y. and Xia, Y. (2007). Synthesis of silver nanostructures with controlled shapes 
and properties. Acc Chem Res, 40(10), 1067-1076. 
Wijnhoven, S. W., Peijnenburg, W. J., Herberts, C. A., Hagens, W. I., Oomen, A. G., Heugens, 
E. H., Roszek, B., Bisschops, J., Gosens, I., Van De Meent, D., Dekkers, S., De Jong, 
W., Van Zijverden, M. and Geertsma, R.  (2009). Nano-silver–a review of available data 
and knowledge gaps in human and environmental risk assessment. Nanotoxicology, 3(2), 
109-138. 
Wong, K. K., Cheung, S. O., Huang, L., Niu, J., Tao, C., Ho, C. M., Che, C.M.M. and Tam, 
P.K. (2009). "Further evidence of the anti-inflammatory effects of silver nanoparticles." 
ChemMedChem 4(7), 1129-1135. 
Wu, A.C., Grøndahl, L., Jack, K.S., Foo, M.X., Trau, M., Hume, D.A. and Cassady, A. I. 
(2006). Reduction of the in vitro pro-inflammatory response by macrophages to poly (3-
hydroxybutyrate-co-3-hydroxyvalerate). Biomaterials,27(27), 4715-4725. 
Xin, L., Wang, J., Fan, G., Che, B., Wu, Y., Guo, S. and Tong, J. (2015). Oxidative stress and 
mitochondrial injury‐ mediated cytotoxicity induced by silver nanoparticles in human 
A549 and HepG2 cells. Environ Toxicol. 
Xiong, D., Chen, M. and Li, H. (2008). Synthesis of para-sulfonatocalix [4] arene-modified 
silver nanoparticles as colorimetric histidine probes. Chem Commun, (7), 880-882. 
Xiu, Z. M., Ma, J. and Alvarez, P. J. (2011). Differential effect of common ligands and 
molecular oxygen on antimicrobial activity of silver nanoparticles versus silver ions. 
Environ Sci Technol, 45(20), 9003-9008. 
Xu, Y., Tang, H., Liu, J.H., Wang, H. and Liu, Y. (2013). Evaluation of the adjuvant effect of 
silver nanoparticles both in vitro and in vivo. Toxicol Lett,219(1), 42-48. 
Xu, Y., Gao, C., Li, X., He, Y., Zhou, L., Pang, G. and Sun, S. (2013). In vitro antifungal 
activity of silver nanoparticles against ocular pathogenic filamentous fungi. J Ocul 
Pharmacol Ther, 29(2), 270-274. 
Yan, W., Wang, R., Xu, Z., Xu, J., Lin, L., Shen, Z. and Zhou, Y. (2006). A novel, practical and 
green synthesis of Ag nanoparticles catalyst and its application in three-component 
coupling of aldehyde, alkyne, and amine. J Mol Catal A Chem, 255(1), 81-85. 
Yang, E. J., Jang, J., Lim, D. H. and Choi, I. H. (2012). Enzyme-linked immunosorbent assay of 
IL-8 production in response to silver nanoparticles. Nanotoxicity: Methods and 
Protocols, 131-139. 
Yang, X., Dou, Y., & Zhu, S. (2013). Highly sensitive detection of superoxide dismutase based 
on an immunoassay with surface-enhanced fluorescence. Analyst, 138(11), 3246-3252. 
Yen, H. J., Hsu, S. H., & Tsai, C. L. (2009). Cytotoxicity and immunological response of gold 
and silver nanoparticles of different sizes. Small, 5(13), 1553-1561. 
Zakrzewski, S.F. 2002. Environmental Toxicology. New York: Oxford University Press, Inc. 
Zhang, L. W., William, W. Y., Colvin, V. L. and Monteiro-Riviere, N. A. (2008). Biological 
interactions of quantum dot nanoparticles in skin and in human epidermal keratinocytes. 
Toxicol and App Pharm, 228(2), 200-211. 
Zhang, Y., Tekobo, S., Tu, Y., Zhou, Q., Jin, X., Dergunov, S. A., Pinkhassik, E. and Yan, B. 
(2012). Permission to enter cell by shape: nanodisk vs nanosphere. ACS Appl Mater 
Interfaces, 4(8), 4099-4105. 
Zhang, W., Yao, Y., Sullivan, N. and Chen, Y. (2011). Modeling the primary size effects of 
citrate-coated silver nanoparticles on their ion release kinetics. Environ Science Technol, 
45(10), 4422-4428. 
Zuykov, M., Pelletier, E. and Demers, S. (2011). Colloidal complexed silver and silver 
nanoparticles in extrapallial fluid of Mytilus edulis. Mar Environ Res, 71(1), 17-21.
 
 
 
 
  
 
67 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The influence of Citrate or PEG coating on silver 
nanoparticle toxicity to a human keratinocyte cell line 
 
  
 
 
 
 
 
 
 Part of this chapter was submitted as:  
Bastos V.
1
, Ferreira de Oliveira J. M. P.
1
, Brown D.
2
, Johnston H.
2
, Malheiro E.
 2
, Silva A.L.
2
, 
Duarte I.F.
2
, Oliveira H
1
, Santos C.
1,4 
(2016) The influence of Citrate or PEG coating on silver 
nanoparticle toxicity to a human keratinocyte cell line. Toxicology Letters, 13;249:29-41. doi: 
10.1016/j.toxlet.2016.03.005. 
 
Chapter 2 
  
 
68 
 
 
 
 
 
 
 
 
 
 
  
Chapter2 
 
 
 
69 
The influence of Citrate or PEG coating on silver nanoparticle toxicity 
to a human keratinocyte cell line 
 
Bastos V.
1
, Ferreira de Oliveira J. M. P.
1
, Brown D.
2
, Johnston H.
2
, Malheiro E.
 3
, Daniel-da-
Silva A.L.
3
, Duarte I.F.
3
, Santos C.
1,4* and Oliveira H.
1
 
 
 
1CESAM & Laboratory of Biotechnology and Cytomics, Department of Biology, University of Aveiro, 3810-193 Aveiro, Portugal 
2School of Life sciences, Heriot-Watt University, Riccarton, Edinburgh EH14 4AS, UK 
3CICECO – Aveiro Institute of Materials, Department of Chemistry, University of Aveiro, Aveiro, Portugal 
4Department of Biology, Faculty of Sciences, University of Porto, Rua do Campo Alegre, Porto, 
 
 *corresponding author: csantos@fc.up.pt 
 
 
Abstract 
Surface coating of silver nanoparticles may influence their toxicity, in a way yet to decipher. In 
this study, human keratinocytes (HaCaT cells) were exposed for 24 and 48h to well-
characterized 30 nm AgNPs coated either with citrate (Cit30 AgNPs) or with poly(ethylene 
glycol) (PEG30 AgNPs), and assessed for cell viability, reactive oxygen species (ROS), 
cytokine release, apoptosis and cell cycle dynamics. The results showed that Cit30 AgNPs and 
PEG30 AgNPs decreased cell proliferation and viability, the former being more cytotoxic. The 
coating molecules per se were not cytotoxic. Moreover, Ag
+
 release and ROS production were 
similar for both AgNP types. Cit30 AgNPs clearly induced apoptotic death, while cells exposed 
to PEG30 AgNPs appeared to be at an earlier phase of apoptosis, supported by changes in BAX, 
BCL2 and CASP-3 expressions. Concerning the impact on cell cycle dynamics, both Cit30 and 
PEG30 AgNPs affected cell cycle regulation of HaCaT cells, but, again, citrate-coating induced 
more drastic effects, showing earlier downregulation of cyclin B1 gene and cellular arrest at the 
G2 phase. Overall, this study has shown that the surface coating of AgNPs influences their 
toxicity by differently regulating cell-cycle and cell death mechanisms. 
 
Keywords: Apoptosis, Cell cycle, Citrate-coating, Cytokines, Nanotoxicology, PEG-coating, 
ROS, silver nanoparticles. 
 
Introduction 
Silver nanoparticles (AgNPs) have very efficient antimicrobial activity, which has encouraged 
their widespread use in a range of applications, from medicine and industry to household and 
personal care products or clothing (Abdelhalim and Jarrar 2011; Behra et al. 2013; Benn and 
Westerhoff 2008; Eckhardt et al. 2013; EPA 2010; Nowack et al. 2011). According to the 
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inventory of nanotechnology-based consumer products compiled by the Project on Emerging 
Nanotechnologies (http://www.nanotechproject.org/cpi), ~24% of 1800 “nano” products that 
were introduced in the market to date are nanosilver-containing products. In face of the rapid 
increase in AgNP production and use, concerns about their possible impacts on the environment 
and human health have also grown (Nowack and Bucheli 2007). There are many routes of 
human exposure to AgNPs, including dermal absorption, ingestion, inhalation and injection 
(Ahamed et al. 2010; Chen and Schluesener 2008) and several in vitro studies have reported 
toxic effects of AgNPs towards different types of human cells (Asharani et al. 2012; 
Chairuangkitti et al. 2013; Foldbjerg et al. 2012; Gliga et al. 2014; Grosse et al. 2013; Hsiao et 
al. 2015; Jiang et al. 2013; Kang et al. 2012; Kim et al. 2009). However, the mechanisms of 
AgNPs-induced toxicity are still not completely understood (Browning et al. 2013). In 
particular, it is crucially important to determine how specific physicochemical properties, such 
as particle size and surface chemistry, influence AgNPs uptake, cellular fate and toxicity 
(Ahlberg et al. 2014; Comfort et al. 2014; Lu et al. 2010; Samberg et al. 2010). 
Different properties such as NP formulation (Boonkaew et al. 2014) and size (Kim et al. 2012; 
Park et al. 2011), the storage environment (Ahlberg et al. 2014) and the duration of exposure 
(Comfort et al. 2014) have all been previously assessed in different cell types with regard to 
AgNPs toxic potential. However, little attention has been paid so far to the coating-dependent 
toxicity of AgNPs. AgNPs are frequently coated to promote stability and avoid aggregation, 
citrate being the most commonly used reducing agent and stabilizer (Sharma et al. 2009). 
Numerous polymers have also been used to coat AgNPs, such as polyvinyl pyrrolidone (PVP) 
(Haberl et al. 2013; Nymark et al. 2013; Wang et al. 2014), and poly(ethylene glycol) (PEG) 
(Fernández-López et al. 2009; Tao et al. 2007). Citrate renders NPs a negative surface charge 
and provides colloidal stability through electrostatic repulsions, while low molecular weight 
PEG can neutralize surface charge and stabilize NPs through steric hindrance. PEG coating has 
been reported to reduce NP reactivity (Povoski et al. 2013) and to improve penetration through 
the mucus layer, increasing the interest in the use of this polymer for nanomedicine purposes 
(Suk et al. 2011; Thorley and Tetley 2013). 
The few studies which have addressed the influence of coating on AgNPs toxicity provided 
conflicting information. It has been reported that the charged citrate coating improved the 
stability of AgNPs and decreased their toxicity (Zhang et al. 2014), while other studies found 
that citrate-coated AgNPs could be highly cytotoxic to mammalian cells (Grosse et al. 2013; 
Wang et al. 2014). On the other hand, Gliga et al. (2014) compared the cytoxicity of uncoated, 
PVP- and citrate-coated AgNPs in bronchial BEAS-2B cells and found no coating-dependent 
differences in cytotoxicity. Caballero-Díaz et al. (2013) reported that pegylation of AgNPs 
reduced cellular uptake and reduced the toxicity in NIH/3T3 (mouse embryonic fibroblasts), 
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compared to AgNPs coated with other polymers. Using an in vivo system, England et al. (2013) 
demonstrated that PEG coating could “mask” the NPs from the immune system, decreasing 
their toxicity. However, α-methoxy-poly(ethylene glycol)-ω-mercapto (mPEG-SH)-coated 
AgNPs decreased viability and affected cell cycle dynamics of human liver cells (HL-7702) 
(Song et al. 2012). The differential effects of citrate and PEG coatings have been assessed for 
gold nanoparticles (AuNPs) (Brandenberger et al. 2010) in human alveolar epithelial cells 
(A549) cells. The authors found that the uptake of citrate-coated AuNPs by A549 cells was 
significantly increased compared to that of the PEG-coated AuNPs, concluding that NP surface 
coatings can modulate endocytic uptake pathways and cellular NP trafficking.  
In this study, we aimed to compare the cytotoxic effects of AgNPs coated with citrate or PEG 
on human keratinocytes. Given that skin is a major entry route of AgNPs into the body, HaCaT 
(human keratinocyte) cells have been chosen as an in vitro model. Indeed, there has been 
evidence that AgNPs with diameters in the 20-40 nm range can penetrate skin in vivo and be 
detected in deeper layers (George et al. 2014; Larese et al. 2009). HaCaT cells were exposed to 
citrate- and PEG-coated AgNPs of 30 nm (Cit30 and PEG30, respectively) and the effects on 
cell viability, intracellular ROS production, cytokines expression, apoptosis induction and cell 
cycle profile were assessed after 24 and 48h. Putative toxicity of the coatings alone was also 
investigated. 
 
Material and methods 
Chemicals 
Sterile, purified and endotoxin-free silver nanoparticles (Biopure AgNPs 1.0 mg/mL in water), 
with a diameter of 30 nm and a citrate or polyethyleneglycol (PEG) surface, designated as Cit30 
and PEG30, respectively, were purchased from Nanocomposix Europe (Prague, Czech 
Republic). Citric acid (C6H8O7.H2O) was purchased from Sigma Aldrich (St. Louis, Missouri, 
USA); Poly(ethylene glycol) PEG (Mw 5 kDa) from Laysan Bio® (Arab, Alabama, USA) . 
Dulbecco’s modified Eagle’s medium (DMEM), fetal bovine serum (FBS), antibiotics and 
phosphate buffer saline (PBS, pH 7.4) were purchased from Life Technologies (Carlsbad, CA, 
USA). 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), dimethyl 
sulfoxide (DMSO), dichlorodihydrofluorescein diacetate (DCFH2-DA), propidium iodide (PI), 
RNase and DNase I were obtained from Sigma-Aldrich (St. Louis, MO, USA). FITC Annexin 
V Apoptosis Detection Kit (BD Pharmingen, San Diego, CA-USA); RNeasy Mini Kit columns 
was from Qiagen, Hilden, Germany; Omniscript RT Kit from Qiagen, Hilden, Germany; and iQ 
SYBR Green Supermix from BioRad, Hercules, CA-USA. 
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Physicochemical characterization of AgNPs  
The morphology and size of AgNPs was assessed by scanning transmission electron microscopy 
(STEM, Hitachi SU-70 (Hitachi High-Technologies Europe GmbH, Germany) operating at 30 
kV. Samples for STEM analysis were prepared by evaporating dilute suspensions 
(concentration) of the nanoparticles on a copper grid coated with an amorphous carbon film. 
The hydrodynamic diameter and polydispersity index (PdI) of the nanoparticles were measured 
by dynamic light scattering (DLS) and the zeta potential was assessed by electrophoretic 
mobility, both measurements using a Zetasizer Nano ZS (Malvern Instruments, UK).  
Silver quantification measurements were performed by inductively coupled plasma optical 
emission spectrometry (ICP-OES) in an Activa M Radial spectrometer (Horiba Jobin Yvon, 
France), employing a charge coupled device (CCD) array detector, with a wavelength range of 
166–847 nm and radial plasma view. Samples were introduced into the ICP plasma using an HF 
resistant sample introduction system including a Burgener nebulizer, a cyclonic spray chamber 
and a quartz torch with aluminium injector. Samples for ICP-OES were prepared by addition of 
10 µL AgNPs (1.0 mg/mL) to 990 µL of either ultrapure water or complete culture medium, 
incubation for variable periods (0, 4, 24 or 48h), followed by centrifugation at 40000 rcf for 120 
min at 4ºC (in accordance with the manufacturer’s recommendations) to deposit the 
nanoparticles and separate the supernatant (with dissolved ionic silver). Acid digestion of the 
supernatant was then performed by mixing 500 µL with 100 µL of acids (HCl:HNO3 2:1 v/v) 
and 400 µL of ultrapure water. The % dissolution of AgNPs to ionic silver was calculated as 
100×F×[Ag]/Ci, where F is the dilution factor, Ci the initial concentration of AgNPs (based on 
the stock solution concentration, indicated by the manufacturer) and [Ag] the concentration of 
silver determined by ICP-OES. 
 
Cell Culture 
The HaCaT cell line, a nontumorigenic immortalized human keratinocyte cell line (Boukamp et 
al., 1988), was obtained from Cell Lines Services (Eppelheim, Germany). Cells were grown in 
complete medium, (Dulbecco’s modified Eagle’s medium, supplemented with 10% fetal bovine 
serum (FBS), 2 mM L-glutamine, 100 U/mL penicillin, 100 µg/mL streptomycin and 250 
µg/mL fungizone) at 37°C in 5% CO2 humidified atmosphere. For each experiment, cells were 
seeded at a concentration 60000 cells/mL in 96 well plates, and allowed to adhere for 24h and 
then medium was replaced with fresh medium containing citrate- or PEG-coated AgNPs. 
Depending on the experiment, the silver ion and the coating agent per se, dissolved in complete 
medium, were used as controls. The effects were measured after 24 and 48h.  
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Exposure and Viability assay 
Cell viability was determined by the colorimetric 3-(4,5- dimethyl-2-thiazolyl)-2,5-diphenyl 
tetrazolium bromide (MTT) assay (Twentyman and Luscombe 1987). Cells were seeded in 96-
well plates and cultured as described above. Cell viability was assessed in cells exposed to free 
citrate and PEG (same Mw as in AgNPs coating) at concentrations below the maximum 
quantity added at the time of NP synthesis (before wash process), which was 2 mM for citrate 
(~378 µg/mL) and 200 µg/mL for PEG (information provided by the manufacturer 
Nanocomposix). Cells were exposed to citrate or PEG dissolved in complete culture medium at 
0, 50, 100, 200, 300, 350 and 400 µg citrate/mL, and 0, 6, 12.5, 25, 50, 100 and 200 µg 
PEG/mL. Silver nitrate was dissolved in complete medium at concentrations of 0, 0.2, 0.5, 1, 
2.5, 5, 7.5, 10 and 50 µg Ag
+
/mL. Cells were exposed to citrate- or PEG-coated AgNPs at 
concentrations of 0, 0.5, 5, 10, 25, 50, 75 and 100 µg/mL. Cell viability was measured after 24h, 
but in the case of Ag
+
 and coated AgNPs a 48h exposure was also assayed. Fifty microliters of 
MTT (1 mg/mL) in phosphate buffered saline (PBS) was then added to each well, and incubated 
for 4h at 37°C, 5% CO2. Medium was then removed and 150 µL of DMSO were added to each 
well to solubilize the formazan crystals. 
The optical density of reduced MTT was measured at 570 nm in a microtiter plate reader 
(Synergy HT Multi-Mode, BioTeK, Winooski, VT), and the relative cell metabolic activity 
(MA) (calculated as a % with respect to control cells) was calculated as: MA = [(Sample Abs –
DMSO Abs) / (Control Abs – DMSO Abs)]*100. Three independent assays were performed 
with at least 2 technical replicates each and the results compared with the control (no exposure). 
From the MTT results, the IC50 for citrate coated AgNPs (the most cytotoxic) was 40 µg/mL 
and 37.4 µg/mL at 24 and 48h respectively. Therefore, the concentrations of coated AgNPs 
corresponding to IC50 and IC20 (40 µg/mL and 10 µg/mL, respectively) were selected for the 
following assays, for the silver ion, the IC50 was 1.26 µg/mL and in that case a concentration 
which didn’t cause significant cytotoxicity (0.8 µg/mL) was selected. This concentration was 
higher than the Ag
+
 concentration released from citrate-coated AgNPs at time 0h (3.77% in 10 
µg/mL of citrate- AgNPs, which corresponds to 0.377 µg/mL of Ag
+
), but was a dose that did 
not cause significant cytotoxicity through MTT assay. 
 
Uptake potential by flow cytometry 
Uptake potential of Cit30 and PEG30 by HaCaT cells was assessed by flow cytometry (FCM) 
as previously described by Suzuki et al (2007). Briefly, cells were seeded in 6-well plates and 
after AgNPs exposure they were trypsinized, collected to FCM tubes and analyzed by FCM. 
Both parameters, forward scatter (FS), which give information on the cell’s size, and side scatter 
(SS), information on complexity of cells, were measured in a Coulter XL Flow Cytometer 
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(Beckman Coulter, Hialeah, FL-USA) equipped with an argon laser (15 mW, 488 nm). 
Acquisitions were made using SYSTEM II software v. 3.0 (Beckman Coulter, Hialeah, FL). For 
each sample, 5000–20000 cells were analyzed at a flow rate of about 1000 cells/s. 
 
Intracellular ROS Formation  
Intracellular ROS production was assessed by flow cytometry (FCM) with the use of 
dichlorodihydrofluorescein diacetate (DCFH2-DA) as a fluorescent probe. This probe enters the 
cells and is deacetylated by cellular esterases producing non-fluorescent DCFH2 and diacetate. 
In the cytosol DCFH2 is quickly oxidized to fluorescent DCF by intracellular ROS. Cells were 
seeded in 6-well plates at a concentration of 60000 cells/mL and after AgNPs exposure for 24h, 
medium was discarded and cells were incubated for 30 min, at 37ºC, in the dark with serum-free 
DMEM containing 10 mM DCFH2-DA. Cells were washed with PBS, trypsinised and collected 
for analysis. Acquisitions were made using a Coulter EPICS XL flow cytometer (Coulter 
Electronics, Hialeah, Florida, USA) equipped with an argon laser (15 mW, 488 nm). 
Acquisitions were made using SYSTEM II software v. 3.0 (Beckman Coulter, Hialeah, FL). 
ROS formation was estimated from the median fluorescence intensity (MFI) of DCF using the 
FlowJo software (Tree Star Inc., Ashland, OR-USA). For each sample, the number of events 
reached at least 10000. 
 
Cytokine estimation using cytometric bead array 
Cytokine production was assessed using Bioplex kits. Briefly, the cell supernatants (removed, 
centrifuged and frozen at -80ºC) were used to estimate the release of the following cytokines 
from treated cells: interleukin-1 beta (IL-1β), IL-6, tumour necrosis factor-alpha (TNF-α), IL-10 
and monocyte chemoattractant protein-1 (MCP-1). Lipopolysaccharide (LPS) was used as a 
positive control.  Bead array kits were obtained from Beckton Dickinson (Oxford, UK) and a 
master mix prepared according to the manufacturer’s instructions. The master mix was 
incubated with each of the test supernatants for 1 h, followed by the addition of detection beads 
and incubated for a further 2 h at room temperature. The beads were then washed in wash buffer 
and analyzed using a BD
TM
 FACS array flow cytometer which had previously been set up and 
calibrated using standard beads for each cytokine under investigation.  
 
Annexin V assay 
Apoptosis and cell viability were measured by flow cytometry (FCM) in a Coulter XL Flow 
Cytometer (Beckman Coulter, Hialeah, FL-USA), through the FITC Annexin V Apoptosis 
Detection Kit, according to manufacturer. Briefly, cells were detached and washed with PBS, 
and the cells resuspended in diluted binding buffer provided with the kit (1:10 in distilled water) 
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at 1×10
6
 cells/ml. To stain the cell suspension, 5µL of FITC-Annexin V and 5µL of PI were 
added for 15 min at room temperature in the dark, after which each sample was diluted in 
400μL binding buffer. For each sample, 10000 events were analyzed and the percentages were 
calculated from the number of cells in each quadrant divided by the total number of cells. 
 
Gene expression of apoptosis related genes 
Total RNA of control and exposed cells was extracted using the TRIzol method. Organic phase 
separation was achieved in Phase-Lock Gel Heavy tubes (5 Prime 3 Prime, Inc., Boulder, CO). 
The aqueous phase was mixed with 1 vol 70% ethanol and RNA was purified using RNeasy 
Mini Kit columns. Synthesis of cDNAs was performed by a reverse transcriptase (RT) reaction: 
2 μg total RNA were pre-incubated with DNase I and reverse-transcribed with 1 μM Oligo 
dT18, using the Omniscript RT Kit. The cDNA samples were prediluted in ultrapure MilliQ 
water (1:20). The final individual qPCR reactions contained iQ SYBR Green Supermix, 150nM 
each gene-specific primer and 1:4 (v/v) prediluted cDNA (1:20).  Primers were designed using 
the program Primer3 (Rozen and Skaletsky 2000) and confirmed for specificity by the UCSC 
In-Silico PCR Genome Browser (http://genome.ucsc.edu/cgi-bin/hgPcr). The qPCR program 
included 1 min denaturation at 95 °C, followed by 40 cycles at 94 °C for 5 s, 58 °C for 15 s, and 
72 °C for 15 s. After qPCR, a melting temperature curve was performed. At least two technical 
replicates per sample of qPCR were used from each of three independent biological replicates. 
Average PCR and cycle thresholds were determined from the fluorescence data using the 
algorithm Real-Time PCR Miner (Zhao and Fernald 2005). Gene expression of BAX, BCL2, 
CASP3 were normalized with the GAPDH reference gene and expressed relative to control cells, 
calculated from the average efficiencies and cycle thresholds using the Pfaffl method (Pfaffl 
2001). 
 
Cell cycle 
Cell cycle was analyzed by flow cytometry according to the method previously described 
(Oliveira et al. 2014). Briefly, cells were seeded in 6-well plates and after exposure they were 
washed with PBS, harvested using Trypsin-EDTA and centrifuged twice at 300 xg for 5 min. 
Cells were then fixed with 85% cold ethanol and kept at -20 ºC until analysis. At the time of 
analysis cells were centrifuged at 300 g for 5 min, resuspended in PBS and filtered through a 
35-µm nylon mesh to separate aggregates. Then, 50 μL RNase (1mg/mL) and 50 μL propidium 
iodide (PI) (1mg/mL) were added to each sample which were then incubated for 20 min in 
darkness at room temperature until analysis. The relative fluorescence intensity of the stained 
nuclei was measured in a Coulter XL Flow Cytometer. For each sample, the number of nuclei 
analyzed was approximately 5,000. The percentage of nuclei in each phase of the cell cycle 
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(G0/G1, S and G2 phases) was analyzed using the FlowJo software (Tree Star Inc., Ashland, 
Oregon, USA).  
 
Gene expression of cell cycle related genes 
Total RNA extraction and cDNA synthesis were performed as described above. Gene 
expression of cyclin B1 (CCNB1), cyclin E1 (CCNE1), cyclin-dependent kinase 1 (CDK1) and 
cyclin-dependent kinase 2 (CDK2) were normalized with the GAPDH reference gene and 
expressed relative to control cells, calculated from the average efficiencies and cycle thresholds 
using the Pfaffl method (Pfaffl 2001). 
 
Statistical analysis 
The results are reported as mean ± standard deviation (SD) of 2 technical replicates in each of 
the 3 independent experiments. For MTT assay, the statistical significance between control and 
exposed cells was performed by one-way ANOVA, followed by Dunnet and Dunn’s method (as 
parametric and non-parametric test, respectively), using Sigma Plot 12.5 software (Systat 
Software Inc.). For the other assays, results were compared using two-way ANOVA, followed 
by Holm-Sidak test using also Sigma Plot 12.5 software (Systat Software Inc.). The differences 
were considered statistically significant for p < 0.05. Principal Component Analysis (PCA) was 
used to perform multivariate analysis. All multivariate analyses in this paper were carried out 
using the Canoco for Windows vs 4.5. 
 
Results 
Physicochemical characterization of AgNPs dispersed in water and in cell culture medium 
Scanning transmission electron microscopy (STEM) images (Figure 2.1) showed that AgNPs 
were mainly spherical in shape with a mean diameter of 27.1 ± 3.0 nm and 27.7 ± 3.2 nm, for 
citrate and PEG coated nanoparticles respectively, and with a narrow size distribution. The 
hydrodynamic diameter (Z-average size) in water was above the primary particle size (Table 
2.1), especially in the case of PEG30 AgNPs, as expected based on the larger volume of PEG 
molecules compared to citrate. The values of polydispersity indexes (PdI) were below 0.3, thus 
indicating monodisperse distributions. As to the zeta potential, citrate-stabilized NPs carried a 
strong negative surface charge (-42.7 ± 2.7 mV), while the surface of the PEG-stabilized NPs 
was less negative (-12.1 ± 0.5 mV, Table 1). The amount of dissolved ionic silver in ultrapure 
water suspensions of Cit30 and PEG30 AgNPs was 3.32 ± 0.04% and 0.63 ± 0.01%, 
respectively. 
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 Table 2.1: Hydrodynamic diameter Dh (with respective polydispersity index PdI) and zeta potential ( of 
Cit30 and PEG30 AgNPs (30 nm nominal diameter, citrate and polyethyleneglycol coating, respectively) 
dispersed in ultrapure water or in DMEM culture medium (10 µg/ml). Standard deviations calculated 
from 3 replicate measurements. 
 
AgNPs  Dh (nm) PdI  (mV) 
Cit30 In water 43.3 ± 0.5 0.25-0.26 -42.7 ± 2.7 
 In DMEM 64.8 ± 0.4 0.40-0.41 -8.5 ± 0.4 
PEG30 In water 62.1 ± 0.5 0.15-0.16 -12.1 ± 0.5 
 In DMEM 57.7± 0.3 0.25-0.27 -6.5 ± 0.4 
 
 
 
 
 
Figure 2.1: STEM micrographs of AgNPs Citrate- and PEG- AgNPs (30 nm nominal diameter, citrate and 
polyethyleneglycol coating, respectively) dispersed in deionised water (5 µg/ml). 
 
Regarding the behavior of AgNPs in cell culture medium (DMEM with 10% FBS), Cit30 
AgNPs increased their hydrodynamic diameter, as soon as they were suspended in the medium 
and progressively over time up to 93.7 nm after 48h (Figure 2.2a), possibly reflecting the 
formation of a protein corona. Additionally, the zeta potential (increased from -42.7 ± 2.7 in 
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water to -8.5 ± 0.4 mV in the cell culture medium, indicating a less negative surface, hence 
lower electrostatic repulsions. The release of ionic silver (Ag
+
) increased to 7.6 ± 0.1% at 48h, 
which corresponds to an absolute concentration of 0.77 µg/mL Ag
+
 (Figure 2.2b). PEG30 
AgNPs showed a more stable hydrodynamic diameter over incubation time, likely because PEG 
was not as readily displaceable as citrate by the medium proteins. The dissolution behavior of 
PEG30 AgNPs was very similar to that of Cit30 AgNPs, reaching identical ionic silver 
concentrations at 48h (Figure 2.2b).  
 
a)                                                               b) 
 
 
 
 
 
 
Figure 2.2: a) Z-average size and b) % dissolution to Ag
+
 of AgNPs Citrate-and PEG- AgNPs (30 nm 
nominal diameter, citrate and PEG coating, respectively) incubated in culture medium (10 µg/mL) at 
37ºC for 4, 24 and 48h. Error bars correspond to the standard deviations of 3 replicate measurements.  
 
 
Effects on cell growth and morphology 
HaCaT cells in control conditions (exposed to cell culture medium) showed typical morphology 
(Figure 2.3a, f). When cells were exposed to Cit30 AgNPs for 24 and 48h, their confluence 
decreased, especially at the highest concentration tested (40 µg/mL) (Fig. 2.3c, h). Compared to 
Cit30 AgNPs, PEG30 AgNPs induced a lesser decrease in cell confluence, which was only 
visible after 48h (Fig. 2.3j). No visible morphological alterations were detected at 24h for Cit30 
NPs.  
 
Cell Viability 
The viability of HaCaT cells was negatively affected by AgNPs coated either with citrate or 
with PEG, although to different extents (Fig. 2.4a, b). Upon exposure to Cit30 AgNPs at 
concentrations higher than 25 µg/mL and 50 µg/mL cell viability was significantly reduced after 
24h and 48h. Furthermore, Cit30 AgNPs at concentrations higher that 50 g/mL reduced cell 
viability to < 20% even after 24h.  
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Figure 2.3: Light microscopy images (100X) of HaCaT cells in control conditions at 24h (a) and 48h (f) 
and exposed to 30 nm citrate-coated AgNPs for 24h - b) 10 µg/mL; c) 40 µg/mL; 48h – g) 10 µg/mL; h) 
40 µg/mL and 30 nm PEG-coated AgNPs for 24h - d) 10 µg/mL; e) 40 µg/mL; 48h – i) 10 µg/mL; j) 40 
µg/m. Bar corresponds to 100 µm. 
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In contrast, PEG30 AgNPs, decreased cell viability significantly from concentrations >25 
µg/mL, but only after 48h. The viability results were also expressed using surface area as dose 
metrics, instead of mass concentration. The curves obtained (Fig. 2.5) actually had very similar 
profiles to those shown in Figure 2.4a-b, indicating that surface area was not determinant for the 
different toxicity of the two AgNP types.  
  
 
                                                                                                  
 
 
 
  
 
 
                                                                                        
 
 
 
e 
 
Figure 2.4: Relative cell viability of HaCaT 
(%), measured by MTT assay, for 24h and  
48h. a) 30 nm citrate-coated AgNPs; b) 30 
nm PEG coated AgNPs; c) Citrate – for 
24h; d) PEG – for 24h; and e) Ag+. Data 
expressed as mean and standard deviation. 
* indicate significant differences between 
control at p < 0.05 for 24h and # indicate 
significant differences between control at p 
< 0.05 for 48h. Vertical line in c) and d) corresponds to the maximum dose of citrate and PEG that exists 
in the concentrations used of AgNPs.  
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In order to investigate potential inherent toxicity of the coating substances, the viability of cells 
upon exposure to citrate and PEG (in the same Mw as in AgNP coating) was assessed (Fig. 
2.4c, d). Citrate induced a significant decrease in cell viability at concentrations above 100 
µg/mL. However, the concentrations of citrate that corresponded to the administered AgNPs 
doses were well below this value (at 100 µg/mL of Cit30 AgNPs the maximum citrate 
concentration is 37.8 µg/mL (Nanocomposix® information)), thus not accounting for the 
observed toxicity of Cit30 AgNPs. In the case of exposure to PEG, the viability did not decrease 
significantly for any of the concentrations tested. Concerning silver ions (Fig. 2.4e), viability 
decreased sharply for concentrations higher than 1.25 µg/mL for both 24 and 48h.   
 
Figure 2.5: Cell viability results expressed as a function of AgNPs mass concentration (top) or of AgNPs 
total surface area (bottom). Surface area was calculated by: i) considering the TEM diameter to calculate 
the number of particles present at each silver concentration (assuming a spherical shape for AgNPs), ii) 
considering the hydrodynamic diameter in water to calculate the area of each particle, iii) multiplying the 
no. particles by the area of one particle. Data expressed as mean and standard deviation. 
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Uptake potential by flow cytometry 
The uptake of both Cit30 and PEG30 AgNPs at 24h was determined by quantitative analysis of 
the intracellular side scatter signal by flow cytometry (Figure 2.6). Both concentrations (10 and 
40 µg/mL) induced an increase in the uptake potential of Cit30 AgNPs by HaCaT cells, while 
for PEG30 an increase in the uptake potential was only observed for the highest concentration 
(40 µg/mL). Overall, the results suggest that PEG30 AgNPs are taken up by HaCaT cells to a 
lower extent than Cit30 AgNPs. 
 
 
 
Figure 2.6: Uptake potential of AgNP by HaCaT cells assessed by the side scattered light by flow 
cytometry. The results were expressed as the mean +/- SD versus control. ** indicate significant 
differences between control at p < 0.01. 
 
Intracellular ROS Formation 
The quantification of intracellular ROS in HaCaT cells exposed to AgNPs for 24h is presented 
in Fig. 2.7. Both Cit30 and PEG30 AgNPs induced the production of ROS reaching a significant 
1.2 fold increase at the highest dose tested (40 µg/mL), compared to control cells. The ROS 
levels were similar for the two NP types. 
 
Inflammatory Cytokine release 
Significant differences in cytokine release upon AgNPs exposure were noted only for MCP-1, 
while there was no effect on the other cytokines studied (IL-1β, IL-6, IL-10 and TNF-α) (data 
not shown). The results regarding the release of MCP-1 by HaCaT cells treated with Cit30 and 
PEG30 AgNPs are shown in Fig. 2.8. While LPS, used as positive control, induced a significant 
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increase in MCP-1 release at 48h, both Cit30 and PEG30 AgNPs induced a significant decrease 
compared to control cells. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.7: Characterization of intracellular ROS production of HaCaT after exposure to citrate- and 
PEG- AgNPs for 24h, using the DCFDA assay. The results were expressed as the mean +/- SD versus 
control. ** indicate significant differences between control at p < 0.01 and * at p < 0.05. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.8:  MCP-1 release by HaCaT cells after 24 and 48h exposure to Citrate- and PEG- AgNPs. Data 
represent the mean ± SEM (n = 3) of the concentration (pg /ml) of MCP-1 cytokine released from the 
cells after NPs treatment. ** indicate significant differences between control at p < 0.01. 
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Annexin V assay 
The potential of AgNPs to induce apoptosis in HaCaT cells was assessed by the Annexin V-
FITC/PI assay. As shown in Fig. 2.9a-b, Ci30 AgNPs decreased the percentage of intact cells 
(not significantly for 48h exposure to the lowest concentration) and increased the percentage of 
dead cells, especially at 24h exposure to the high concentration. Concerning early apoptosis, the 
results showed a significant increase after 48h exposure to 40 µg/mL Cit30 AgNPs, while the 
percentage of cells at late apoptosis/necrosis was increased for all conditions (not significantly 
for 48h exposure to the low concentration) In contrast, the exposure of HaCaT cells to PEG30 
AgNPs did not induce any significant changes in the apoptosis profile for neither periods or NP 
concentrations (Fig. 2.9c-d). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.9: Citrate- and PEG- AgNPs effects on HaCaT cells exposed to 10 and 40 µg/mL during 24 and 
48h, measured by annexin V assay. Intact cells are represented by “A-P-“, dead cells “A-P+”, early 
apoptotic cells “A+P-“ and late apoptotic cells “A+P+”. The results were expressed as the mean +/- SD 
versus control. ** indicate significant differences between control at p < 0.01. 
 
Gene Expression of apoptosis related genes 
Apoptosis was evaluated at transcriptional level by the analysis of the expression of apoptosis 
related genes BAX, BCL2 and CASP3 (Fig. 2.10). In cells exposed to Cit30 AgNPs, there was a 
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trend for BAX expression to be upregulated, reaching statistical significance at low 
concentration (10 µg/mL) 24h exposure and at high concentration (40 µg/mL) 48h exposure. 
Moreover, BCL2 was found to be upregulated at 48h exposure to high concentration of Cit30 
AgNPs. On the other hand, the three genes showed consistent upregulation in cells exposed to 
PEG30 AgNPs. The statistical comparison between Cit30 and PEG30 AgNPs exposed cells 
showed that for both times and concentrations the expression level of the three selected genes 
was significant lower in cells exposed to Cit30 AgNPs. 
 
 
  
 
 
 
 
 
 
    
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.10: HaCaT gene expression of apoptotic genes, after 24h and 48h exposure to Citrate- and PEG- 
AgNPs. The results were expressed as the mean relative to control cells (normalized with the GAPDH 
reference gene) +/- SD versus control. 
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Cell cycle and clastogenicity 
Figure 2.11 shows the effect of Cit30 and PEG30 AgNPs on the cell cycle of HaCaT cells. 
Cit30 AgNPs in both doses induced a decrease in the percentage of cells in G0/G1 and an 
increase in the percentage of cells in G2, this effect being visible for both periods, but more 
pronounced at 48h (p < 0.01) (Fig. 2.11a).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.11: Effects of AgNPs on cell cycle dynamics, measured by flow cytometry, exposed for 24h and 
48h. a) citrate-coated AgNPs; b) PEG-coated AgNPs; and c) Ag ion. The results were expressed as mean 
and standard deviation. ** indicate significant differences between control at p < 0.01. 
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As for PEG30 AgNPs, in addition to a decrease in the number of cells in G0/G1 and a slight 
increase in cells at G2 there was a significant increase in the number of cells in S phase. An 
example of the histograms obtained after 40 µg/mL Cit30 and PEG30 AgNPs exposure during 
48h are shown in Fig. 2.12. HaCaT exposed to Ag
+
 for 24h and 48h did not induce significant 
alterations to the cell cycle dynamics (Fig. 2.11c). The coefficient of variation (CV) 
corresponding to cells in G0/G1 peak does not change significantly with exposure to Ag
+
 or 
AgNPs, comparatively to the respective controls (Table 2.2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.12: Examples of HaCaT cell cycle histograms obtained after AgNPs exposure, measured by flow 
cytometry. a) Control after 48h; b) 40 µg/mL of citrate- AgNPs after 48h; and c) 40 µg/mL of PEG- 
AgNPs after 48h. 
 
 
 
Table 2.2: Coefficient of variation (CV) values of cells exposed to AgNPs and Silver Ion. 
 
 
 
 
 
                                                                                                                    
Expression of cell cycle related genes 
Exposure to AgNPs significantly changed the expression levels of selected genes involved in 
cell cycle regulation (Fig. 2.13). Exposure to Cit30 AgNPs downregulated the expression of 
cyclin B1 gene (CCNB1) for 40 µg/mL at both time points. For PEG30 AgNPs CCNB1, 
expression was decreased for 40 µg/mL only at 48h exposure. The expression of the CDK2 
gene, for cells exposed to citrate- AgNPs was increased for 40 µg/mL at 24h and decreased at 
24h 48h 
Control 10 µg/mL 40 µg/mL Control 10 µg/mL 40 µg/mL 
Citrate coated AgNPs 5.8±0.82 5.9±0.67 8.3±0.87 5.3±0.84 6.9±1.43 9.3±1.89 
PEG coated AgNPs 5.3±0.998 5.6±0.79 5.7±0.77 5.3±1.0 6.4±1.14 6.4±0.62 
 Control 0.8 µg/mL Control 0.8 µg/mL 
Silver ion 6.1±1.24 6.5±1.5 11.9±1.97 10.6±2.22 
a b c 
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48h for the same concentration. The expression of the other genes tested was not significantly 
altered upon exposure to AgNPs.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.13: HaCaT gene expression of cell cycle genes after exposure to: a) and b) citrate-coated AgNPs 
24h and 48h, respectively; c) and d) PEG-coated AgNPs 24h and 48h, respectively. The results were 
expressed as mean relative to control cells (normalized with the GAPDH reference gene) and standard 
deviation. ** indicate significant differences between control at p < 0.01. 
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Discussion  
In this work, we have investigated the cellular effects of well-characterized AgNPs with 
different coatings (citrate and PEG) but the same nominal diameter (30 nm), in order to address 
the influence of NP surface coating on biological outcomes in keratinocytes, assessing, among 
other endpoints, less commonly reported changes in cell cycle dynamics. Further motivation for 
testing the toxicity of these NP types arose from the growing interest in using PEG-coated NPs 
in nanomedicine applications (Jokerst et al. 2011) and the widespread use of citrate coating in 
AgNPs synthesis (Zhang et al. 2011), thus making it timely and useful to report on the cytotoxic 
effects of such particles.  
The characterization results revealed that AgNPs exhibited different time-course behavior in 
culture medium, depending on the coating surface. The hydrodynamic diameter of Cit30 AgNPs 
increased immediately after suspension in culture medium, which is in agreement with previous 
observations (Wang et al. 2014) and is likely to be due to the formation of a protein corona, as 
reported for metal nanoparticles (Casals et al. 2010; Maiorano et al. 2010). Moreover, some 
aggregation induced by the high ionic strength of the culture medium may also have occurred 
(El Badawy et al. 2012; Li et al. 2012; Robert 2010). Conversely, the hydrodynamic diameter of 
PEG30 AgNPs did not show significant variation in culture medium indicating high colloidal 
stability, which is likely to derive from steric repulsions (Caballero-Díaz et al. 2013), and lower 
propensity for the PEG coating molecules to be displaced by proteins (Michel et al. 2005).  
In terms of cell viability, evaluated through the MTT mitochondrial activity assay, Cit30 AgNPs 
were found to be more cytotoxic than PEG30 AgNPs. Although, to our knowledge, the direct 
comparison between these two NP types hasn’t been previously reported, Wang et al. (2014) 
found a significant decrease in the viability of bronchial BEAS-2B cells upon 24h exposure to 
20 nm citrate-coated AgNPs at 6.25-50 µg/mL, while Song et al. (2012) showed PEG-coated 
AgNPs to cause significant viability decreases in human liver cells (HL-7702) at concentrations 
as low as 6.25 μg/mL. Differences in NP properties (e.g. size and surface area) as well as cell 
type-dependent effects (e.g. uptake) may account for the discrepancy in relation to our results. 
The coating substances per se were not responsible for the larger cytotoxicity hereby found for 
Cit30 NPs compared to PEG30 NPs, as neither of them decreased cell viability at the 
concentrations present when AgNPs were administered to cells. Also, Cit30 and PEG30 NPs 
showed similar dissolution behavior in culture medium, thus extracellular Ag
+
 could not justify 
the difference in the toxicity of the two NP types. Also, the tested doses of Ag
+
 (0.8 µg/mL a 
concentration bellow IC50 value) did not induce changes in the cell cycle dynamics. As 
observed by Cronholm et al. (2013) after cells exposure to AgNO3, released silver ions outside 
the cells can act by disrupting the cell membrane, which can explain the fact that lower 
** ** 
** ** 
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concentrations of silver ion induce more cytotoxicity than AgNPs. This could also explain why 
the concentrations below IC50 for silver ion did not cause cell cycle alterations. Moreover, the 
results of Kim et al. (2009) indicated that AgNPs treated cells have limited exposure to silver 
ions, despite their potential release from AgNPs in cell culture; the authors reported also that 
AgNPs cytotoxicity is primarily the result of oxidative stress and is independent of the toxicity 
of silver ion. Cronholm and coworkers (2013) also suggest that silver ion toxicity differs from 
the mechanisms of AgNP cytotoxicity since this last one resulted from a mechanism driven by 
oxidative stress and released silver ions after cellular uptake of the particles. Accordingly, Gliga 
and co-workers (Gliga et al. 2014) have shown that AgNPs supernatants, containing ionic silver, 
did not affect cells. On the other hand, the intracellular release of Ag
+
 following cellular uptake 
(sometimes called the Trojan horse effect) has been proposed by several authors (Hsiao et al. 
2015; Park et al. 2010) to be greatly responsible for AgNPs toxicity. Thus, it is possible that the 
different coatings used in our study influenced cytotoxicity indirectly, by modulating the 
interaction of NPs with cells, namely the extent of NP uptake and intracellular release of Ag
+
.   
To quantitatively evaluate the cellular uptake of AgNPs we have used flow cytometry and 
related the increase in side scatter (SS) intensity with an increase in intracellular AgNPs, as 
previously described (e.g. Greulich et al. 2011, Zucker et al. 2013). The obtained data suggested 
that PEG30 AgNPs were taken up by cells to a lower extent than Cit30 AgNPs, which could 
justify the lower cytotoxic potential of the former particles. Concordantly, Caballero-Díaz et al 
(2013) showed that pegylation of polymer-coated AgNPs reduced cellular uptake and toxicity to 
mouse embryonic fibroblasts (NIH/3T3 cells). Furthermore, it can be postulated that thiolated 
PEG may complex Ag
+
 ions and lower their bioavailability and toxicity, as proposed for PVP-
coated AgNPs (Wang et al. 2014). Also, when evaluating the uptake rates of gold NPs on 
human alveolar epithelial cells (A549), Brandenberger et al (2010) observed that significantly 
more plain NPs (i.e., stabilized with citrate buffer) could enter the cells than PEG-coated gold 
NPs. 
ROS can be generated either by a direct pro-oxidant effect of the NP or endogenously upon 
interaction with cellular material. In our work, both NP types caused a similar increase in 
intracellular ROS, supporting ROS-induced cytotoxicity, although not explaining the higher 
toxicity of Cit30 compared to PEG30 AgNPs. Enhanced ROS production has been often 
highlighted as a major cause for AgNP toxicity in several cell types (Kim and Ryu 2013), 
although it has also been reported, in human liver and colon cells, that AgNPs could cause 
cytotoxicity without oxidative stress (Sahu et al. 2014). Furthermore, Chairuangkittia et al. 2013 
described that the toxicity of AgNPs to A549 was due both to ROS dependent and independent 
pathways, the latter related with cell cycle arrest. Our results show that both AgNPs induce 
arrest in cell cycle at 24h with more drastic effects for Cit30 at 48h. In fact, in previous studies 
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from our group (Carrola et al. 2016) the cell metabolic profile of HaCaT cells exposed to the 
same Cit30 AgNPs was evaluated and an increase in GSH was detected, suggesting the 
triggering of a protective mechanism against ROS-induced oxidative damage, which is 
consistent with the strong antioxidant capacity of this cell line (Mukherjee et al 2012). 
Therefore, from our results we can hypothesize that the induction of ROS is one of several 
mechanisms of AgNP induced toxicity in HaCaT cells. Further studies are needed to clarify how 
the different coatings modulate ROS dependent and independent pathways of AgNPs induced 
toxicity.  
Regarding cytokine release, the only significant effect was a decrease in MCP-1 production 
compared to control cells, caused in similar extent by Cit30 and PEG30 NPs. Other cytokines, 
namely IL-1β, IL-6, IL-10 and TNF-α did not vary upon AgNPs exposure. These results are 
comparable to those reported by Orlowski et al. (2013), where AgNPs coated with tannic acid 
led to a decrease of MCP-1 and non-relevant changes in the IL family in murine monocytes and 
keratinocytes cells. However, the same study reported an increase of MCP-1 after exposure to 
unmodified AgNPs, showing that coating can influence the inflammatory response to AgNPs. 
Oppositely to our results, increases in cytokines release have also been reported by others 
(Suliman Y et al. 2015; Yang et al. 2012); different cell types as well as different properties of 
the AgNPs tested may account for the discrepancies observed. Also, adsorption of cytokine 
proteins onto the NP surface may have occurred contributing to a decrease in protein function 
(Brown et al. 2010). 
Apoptosis and necrosis results showed that Cit30 AgNPs increased the number of necrotic/late 
apoptotic cells, as well as early apoptotic cells. A slight increase of apoptotic and necrotic A549 
cells after exposure to citrate-stabilized AgNPs has also been reported by Foldbjerg et al. 
(Foldbjerg et al. 2012). On the other hand, PEG30 AgNPs did not significantly influence these 
populations, although a trend to increase early-apoptotic cells was seen, in agreement with the 
results reported by Zhang and co-workers (2015) for male somatic Leydig (TM3) and Sertoli 
(TM4) cells. Interestingly, in the present work, the expression of apoptosis-related genes was 
also found to differ between Cit30 and PEG30 AgNPs. In particular, PEG30 AgNPs increased 
the expression of BAX (pro-apoptotic), BCL-2 (anti-apoptotic) and CASP-3 genes at both 
concentrations and time points. Piao and co-workers (2011) observed that AgNPs induced a 
mitochondria-dependent apoptotic pathway via modulation of BAX and BCL-2 expressions, 
resulting in the disruption of mitochondrial membrane potential, followed by cytochrome c 
release from the mitochondria and activation of caspases 9 and 3. Furthermore, Jeyaraj and co-
workers (2015) found an upregulation of BAX, caspases-6 and -9 and downregulation of BCL-2. 
In our study, both BCL-2 and BAX and of the effector CASP-3 were upregulated, particularly by 
PEG30 AgNPs, supporting that these NPs were more prone to induce intrinsic apoptosis than 
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Cit30 NPs. This difference between the two NP types concerning the effects on 
apoptotic/necrotic cells and on the transcripts of apoptotic-related genes strongly suggests that, 
when exposed to PEG30 AgNPs, HaCaT cells may cope with the apoptotic cascade at the early 
stage, promoting apoptotic and antiapoptotic expression and resulting in lower cytotoxicity. The 
upregulation of BCL-2 by PEG30 AgNPs was particularly relevant. Belonging to the anti-
apoptotic protein family, it performs its anti-death function by sequestering monomeric BAX 
and BAK. It is known that certain cancer cells depend upon BCL-2 and other anti-apoptotic 
proteins for survival (Brunelle and Letai 2009). In contrast, Cit30 AgNPs seemed to act mainly 
at a necrotic and/or late apoptotic level and, in the cells undergoing apoptosis, this will lead to 
cell death. Overall, our data showed that Cit30 and PEG30 AgNPs differed in the way they 
induced apoptosis, with the former leading to necrotic/late apoptotic processes, and the latter 
stimulating both apoptotic and anti-apoptotic transcripts, which may modulate cells apoptotic 
response at the early stage. This influence of NP coating on the apoptotic/necrotic mechanisms 
was also evidenced by the PCA analyses (Figure 2.14). 
Both Cit30 and PEG30 AgNPs were found to induce changes on the cell cycle dynamics of 
HaCaT cells. In particular, Cit30 AgNPs induced a significant increase in the percentage of cells 
in G2, indicating an arrest at this phase, visible for both concentrations and time periods, while 
the PEG30 AgNPs induced an increase in the number of cells in S phase, more visible at 24h, 
pointing to an S phase delay. The cell cycle arrest in G2/M phase after exposure to NPs was 
previously related to DNA damage repair (AshaRani et al. 2009). Indeed, 24hin another report, 
we have presented data showing that Cit30 AgNPs induced DNA damage and micronucleus 
(MNi) formation, increased mononucleated cells, and decreased binucleated cells and the 
nuclear division index, thus pointing to clear cytostatic effects even at a low dose (~IC20) and 
after a short period of exposure (24h) (Chapter 4). Cell cycle arrest at G2 as a result of AgNP 
exposure was previously observed by others (AshaRani et al. 2009; Kang et al. 2012; Lee et al. 
2011; Wei et al. 2010). For instance, Song et al. (2012) found an increase in the percentage of 
liver cells at the G2/M phase upon 24h exposure to 100 µg/mL mPEG-SH coated AgNPs. Also, 
Foldbjerg et al. (2012) found that PVP-coated AgNPs significantly increased the percentage of 
A549 cells in G2/M and S phases. S phase delay was also observed by Liu et al. (2010) in 
HepG2 cells exposed to PVP-coated AgNPs. Furthermore, an increase in the sub-G1 population 
of cells (which may indicate apoptosis) was reported by Jiang et al. (2013) in CHO-K1 cells 
exposed to BSA-coated AgNPs and by Chairuangkitti et al. (2013) in A549 cells exposed to 200 
µg/mL AgNPs. Li et al. (2013) reported cell cycle arrest at G0/G1 phase and a shortened S 
phase after only 8 h of AgNPs exposure, showing that AgNPs may interfere in cell cycle 
regulation at different checkpoints. In the present work, we have also assessed the expression of 
selected cell cycle regulator genes. Exposure to Cit30 AgNPs at 40 µg/mL for 24 and 48h 
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induced downregulation of CCNB1, while for PEG30 AgNPs, the expression of CCNB1 was 
only significantly decreased after exposure for 48h. Cyclin B1, encoded by the CCNB1 gene, is 
a regulatory protein which complexes with CDK1, both playing a determinant role in G2/M 
phase transition of the cell cycle. In general, our results agree with the study of Foldbjerg and 
co-workers (2012), where they found downregulation of CCNB1 and CDK1 for the A549 cell 
line exposed to AgNPs during 24 and 48h. Furthermore, we found a statistically significant 
difference between the two NP types for the expression of CCNE1. Cyclin E1, encoded by the 
CCNE1 gene, forms a complex with CDK2, which accumulates at the G1-S phase and is 
degraded as cells progress through the S phase. CCNE1 expression was generally lower upon 
exposure to PEG30 compared to Cit30 exposure, which agrees with the increase in the 
percentage of cells in S phase observed for PEG30 AgNPs. AshaRani et al. (2012) also reported 
downregulation of CCNB1 and CCNE1 genes in lung and brain cells exposed to AgNPs. In 
summary, as corroborated by the PCA analysis (Figure 2.14), coating influenced the way that 
AgNPs interfered with the cell cycle, with Cit30 AgNPs leading to an impairment of the MPF 
(maturation promoting factor) complex and blocking cells in G2, and PEG30 AgNPs leading to 
a delay in the S-phase. Impacts on cell cycle are not routinely assessed for NPs, and we suggest 
that this response is tested for a wider range of NPs and cell types in the future. 
 
 
Conclusions 
In summary, this study demonstrates that the widely used citrate-coated AgNPs decreased 
the viability of HaCaT cells more severely than PEG-coated AgNPs. This difference was not 
due to putative effects of the coating molecules per se (as they produced no cytotoxicity), 
neither to the extent of extracellular release of ionic silver or the amount of ROS produced, as 
they were similar for both NP types. The differently coated AgNPs produced, however, distinct 
effects regarding the mode of cell death and cell cycle progression. While Cit30 AgNPs clearly 
induced apoptotic/necrotic death, cells exposed to PEG30 AgNPs appeared to be at an earlier 
phase of apoptosis mechanisms, as supported by gene expression analysis. With regard to the 
impact on cell cycle progression, both Cit30 and PEG30 AgNPs affected cell cycle regulation of 
HaCaT cells, but, again, citrate-coating induced more severe effects, showing earlier 
downregulation of the cyclin B1 gene and blockage of cells at G2. 
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Figure 2.14: Principal Component Analysis (PCA) was used to perform multivariate analysis. All 
multivariate analyses in this paper were carried out using the Canoco for Windows vs 4.5. The analysis 
was conducted for the medium values of 48h citrate- and PEG- AgNPs exposure. “Peg10” and “Peg40” 
represents PEG- AgNPs 10 µg/mL and PEG- AgNPs 40 µg/mL, respectively; and “Cit10” and “Cit40” 
represents citrate- AgNPs 10 µg/mL and citrate- AgNPs 40 µg/mL, respectively. 
 
 
Considering that AgNPs are present in a vast number of consumer products, it is important to 
determine if or which NPs are more cytotoxic. This study suggests that PEG-coating can be 
regarded as a good alternative to citrate stabilization of AgNPs used in industrial and medical 
applications, where it is important to reduce the toxicity towards human skin cells. The 
applicability of these findings to other cell types needs to be investigated in future studies. 
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Abstract 
Silver nanoparticles (AgNPs) are among the most commonly used engineered NPs and various 
commercially available products are designed to come in direct contact with the skin (wound 
dressings, textiles, creams, among others). Currently, there is limited understanding of the 
influence of coatings on the toxicity of AgNPs and in particular their ability to impact on AgNP 
mediated inflammatory responses. As AgNPs are often stabilized by different coatings, 
including citrate and polyethyleneglycol (PEG), in this study we investigate the influence of 
citrate (Cit10) or PEG (PEG10) coatings to 10 nm AgNP on skin using human HaCaT 
keratinocytes. AgNPs cytotoxicity and inflammatory response (nuclear factor (NF)-κB 
induction and cytokine production) of HaCaT were assessed after in vitro exposure to 10 µg/mL 
and 40 µg/mL 4, 24 and 48h. Results showed that although both types of coated AgNPs 
decreased cell proliferation and viability, Cit10 AgNPs were most toxic. NF-κB inhibition was 
only observed for the highest concentration (40 µg/mL) of PEG10 AgNPs, and the putative link 
to early apoptotic pathways observed in these cells is discussed. No production of IL-1β, IL-6, 
IL-10 and TNFα was stimulated by AgNPs. Cit10 and PEG10 AgNPs decreased the release of 
monocyte chemoattractant protein-1 (MCP-1) by HaCaT cells after 48h of exposure. As 
cytokines are vital for the immunologic regulation in the human body, and it is demonstrated 
that they may interfere with NPs, more research is needed to understand how different AgNPs 
affect the immune system. 
 
Keywords: Silver nanoparticles, Coating, Cytokines, HaCaT, Nanotoxicology, NF-κB, Skin, 
Viability. 
 
Introduction 
Nanotechnology-based consumer products are exponentially increasing and nanosilver-
containing products are among the most commonly used (Vance et al., 2015). Silver 
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nanoparticles (AgNPs) are widely used due to their enhanced physicochemical properties and 
biological activities such as their antimicrobial activity. Their applications range from medicine 
and industry to household and personal care products (EPA, 2010) or clothing (Abdelhalim and 
Jarrar, 2011; Behra et al., 2013; Benn and Westerhoff, 2008; Eckhardt et al., 2013; Nowack et 
al., 2011). The increased exploitation of AgNPs and consequent release into the environment 
raises concern about their possible impacts on the environment and on human health (Nowack 
and Bucheli, 2007). There is an array of AgNPs that are being exploited, which vary with 
respect to their physico-chemical properties (e.g. size, shape, charge, surface coating, dispersion 
state) (Ahlberg et al., 2014; Boonkaew et al., 2014; Comfort et al., 2014; Kim et al., 2012; Park 
et al., 2011b). Existing studies have demonstrated that the physico-chemical properties of 
AgNPs are able to influence their toxicity for different cell lines [eg., human keratinocytes 
(HaCaT and primary HEK) and normal fibroblasts (NHF), rat adrenal pheochromocytoma cell 
line (PC12), and mouse osteoblastic cell line (MC3T3-E1), fibroblasts (L929) and macrophages 
(RAW 264.7)]. However, little attention has been given to the coating-dependent toxicity of 
AgNPs. Thus, research on the toxicity of AgNPs of varied physico-chemical properties is 
critical in order to better predict the risks they pose. 
It has been reported that nanoparticle coating, media composition and ionic strength influence 
the surface chemistry, shape, aggregation state and dissolution of AgNPs, which in turn can 
differently affect their cellular uptake and biological effects (Tejamaya et al., 2012). Indeed, a 
few studies addressing the uptake (by embryonic fibroblasts NIH/3T3, keratinocytes HaCaT and 
hepatoma cells Hepa-1c1c7, respectively) of different coated AgNPs and their influence on 
cytotoxicity have been reported (Caballero-Díaz et al., 2013; Lu et al., 2010; Pang et al., 2015). 
Citrate is the most commonly used reducing and stabilizing agent of AgNPs, rendering NPs 
with a negative surface charge and providing colloidal stability through electrostatic repulsions 
(Sharma et al., 2009). Among other coating agents of AgNPs, low molecular weight 
polyethyleneglycol (PEG), which stabilizes AgNPs through steric interactions, has been 
increasingly used in biomedical applications as it enhances biocompatibility and increases blood 
circulation time (Ginn et al., 2014; Ryan et al., 2008). 
Assessment of the ability of NPs to induce inflammatory responses is commonly used as an 
indicator of toxicity. For example, Chalew and Schwab (2013) studied the inflammatory effects 
of AgNPs, titanium dioxide (TiO2NPs), and zinc oxide (ZnONPs) (0, 0.1, 1, 10, and 100 mg/L) 
on human intestinal Caco-2 and SW480 cells and found that all NPs increased IL-8 cytokine 
generation in both cell lines. Also, Park et al (2011a) observed that pro-inflammatory cytokines 
(IL-1, TNF-α, and IL-6) and Th0 cytokine (IL-2) were progressively increased by day 28 after a 
single intratracheal instillation of AgNPs  in mice. Suliman and co-workers (2013b) found that 
50 µg/mL AgNPs exposure to human lung epithelial (A549) cells significantly increased the 
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level of pro-inflammatory cytokines, namely interleukin-1β (IL-1β) and interleukin-6 (IL-6). 
Yang and collaborators also observed IL-1β release by human blood monocytes in response to 
AgNPs (Yang et al., 2012). However, Wong et al (2009) found an anti-inflammatory effect of 
AgNPs to two mouse macrophage cell lines, RAW264.7 and J774.1, where AgNPs blocked 
TNF-α production. On the other hand, we could not found studies reporting the induction of 
anti-inflammatory cytokines after exposure to NPs (Murray et al., 2013; Orlowski et al., 2013; 
Samberg et al., 2009). Cytokines can strongly activate inflammatory responses and cell death in 
various tissues, including the skin (Fujiwara and Kobayashi, 2005; Graves et al., 2004). Indeed, 
a study on the effects of UVB radiation using HaCaT cells reported an increase of various pro-
inflammatory cytokines - interleukin (IL)-1beta, IL-6, IL-8, interferon (IFN)-gamma, 
granulocyte-colony stimulating factor (G-CSF), macrophage inflammatory protein (MIP)-1beta, 
and tumor necrosis factor (TNF)-alpha (Yoshizumi et al., 2008). Murray et al (2013) found 
increased IL-8 and IL-6 in human epidermal keratinocytes (HEK cells) after exposure to 
superparamagnetic iron oxide (SPION) NPs (2.6,   5.2,   13,   or   26 µg/cm2 for 24h). In other 
study using HEK cells, quantum dot NPs significantly increase IL-6 at 1.25 nM to 10 nM, while 
IL-8 increased from 2.5 nM to 10 nM after 24h and 48h (Zhang et al., 2008). Thus, as products 
containing AgNPs can be applied to the skin (e.g. wound dressing), and as there are 
experimental evidence for skin penetration of  25 ± 7 nm AgNPs (also in intact skin) (Larese et 
al., 2009)  and 20 – 40 nm AgNPs (George et al., 2014), the human keratinocyte cell line 
HaCaT was used as an in vitro model in this study. It is well known that cytokines play crucial 
roles in immunologic regulation in the human body and are involved in the induction of 
proliferation, differentiation, and cell death in many cell types (Yarilin and Belyakov, 2004). 
Moreover, activation of the transcription factor nuclear factor kappa B (NF-κB) has been shown 
to play a central role in the enhanced expression and regulation of cytokine genes (Kelso, 1998). 
There is also evidence that carbon NPs can activate NFkB in macrophages which stimulates 
TNFα production (Brown et al., 2004). To our knowledge, the activation of NFkB in 
keratinocytes has not been studied previously. 
In this study, we aimed to compare the inflammatory responses of HaCaT cells exposed to well-
characterized 10 nm AgNPs coated with citrate or PEG. In particular, the effects on viability, 
expression of the pro-inflammatory transcription factor NF-κB and production of cytokines such 
as interleukin-1 beta (IL-1β), IL-6, tumour necrosis factor-alpha (TNF-α), IL-10 and monocyte 
chemoattractant protein-1 (MCP-1) were assessed. 
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Material and methods 
Chemicals 
Sterile, purified and endotoxin-free silver nanoparticles (Biopure AgNPs 1.0 mg/mL in water), 
with a diameter of 10 nm and a citrate or polyethyleneglycol (PEG) surface, designated as Cit10 
and PEG10, respectively, were purchased from Nanocomposix Europe (Prague, Czech 
Republic). Dulbecco’s modified Eagle’s medium (DMEM), fetal bovine serum (FBS), 
antibiotics and phosphate buffer saline (PBS, pH 7.4) were purchased from Life Technologies 
(Carlsbad, CA, USA). 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), 
Mowoil and DAPI were obtained from Sigma-Aldrich (St. Louis, MO, USA). 
 
Physicochemical characterization of AgNPs  
The morphology and size of AgNPs were assessed by transmission electron microscopy (TEM) 
using a transmission electron microscope Hitachi H9000 NAR (Hitachi High-Technologies 
Europe GmbH, Germany) operating at 300 kV. The hydrodynamic diameter and polydispersity 
index (PdI) were measured by dynamic light scattering (DLS) and the zeta potential was 
assessed by electrophoretic mobility, both measurements using a Zetasizer Nano ZS (Malvern 
Instruments, UK). Silver quantification measurements were performed by inductively coupled 
plasma optical emission spectrometry (ICP-OES) in an Activa M Radial spectrometer (Horiba 
Jobin Yvon), employing a charge coupled device (CCD) array detector, with a wavelength 
range of 166–847 nm and radial plasma view. Samples for ICP-OES were prepared by addition 
of 10 µL AgNPs (1.0 mg/mL) to 990 µL of either ultrapure water or complete culture medium, 
incubated for 0, 4, 24 or 48h, then centrifuged at 40000 rcf for 120 min at 4ºC (in accordance 
with the manufacturer’s recommendations) to deposit the nanoparticles and separate the 
supernatant, which was then digested with acid (HCl:HNO3 2:1 v/v) before ICP-OES analysis. 
 
Cell Culture 
The HaCaT cell line, a nontumorigenic immortalized human keratinocyte cell line (Boukamp et 
al., 1988), was obtained from Cell Lines Services (Eppelheim, Germany). Cells were grown in 
complete medium, i.e., Dulbecco’s modified Eagle’s medium, supplemented with 10% fetal 
bovine serum (FBS), 2 mM L-glutamine, 100 U/mL penicillin, 100 µg/mL streptomycin and 
250 µg/mL fungizone at 37°C in 5% CO2 humidified atmosphere. Cells were observed daily 
under an inverted phase-contrast Eclipse TS100 microscope (Nikon, Tokyo, Japan). For each 
experiment, cells were allowed to adhere for 24h and then exposed to Cit10 or PEG10 AgNPs 
(dispersed through vortex in cell culture medium). The effects were measured after 4, 24 and 
48h. 
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Viability assay 
Cell viability was determined by the colorimetric 3-(4,5- dimethyl-2-thiazolyl)-2,5-diphenyl 
tetrazolium bromide (MTT) assay, measuring intracellular reduction of tetrazolium salts into 
purple formazan by viable cells (Twentyman and Luscombe, 1987). Cells were seeded in 96-
well plates at a concentration of 6x10
4
 cells/mL. Fifty microliters of MTT (1 mg/mL) in 
phosphate buffered saline (PBS) were then added to each well, and incubated for 4h at 37°C, 
5% CO2. Medium was then removed and 150 µL of DMSO were added to each well for 
solubilization of formazan crystals. The optical density of reduced MTT was measured at 570 
nm in a microtiter plate reader (Synergy HT Multi-Mode, BioTeK, Winooski, VT), and the ratio 
of cell metabolic activity (MA, a usual marker for cell viability) was calculated as: MA = 
[(Sample Abs –DMSO Abs) / (Control Abs – DMSO Abs)]*100. Three independent assays 
were performed with at least 2 technical replicates each and the results compared with the 
control (no exposure). 
 
Immunofluorescence of p65 subunit of NF-κB in human keratinocytes 
After the 4h treatments with 10 and 40 µg/mL of Cit10 or PEG10 AgNPs, coverslips were 
washed with PBS and permeabilized with 0.2% Triton X-100 for 15 min followed by three 
washes with PBS. Cells were treated with PBS containing BSA at a concentration of 1 mg/mL 
as a blocking agent for 1 hour. Cells were then washed three times with PBS and treated with 
anti-human NF-κB antibody (p65 subunit, Santa Cruz Biotechnology,Inc. Dallas, Texas USA) 
diluted 1/200 in PBS plus 0.5% BSA for 1 hour at room temperature. After three washes with 
PBS, coverslips were treated with a second antibody, Alexa fluor 488 anti-rabbit IgG diluted 
1:200 in PBS plus 0.5% BSA for 1 hour at room temperature. After three washes with PBS, 
coverslips were treated with 0.5 μg/ml DAPI in PBS plus 0.5% BSA for 20 seconds, washed in 
PBS and mounted on glass microscope slides using Mowoil. Cells were imaged using confocal 
microscopy. 
 
Cytokine estimation using cytometric bead array 
Cytokine production was assessed using Bioplex kits. Briefly, the supernatants (collected from 
cell viability studies, centrifuged and frozen at -80ºC) were used to estimate the release of the 
following cytokines from treated cells: interleukin-1 beta (IL-1β), IL-6, tumour necrosis factor-
alpha (TNF-α), IL-10 and monocyte chemoattractant protein-1 (MCP-1). Bead array kits were 
obtained from Beckton Dickinson (Oxford, UK) and a master mix prepared according to the 
manufacturer’s instructions. The master mix was incubated with each of the test supernatants for 
1 h, followed by the addition of detection beads and incubated for a further 2 h at room 
temperature. The beads were then washed in wash buffer and analysed using a BD 
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FACSArray
TM
 flow cytometer which had previously been set up and calibrated using standard 
beads for each cytokine under investigation. 
 
Statistical analysis 
The results are reported as mean ± standard deviation (SD) of 2 technical replicates in each of 
the 3 independent experiments. For MTT assay, the statistical significance between control and 
exposed cells was performed by one-way ANOVA, followed by Dunnet and Dunn’s method (as 
parametric and non-parametric test, respectively), using Sigma Plot 12.5 software (Systat 
Software Inc.). For the other assays, results were compared using two-way ANOVA, followed 
by Holm-Sidak test using also Sigma Plot 12.5 software (Systat Software Inc.). The differences 
were considered statistically significant for p < 0.05. 
 
Results 
Physicochemical characterization of AgNPs  
A summary of the physico-chemical properties of the NMs is provided in table 3.1. The 
spherical shape and diameter of the AgNPs were verified by transmission electron microscopy 
(TEM) and found to agree with the manufacturer information (Table 3.1). The wavelength of 
the maximum absorbance peak in the UV-Vis spectra also matched the expected values. 
Regarding the DLS assessment of hydrodynamic diameters (Dh), polydispersity indexes (PdI > 
0.3) indicated large variability in particle size, especially for the Cit10 NPs, hence the Z-average 
sizes may lack accuracy. PEG10 NPs showed higher Dh than Cit10, as expected based on the 
larger size of PEG compared to citrate. The zeta-potential values confirmed Cit10 AgNPs to 
have a negative surface charge (-34 mV), which is expected as citrate is using as a coating to 
prevent agglomeration/aggregation through electrostatic repulsions, whereas PEG10 NPs, which 
are also designed to stabilize NPs through steric interactions, showed a less negative surface (ζ -
14 mV). We have also assessed the amount of ionic silver (Ag
+
) released from AgNPs, which 
was found to be low in water (< 1%), but significantly increased when the NPs were incubated 
in culture medium. Dissolved Ag
+ 
reached 14% in Cit10 suspensions after 4h and 11 % in 
PEG10 suspensions after 24 and 48h, this lower value likely relating to a more efficient 
protection of PEG coating against NP surface oxidation. 
 
Effects on cell growth and viability 
HaCaT cells in control conditions (exposed to cell culture medium) showed typical morphology 
(Fig. 3.1a and 3.2a). When cells were exposed to Cit10 and PEG10 AgNPs for 24h (3.1b, 3.1c, 
3.1d and 3.1e), their confluence decreased, especially at the highest concentration (40 µg/mL). 
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The decrease in cell confluence was more visible after 48h (Fig. 3.2b, 3.2c, 3.2d and 3.2e). 
Morphologically, exposed cells (to both Cit10 and PEG10 NPs) showed large 
precipitates/aggregates of AgNPs in the medium, and confluence appeared to be, on average, 
lower for Cit10 exposed cultures.    
 
 
Table 3.1. Physicochemical properties of AgNPs.  
 Cit10 PEG10 
D (nm)
a
 9.3±1.8 9.8±2.0 
D (nm)
b
 11.0±2.4 9.4±2.8 
Dh (nm)
c
 25.1±3.6 40.6±3.8 
PdI
c
 0.42-0.52 0.26-0.37 
ζ (mV)d -34.5±3.3 -14.3±1.0 
λmax
e
 (nm) 389 396 
%Ag
+
 in water 0h
f 
0.93±0.02 n.a. 
%Ag
+
 in DMEM 0h
f
 3.7±0.05 9.1±0.13 
%Ag
+
 in DMEM 4h
f
 14.3±0.22 6.0±0.12 
%Ag
+
 in DMEM 24h
f
 13.6±0.35 11.2±0.33 
%Ag
+
 in DMEM 48h
f
 12.9±0.16 11.2±0.34 
a
Diameter indicated by the manufacturer; 
b
Diameter measured by TEM; 
c
Hydrodynamic diameter and 
polydispersity index (PdI) measured by DLS; 
d
Zeta pontential assessed by electrophoretic mobility; 
e
Wavelength of maximum absorbance peak in the UV-Vis spectrum; 
f
Percentage of ionic silver in the 
AgNPs suspension (10 ug/mL). Standard deviations calculated for Dh, ζ and %Ag+ correspond to 3 
replicate measurements. n.a. Not available. 
 
 
The viability of HaCaT cells was negatively affected by both types of AgNP investigated in this 
study (Fig. 3.3). Relative to controls, the viability of exposed cells was significantly reduced (p 
< 0.05) upon exposure to Cit10 AgNPs at 10 µg/mL and 40 µg/mL after 4h, 24h and 48h. 
Following PEG10 AgNP exposure, the viability of cells following exposure at a concentration 
of 10 µg/mL was not affected at 4h but a significant reduction in cell viability was observed at 
24 and 48h at this concentration. At a concentration of 40µg/ml PEG10 NPs significantly 
decreased cell viability at all time points (4, 24 and 48h). 
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Figure 3.1: Light microscopy images (100X) of HaCaT cells exposed to AgNPs for 24h: a) 0, b) citrate- 
AgNPs 10 µg/mL, c) citrate- AgNPs 40 µg/mL, d) PEG-AgNPs 10 µg/mL and e) PEG- AgNPs 40 
µg/mL. Bar corresponds to 100 µm. 
 
 
 
 
 
 
 
 
 
Figure 3.2: Light microscopy images (100X) of HaCaT cells exposed to AgNPs for 48h: a) 0, b) citrate- 
AgNPs 10 µg/mL, c) citrate- AgNPs 40 µg/mL, d) PEG-AgNPs 10 µg/mL and e) PEG- AgNPs 40 
µg/mL. Bar corresponds to 100 µm. 
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Figure 3.3: Relative cell viability (%) of HaCaT after exposure to 10 and 40 µg/mL citrate- AgNPs or 
PEG- AgNPs, measured by MTT assay, for 4, 24 and 48h. Data expressed as mean and standard 
deviation. * indicate significant differences between control at p < 0.05. 
 
 NF-κB and inflammatory cytokine release 
Activation of NF-κB in HaCaT cells by AgNPs was evaluated by immunofluorescence; in its 
inactive state NFkB is located in the cytoplasm, and in its active state is localized in the nucleus. 
Figure 3.4a-c shows a positive control with 240 µM of H2O2 where there is a great intensity of 
p65 staining in the nucleus. Also, controls (including: cells only (no staining), cells stained with 
only the primary antibody and samples stained with the second antibody only) were done to 
check the autofluorescence in cells (data not shown). In control cells, most NFkB staining was 
localized in the cell cytoplasm, with occasional occurrence in the nucleus. Regarding AgNP 
exposed cells, there was no evidence of NFkB activation (i.e. no increase in the intensity of 
staining in the nucleus) (Fig. 3.4e-g). A decrease in p65 staining in the nucleus after exposure to 
40 µg/mL PEG10 AgNPs was observed comparing to control cells (Fig. 3.4h). 
The release of cytokines by HaCaT cells treated with AgNPs is shown in Figure 3.5. 
Lipopolysaccharide (LPS) stimulated a significant increase in MCP-1 release at 48h, when 
compared to the control. MCP-1 production significantly decreased following exposure of 
HaCaT cells to both AgNP types and was most pronounced at a concentration of for 40 µg/mL, 
compared to negative and positive controls (p < 0.001). No effects were observed on the other 
cytokines studied, IL-1β, IL-6, IL-10 and TNF-α, after exposure to both AgNPs at both times 
(data not shown). 
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Figure 3.4: a) - c) are fluorescence microscopy images (400X) of immunofluorescence of HaCaT cells 
treated with anti NF-kB p65 antibody after stimulation with 240 µM H2O2 for 10 min prior fixation. a) 
p65 subunit of NF-kB (alexa fluor 488 anti-rabbit IgG); b) DAPI staining the nucleus; c) Overlap of a and 
b images. d) - h) are confocal microscopy images of immunofluorescence of p65 subunits of NF-kB in 
human HaCaT keratinocytes exposed to AgNPs for 4h: d) 0 (control); e) 10 µg/mL of Cit10; f) 40 µg/mL 
of Cit10; g) 10 µg/mL of PEG10; h) 40 µg/mL of PEG10. Bar corresponds to 100 µm. 
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Figure 3.5: Cytokine release by HaCaT cells after 24 and 48h exposure to citrate- or PEG- AgNPs. 
Control + is a positive control by adding LPS to cells. Data represent the mean ± SEM (n = 3) of the 
concentration (pg /ml) of MCP-1 cytokine released from the cells after NPs treatment. ** indicate 
significant differences between control at p < 0.01. 
 
 
Discussion 
Citrate-coated AgNPs are among the most widely used AgNPs in multiple industrial 
applications  (Tolaymat et al., 2010), while the less used PEG-coated AgNPs  have gained 
increasing attention over recent years by e.g. biomedical industry due to their high stability and 
reduced reactivity (Brandenberger et al., 2010; Ginn et al., 2014; Ryan et al., 2008; Thorley and 
Tetley, 2013). Thus, there is need to better understand the influence of coatings of the biological 
effects of NPs, and in particular the inflammatory responses. As skin represents one of the 
major organs in contact with AgNPs, we compared the viability and inflammatory responses 
induced by citrate or PEG-coated AgNPs with a core diameter of 10 nm (Cit10 and PEG10 
AgNPs) in human epidermis keratinocytes (HaCaT cells). 
From the cytotoxicity results, Cit10 AgNPs were observed to be more toxic than PEG10 
NPs. The greater toxicity of Cit10 AgNPs was particularly relevant for low doses, since a lower 
concentration (10 µg/mL) of Cit10 NPs induced a statistically significant decrease in cell 
viability 4h post exposure, that was not evident for PEG AgNPs. At higher doses (40 µg/mL) 
and exposure periods, PEG10 and Cit10 AgNPs reduced viability in similar ways. These data 
** ** 
** ** 
Citrate- AgNPs PEG- AgNPs 
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suggest that, for these skin cells, the influence of coating is more important at low AgNP 
concentrations, whereas by increasing concentration, the influence of coating seems to be less 
relevant. A significant decrease in BEAS-2B (bronchial epithelial) cell viability upon exposure 
to 20 nm citrate-coated AgNPs at 6.25-50 µg/mL after 24h has been observed previously (Wang 
et al., 2014). Also, Song et al. (2012) showed a decrease on cell viability in human liver cell line 
- HL-7702 after exposure to PEG-coated AgNPs in dose- and time-dependent manner at doses 
from 6.25μg/mL. Future studies could assess the sensitivity of different cell types to the AgNPs 
used in this study. 
A complex interplay between environmental and genetic factors control immune system 
responses and when a deregulation of immune homeostasis occurs, host defense can be 
impaired and at the same time cause excessive and potential harmful inflammatory responses, 
which could be responsible for several immune disorders (Bieber, 2008; Morar et al., 2006). 
The ability of NPs to elicit pro-inflammatory responses is frequently assessed in in vitro and in 
vivo studies as a marker of their toxicity (eg, Schoemaker et al.,  (2002)). Thus, understanding 
NP-dependent regulation of cytokine production is essential since this process conditions shifts 
from acute to chronic phases of allergic inflammation (Rossi and Zlotnik, 2000). NF-κB 
pathways has been traditionally associated to increases in the production of inflammatory 
cytokines which could be implicated in the development of a variety of diseases (Driscoll et al., 
1997; Mossman and Churg, 1998). AgNPs did not activate NFkB in HaCaT cells in this study. 
In fact, NF-κB may be inhibited after exposure to the higher concentration (40 µg/mL) of 
PEG10 AgNPs. It is described in literature that the inhibition or absence of NF-kB activation, 
induces apoptosis or sensitizes cells to apoptosis (Schoemaker et al., 2002). 
Murray et al (2013) found that a co-exposure of human epidermal keratinocytes (HEK cells) 
to superparamagnetic iron oxide (SPION) nanoparticles and UVB induced NF-κB activation 
and release of inflammatory mediators such as the cytokines IL-6 and IL-8. Carbon black NPs 
have also been demonstrated to induce NFkB activation in macrophages and to stimulate TNFα 
production (Brown et al., 2004). However, it has also been recognized that NF-κB signaling has 
important functions in the maintenance of physiological immune homeostasis, particularly in 
epithelial cells (Wullaert et al., 2011). In a previous work (Bastos et al., 2016 manuscript 
submitted), we have demonstrated, by Annexin-V and gene expression, that Cit30 AgNPs 
induced preferably necrotic pathways, while cells exposed to PEG30 AgNPs stimulated 
increases of cells in earlier phase of apoptosis (therefore a more reversible process) and no 
necrosis, supporting that coating conditions how these AgNPs influence the cell 
apoptosis/necrosis pathways. A major role of NF-kB pathways involve the regulation of anti-
apoptotic genes, by NF-KB directly binding and inhibiting CASP3, -7 and -9 which seems to be 
happening in citrate- AgNPs exposed cells (Schoemaker et al., 2002). Considering that only 
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PEG10 AgNPs inhibit NF-κB, we therefore hypothesize that this may be involved in the 
induction of apoptosis by activating CASP3 found in PEG30-exposed cells versus Cit30-
exposed ones. In the future we suggest that NF-kB activation/inhibition may be used to a greater 
extent when assessing the hazard of coating and AgNPs to better understand the mechanisms 
(i.e. cellular and molecular events) underlying their toxicity. On the other hand, Brown et al 
(2004) showed that ultrafine carbon black particles (UfCB)-induced nuclear translocation of 
NF-kB in human monocytes which occurs through ROS-mediated mechanism. Indeed, in our 
previous study Cit30 and PEG30 AgNPs induced a significant increase in the production of 
ROS by HaCaT cells at the highest dose tested (40 μg/mL), compared to control cells. However, 
the ROS levels were similar for both NP types which do not explain the NF-κB inhibition by 
PEG10 AgNPs. Thus, for further studies we also suggest the quantification of NF-kB activation 
(e.g. by western blotting) and determination of ROS production. 
Concerning cytokine release, neither Cit10 nor PEG10 AgNPs induced IL-1β, IL-6, IL-10, 
TNF-α and MCP-1 production by HaCaT cells. Instead, compared to control cells, they 
decreased MCP-1 production after 48h exposure, this reduction being more pronounced at the 
higher concentration (40 µg/mL). The information regarding the influence of AgNPs on the 
stimulation of these cytokines from keratinocytes release is scarce, and sometimes 
contradictory, as different exposure conditions, concentrations, coating, cell type, NP size and 
synthesis have been considered in the literature (Abbott Chalew and Schwab, 2013; Giovanni et 
al., 2015; Miethling-Graff et al., 2014; Orlowski et al., 2013; Samberg et al., 2010; Suliman Y 
et al., 2013a; Wong et al., 2009; Yen et al., 2009). For instance, Orlowski and co-workers 
(2013) found an increase of MCP-1 production in murine keratinocytes (murine 291.03C) and 
by monocytes (RAW 264.7) after exposure to unmodified AgNPs. Also, human umbilical vein 
endothelial (HUVEC) cells showed a significant increase of IL-6, IL-8 and MCP-1 at doses 
higher than 1 mg/L AgNPs (Shi et al., 2014). Moreover, confirming the inflammatory potential 
of AgNPs, several interleukins and TNF-α were reported to increase upon exposure of HEK 
cells (Samberg et al., 2010) and macrophages (Yen et al., 2010) to AgNPs. On the other hand, 
several authors reported an undetectable stimulation of cytokines in response to metal NPs, as 
observed in the present study. For example, Murray et al (2013) demonstrated that HEK cells 
exposed to superparamagnetic iron oxide nanoparticles maintained the IL-1β, IL-10 and TNF-α 
below detectable levels (while increasing IL-6); and also that mouse epidermal cells ( JB6 P+) 
maintained INF-γ and IL-12 below the detectable levels after exposure to the same 
nanoparticles. Similarly, Samberg et al (2010) did not find detectable levels of IL-10 in HEK 
cells exposed to unwashed AgNPs. In mice peritoneal tissues and in RAW cells, Wong et al 
(2009) demonstrated that AgNPs have an anti-inflammatory effect decreasing TNF-α, and INF-
γ. Also, Parnsamut and Brimson (2015) found that AgNPs inhibited TNF-α expression in 
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leukemic cell lines. It is known that cytokines can adsorb onto the surface of particles, which 
may compromise their detection (Brown et al., 2010). Thus, it should not be excluded that 
AgNPs may induce cytokine production by keratinocytes but that the cytokines bind to the 
AgNP surface to prevent their detection. How proteins bind to nanoparticles is currently an 
important topic of debate. For example, Deng et al (2013) showed that human plasma proteins 
differently bind to positively and negatively charged polymer-coated gold NPs, which elicited 
different biological responses, and that only the negatively charged nanoparticles induced 
cytokine release from THP-1 cells. While proteins can bind to different nanoparticles, the 
biological outcome may not be the same. Selection of cytokines for assessment in this study was 
prioritized based on the outcome of a literature search which identified cytokines that are 
commonly produced following exposure of cells to NPs. Future studies could therefore assess a 
wider panel of cytokines.  
In summary, our study demonstrated that while citrate- and PEG-coated AgNPs decreased 
the viability of HaCaT cells, citrate coated AgNPs were more cytotoxic than PEG coated NPs, 
particularly at low concentrations and shorter incubation times. At higher AgNPs concentration, 
the influence of coating became less relevant. Also, we demonstrated that, independent of the 
coating, AgNPs did not induce cytokine production, and decreased MCP-1 release. Finally, 
PEG10 AgNPs at high concentrations inactivated the transcription factor NF-κB, and putative 
correlation with anti-inflammatory and anti-apoptotic homeostasis should be further explored.  
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Abstract 
Silver nanoparticles (AgNPs) are widely used in industrial, cosmetic and biomedical products, 
skin frequently being the first exposed organ. It is widely recognized that the characteristics of 
AgNPs (e.g .size, coating) may influence their cytotoxic effects, but their correlation with DNA 
damage and mitotic disorders remains poorly explored. In this study, human keratinocytes 
(HaCaT cell line) were exposed to well-characterized 30 nm AgNPs coated with citrate and 
their effects on viability, DNA fragmentation (assessed by the Comet assay) and micronuclei 
(MNi) induction (assessed by the cytokinesis-block micronucleus cytome assays, CBMN) were 
investigated. The results showed that 10 and 40 µg/mL AgNPs decreased cell proliferation and 
viability and induced a significant genetic damage. This was observed by an increase of DNA 
amount in comet tail which linearly correlated with dose and time of exposure. Also, 
cytostaticity (increase of mononucleated cells) and MNi rates increased in treated cells. 
Contrarily, no significant changes were observed in nucleoplasmatic bridges (NPBs) nor in 
nuclear buds (NBUDs), although an increasing trend was observed in NBUDs in all conditions 
and periods. The cytostatic effects on HaCaT cells were also shown by the decrease of their 
nuclear division index. Thus, both comet and CBMN assays supported the observation that 
citrate-AgNPs induced genotoxic effects on HaCaT cells. Considering that AgNPs are present in 
a vast number of consumer products, for e.g. nanomedicine skin applications and formulations, 
more research is needed to determine the properties that confer less toxicity of AgNPs to 
different cell lines. 
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Introduction 
Nanomaterials have great prospects for development of new products and applications in 
various sectors, thus making nanotechnology an increasingly important field. According to the 
inventory of nanotechnology-based consumer products compiled by the Project on Emerging 
Nanotechnologies (http://www.nanotechproject.org/cpi), nanosilver-containing products 
represent ~24% of all commercially available nanoproducts. Due to their physicochemical and 
biological properties, namely the efficient antimicrobial activity, silver nanoparticles (AgNPs) 
are often used in medicine, industry, and a vast range of consumer products, including clothing 
and cosmetics (Abdelhalim &Jarrar 2011, Behra et al. 2013, Benn &Westerhoff 2008, Eckhardt 
et al. 2013, Nowack et al. 2011). However, their impressive and useful characteristics and their 
rapid dissemination may become problematic in a toxicological perspective. In the last decade, 
serious concerns about their possible impacts on the environment and human health have 
emerged (Dusinska et al. 2013, Hillegass et al. 2010, Nowack &Bucheli 2007, Promtong 2015, 
Pumera 2011). The routes of human exposure to AgNPs may include dermal absorption, 
ingestion, inhalation and injection (Ahamed et al. 2010, Chen &Schluesener 2008), skin being a 
major entry route of AgNPs into the body.  
There are many in vitro studies focused on the cytotoxicity of AgNPs (Li et al. 2014, Smita et 
al. 2012, Souza et al. 2016, Zhang et al. 2014), but the mechanisms of AgNPs-induced 
genotoxicity are not completely understood (Browning et al. 2013). Furthermore, subtle effects 
not necessarily causing cell death should be taken into account. One important effect is damage 
to DNA, as genetic instability is associated with cancer development (Karlsson 2010). 
Nanoparticles may induce DNA damage through different mechanisms: it was shown that they 
may cause oxidative stress, increasing the number of reactive oxygen species (ROS) either by 
generating oxidants such as the reactive hydroxyl radical (OH·) and/or by stimulating cells to 
produce oxidants/genotoxic compounds, which may eventually affect mitochondrial electron 
transport (e.g. inducing cytochrome P450 enzymes) (Vrček et al. 2014). Particles ability to 
cause inflammation and thus secondary formation of oxidants by inflammatory cells was also 
demonstrated (Knaapen et al. 2004b). Moreover, their eventual direct access to DNA via 
transport into the nucleus must not be excluded, despite being unlikely to occur since nuclear 
pore complex is less than 8 nm in diameter (Knaapen et al. 2004a, Terry et al. 2007). However, 
nanoparticles may contact with DNA during mitosis, when the nuclear membrane breaks down, 
enabling direct interactions with DNA. For example, it was demonstrated that AgNPs 
interference with microtubules during mitosis could give rise to aneuploidy cells (Gonzalez et 
al. 2008). Particles or intracellular metal ions from particles can also enhance the permeability 
of the lysosomal membrane. This permeability may lead to the release of DNase into the 
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cytoplasm and possibly into the nucleus, where it could cut DNA (Banasik et al. 2005).  
Different methods have been used to assess the genotoxicity of nanomaterials (Butler et al. 
2015, Gonzalez et al. 2008, Landsiedel et al. 2009, Singh et al. 2009). In their review on 
nanoparticles genotoxicity, Landsiedel et al (2009) stressed the usefulness of the comet assay to 
assess genotoxicity of several nanoparticles (e.g. TiO2NP, AuNP, SiNP, CoCr, Carbon 
nanotube, Ni and Co nanopowder). More recently, other studies used the comet assay to 
demonstrate AgNPs genotoxicity on human peripheral blood mononuclear cells (Orta-García et 
al 2015), untransformed fibroblasts (AgNPs were more toxic that CeO2 or TiO2) (Franchi et al 
2015), hepatoma and leukemia cells and dermal and pulmonary fibroblasts (Ávalos et al 2015), 
and human microvascular endothelial cells (Castiglioni et al 2015). Also, AgNPs induced DNA 
damage (due to oxidative stress) in human epithelial embryonic cells, but the authors reported 
that it was a transient effect, likely due to DNA repair (Rinna et al 2005). Additionally, a Comet 
chip technology was used to address multiple NP genotoxicity in both suspension human 
lymphoblastoid (TK6) and adherent Chinese hamster ovary (H9T3) cell lines (Watson et al 
2014). Micronuclei (MNi) are induced by several genotoxic carcinogens and are indicative of 
numerical and/or structural chromosomal aberrations (Landsiedal et al 2009). Using the CBMN 
technique, TiO2NPs were shown to cause an increase in micronucleated binuclear cells in 
WIL2-NS human B-cell lymphoblastoids (Wang et al 2007). Also, Gurr et al (2005) showed 
that TiO2 anatase particles induced oxidation and micronuclei formation in human bronchial 
epithelial cells. More recently, Li and co-workers (2013) found dose-dependent increases of 
micronucleation in primary Syrian hamster embryo (SHE) cells after exposure to AgNPs, 
suggesting AgNPs-induced genotoxicity. Also, low doses of polyethylenimine-coated AgNPs 
induced a chromosomal aberration effect and an increase of MNi in HepG2 cells (Kawata et al. 
2009). Jiang et al (2013) reported an induction of MNi in Chinese hamster ovary cells (CHO-
K1) after exposure to BSA-AgNPs. AgNP-induced micronuclei formation has also been shown 
inhuman lung fibroblast cells (IMR-90), human glioblastoma cells (U251) (AshaRani et al 
2009), and HeLa cells (Xu et al 2012), the latter being affected via the JAK-STAT signal 
transduction pathway. For HaCat cells, the only data available has been reported by Zanette et al 
(2011), who found long-lasting inhibition of cell growth after exposure to PVP-coated AgNPs, 
confirming an antiproliferative effect of this type of AgNPs. However, no information is 
available regarding citrate-coated AgNPs, one of the most widely used types of AgNPs. In this 
work, we have used methods providing multiparametric information, namely the single-cell gel 
electrophoresis (comet) assay and the cytokinesis blocked micronucleus (CBMNs) assay, to 
determine the genotoxicity potential of citrate- AgNPs on a human keratinocyte cell line 
(HaCaT). 
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Material and methods 
Chemicals 
Sterile, purified and endotoxin-free silver nanoparticles (Biopure AgNPs 1.0 mg/mL), with a 
diameter of 30 nm and a citrate surface, were purchased from Nanocomposix Europe (Prague, 
Czech Republic). This AgNPs have a hydrodynamic diameter (Z-average size) of 43.3 ± 0.5 in 
water and 64.8 ± 0.4 in cell culture medium. Their polydispersity index (PdI) is 0.25-0.26 and 
their zeta potential () -42.7 ± 2.7. Dulbecco’s modified Eagle’s medium (DMEM), fetal bovine 
serum (FBS), antibiotics and phosphate buffer saline (PBS, pH 7.4) were purchased from Life 
Technologies (Carlsbad, CA, USA). 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT) and dimethyl sulfoxide (DMSO) were obtained from Sigma-Aldrich (St. Louis, 
MO, USA). H2O2 were purchased from Sigma-Aldrich, St. Louis, MO. Cytochalasin B was 
from AppliChem, Darmstadt, Germany. 
 
Cell Culture 
The HaCaT cell line, a non-tumorigenic immortalized human keratinocyte cell line (Boukamp et 
al. 1988), was obtained from Cell Lines Services (Eppelheim, Germany). Cells were grown in 
complete medium, i.e., Dulbecco’s modified Eagle’s medium, supplemented with 10% fetal 
bovine serum (FBS), 2 mM L-glutamine, 100 U/mL penicillin, 100 µg/mL streptomycin and 
250 µg/mL fungizone at 37°C in 5% CO2 humidified atmosphere. Cells were daily observed 
under an inverted phase-contrast Eclipse TS100 microscope (Nikon, Tokyo, Japan). For each 
experiment, cells were allowed to adhere for 24h and then medium was replaced with fresh 
medium containing citrate-coated AgNPs. The effects were measured after 24 and 48h. 
Throughout the experiments, cultures were routinely visualized for confluence and cell 
morphology. 
 
Viability assay 
Cell viability was determined by the colorimetric 3-(4,5- dimethyl-2-thiazolyl)-2,5-diphenyl 
tetrazolium bromide (MTT) assay (Twentyman &Luscombe 1987). Cells were seeded in 96-
well plates and cultured as described above. Cells were exposed to citrate-coated AgNPs at 0, 
10 and 40 µg/mL (corresponding to IC20 and IC50, respectively). Cell viability was measured 
after 24 and 48h. Briefly, 50 µL of MTT (1 mg/mL) in phosphate buffered saline (PBS) were 
added to each well and incubated for 4h at 37°C, 5% CO2. Medium was then removed and 150 
µL of DMSO were added for solubilization of formazan crystals. The optical density of reduced 
MTT was measured at 570 nm in a microtiter plate reader (Synergy HT Multi-Mode, BioTeK, 
Winooski, VT). Three independent assays were performed with at least 2 technical replicates 
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each. The concentrations used of AgNPs in this study were higher than the Ag
+
 concentration 
released from citrate-coated AgNPs at time 0h: 3.77% in 10µg/mL AgNPs (Fig. 2.2; Chapter 2), 
corresponding to 0.377 µg/mL of Ag
+
, an Ag
+
 dose which did not cause significant cytotoxicity, 
as assessed by MTT (Fig. 2.4; Chapter 2). 
 
Comet assay 
The Comet assay was performed according to Singh et al (1998) and Tice et al (2000). Briefly, 
cells were seeded in 6-well plates and, after exposure, they were washed, detached, centrifuged 
for 300g during 4 min and the pellets ressuspended in PBS. For a positive control, cells were 
ressuspended in 100 µM H2O2 for 5 min, centrifuged at 300 g for 5 min and ressuspended in 
PBS. 50 µL of cell suspension and 50 µL of low melting point agarose were added to slides 
previously prepared with normal melting point agarose. A coverslip was immediately added and 
the slides were placed at 4ºC for 10 min. After agarose solidification, the coverslip was removed 
and the slides were immersed in a lysis solution (2.5 M NaCl, 100 mM Na2EDTA, 10 mM Tris-
base, 10 M NaOH, 2% Triton X-100) cooled at 4◦C for at least 1h. Slides were then placed in 
cold electrophoretic buffer (200 mM Na2EDTA, 10 mM NaOH, pH 13), in darkness for 20 min, 
and electrophoresis was performed for 30min at 0.8V/cm, 300mA. The slides were washed two 
times during 10 min in cold PBS, pH 7.4 (as a neutralizing buffer) and dried at room 
temperature, in darkness. For comet scoring, slides were rehydrated with dH2O for 30 min, 
stained with ethidium bromide (20 µg/mL) using a Pasteur pipette (flooding the slide) for 20 
min and water excess was removed with dH2O during 20 min. The slides dried overnight at 
room temperature and at the moment of visualization they were rehydrated with one drop of 
dH2O, covered with a coverslip. Slides were observed under the fluorescence microscope 
Eclipse 80i (Nikon, Tokyo, Japan). For each treatment, 2 gels from each sample were analyzed 
by visual scoring of 100 comets per duplicate gel, quantified by visual classification of 
nucleoids into five comet classes (Fig. 4.1), according to the tail intensity and length, from 0 (no 
tail) to 4 (almost all DNA in tail). The total score was calculated on a scale of 0-400 arbitrary 
units according to Collins (2004) by multiplying the percentage of nucleoids in each class by the 
corresponding factor, according to this formula: GDI (genetic damage indicator) = [(%nucleoids 
class 0)x0] + [(%nucleoids class 1)x1] + [(%nucleoids class 2)x2] + [(%nucleoids class 3)x3] + 
[(%nucleoids class 4)x4]. 
 
 
 
 
Figure 4.1: Examples of the five comet classes for the nucleoids visual scoring quantification. 
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Cytokinesis-block micronucleus (CBMN) assay 
The cytokinesis-block micronucleus assay (CBMN) was performed according to Fenech (2007). 
Briefly, cells were seeded on coverslips inside 6-well plates incubated for 24h and, after 
exposure, cytochalasin B at 3.5μg/ml was added to each well and incubated during 29 h, in 
order to block cytokinesis. Cells were then fixed with absolute methanol cooled at 4ºC during 
15 min and removed from the 6-well plates. Samples were stained with acridine orange (Merck, 
Darmstadt, Germany), and mounted in slides. These samples were scored for nuclear division 
index (NDI), micronuclei (MNi), nucleoplasmic bridges (NPBs) and nuclear buds (NBUDs) 
(Fig. 4.2). NDI was calculated by scoring at least 500 cells for the presence of 1, 2, 3, or 4 
nuclei, through the formula: NDI = (M1 + 2 x M2 + 3 x M3 + 4 x M4)/N, where M1–M4 is the 
number of cells with 1–4 nuclei, and N is the total number of cells scored. The NDI and the 
proportion of binucleated cells provide the information about mitogenic response and cytostatic 
effects of AgNPs. MNi, NPBs and NBUDs were scored in 1000 binucleated cells per replicate 
(2 replicates per concentration) and MNi was examined for the presence of 1, 2, or more MNi. 
 
 
 
 
Figure 4.2: Examples of a) micronuclei (MNi), b) nucleoplasmic bridges (NPBs) and c) nuclear buds (NBUDs). 
 
Statistical analysis 
The results are reported as mean ± standard deviation (SD) of 2 technical replicates in each of 
the 3 independent experiments. For the MTT assay, the statistical significance between control 
and exposed cells was assessed by one-way ANOVA, followed by Dunnet or Dunn’s method 
(parametric and non-parametric tests, respectively), using Sigma Plot 12.5 software (Systat 
Software Inc.). For the other assays, results were compared using two-way ANOVA, followed 
by Holm-Sidak test using also Sigma Plot 12.5 software (Systat Software Inc.). The differences 
were considered statistically significant for p < 0.05. 
 
Results 
Cell Viability 
The viability of HaCaT cells was negatively affected by citrate- AgNPs (Fig. 4.3). Relatively to 
controls, the viability of exposed cells was significantly reduced (p < 0.01) upon exposure to 
AgNPs at both times, 24 and 48h, and both concentrations, 10 and 40 µg/mL. The effect was 
more severe in cells exposed to 40 µg/mL of AgNPs with a viability reduction of ~50%. 
a b c 
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Figure 4.3: Relative cell viability (%) of HaCaT  after exposure to 10 and 40 µg/mL AgNPs, measured by 
MTT assay, for 24h and 48h. Data expressed as mean and standard deviation. ** indicate significant 
differences between control at p < 0.01. 
 
Comet assay 
Negative control cells showed a predominance of cells in class 0 (~40% after 24h and ~25% 
after 48h) and class 1 (~55% after 24h and ~70% after 48h), and in both periods less 5% of cells 
showed nucleoids at class 2 or higher.  
In AgNP-exposed cells, the genetic damage indicator (GDI) significantly increased (p < 0.05) 
for both times and concentrations, the effects being more pronounced after 48h (Fig. 4.4). 
Regarding individual DNA damage level (Fig. 4.5), the amount of nucleoids at class 0 
significantly decreased after exposure to AgNPs for both times (p < 0.01). There was no 
difference between the amounts of cells at class 1 after both exposure times, however the 
amount of cells at class 2 significantly increased for both concentrations after 48h. Concerning 
the amount of cells at classes 3 and 4, which have a greater increase in DNA in tail, there was a 
significant increase for the higher concentration, 40 µg/mL, at both exposure times.  
Comparatively to the 24h exposure, the 48h exposure of AgNPs induced a significant decrease 
of cells at class 0 and a significant increase of cells at class 3. For the higher concentration, 40 
µg/mL, the amount of cells at class 1 and 2 was significantly increased after 48h compared to 
24h exposure 
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Figure 4.4: Mean values of genetic damage indicator (GDI) measured by the standard (alkaline) comet 
assay of HaCaT cells after exposure to 10 and 40µg/mL citrate- AgNPs 30 nm during 24h and 48h. The 
results were expressed as the mean +/- SD versus control. ** indicate significant differences between 
control at p < 0.01.  
 
 
 
 
 
 
 
 
 
 
 
Figure 4.5: Individual DNA damage classes of HaCaT after exposure to 10 and 40µg/mL of citrate- 
AgNPs 30 nm during a) 24h and b) 48h. The results were expressed as the mean +/- SD versus control. ** 
indicate significant differences between control at p < 0.01. 
 
Cytokinesis-block micronucleus (CBMN) assay 
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occurrence of MNi (was only found one per binucleated cell) around or below 10% and NPBs 
or NBUDs lower than 5%. Also, a slight increase was found after 48h in MNi, but the amount 
of NPBs and NBUDs remained residual. The amount of HaCaT cells with MNi significantly 
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increased after AgNPs exposure for both times and concentrations (p < 0.01), and this increase 
was generally more pronounced after 48h (Fig. 4.6). The amount of NBUDs also had a tendency 
to increase after AgNPs exposure at both times and concentrations, although not reaching 
statistical significance. 
Moreover, a significant increase of mononucleated cells (M1) and a significant decrease of 
binucleated (M2) cells after AgNPs exposure was found for both times and concentrations (Fig. 
4.7). These results indicate a cytostatic effect induced by AgNPs exposure. The nuclear division 
index (NDI) significantly decreased for both exposure times and concentrations of AgNPs, 
which confirms the cytostatic effect of AgNPs on HaCaT cells (Fig. 4.8). 
 
 
 
 
 
 
 
 
 
 
Figure 4.6: MNi, NPBs and NBUDs score of HaCaT after exporure to 10 and 40µg/mL of citrate- AgNPs 
30 nm during a) 24h and b) 48h. The results were expressed as the mean +/- SD versus control. ** 
indicate significant differences between control at p < 0.01. 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.7: Quantity per 500 cells of M1(mononucleated cells), M2 (Binucleated cells), M3 (Trinucleated 
cells) and M4 (Tetranucleated cells) of  HaCaT after exporure to 10 and 40µg/mL of AgNPs during a) 
24h and b) 48h. The results were expressed as the mean +/- SD versus control. ** indicate significant 
differences between control at p < 0.01. 
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Figure 4.8: Nuclear divisin index (NDI) of HaCaT cells after exporure to 10 and 40µg/mL AgNPs during 
a) 24h and b) 48h. The results were expressed as the mean +/- SD versus control. ** indicate significant 
differences between control at p < 0.01. 
 
Discussion 
In this work, we have investigated the cytotoxic and genotoxic potential of citrate-coated 
AgNPs in human keratinocytes, motivated by the wide usage of these nanoparticles in several 
applications, namely in cosmetic products (Tolaymat et al. 2010), and the need to improve 
current understanding of their biological effects towards human skin. 
The MTT viability results showed that the keratinocytes viability decreased even at the lowest 
concentration of AgNPs. This decrease is in line with the described loss of viability induced by 
this type of NPs in other cell lines. For example, a significant decrease in the viability of lung 
epithelial BEAS-2B cells was observed upon exposure to 20 nm citrate-coated AgNPs at 6.25-
50 µg/mL after 24h (Wang et al. 2014). Also, Milić et al. (2015) found a significant viability 
decrease of mammalian kidney cells after exposure to citrate-coated AgNPs at concentrations 
above 25 µg/mL.  
We further demonstrated, for the first time to our knowledge, that these citrate-coated AgNPs 
induced DNA damage in keratinocyte cells, even for the lower concentration and as soon as 
24h. These genotoxic effects were evident by a significant increase of classes 3 and 4 (which are 
the classes with the greater amount of DNA in the tail) in exposed cells, at expenses of 
decreased class 0. This effect was higher for higher doses and longer periods (48h). These 
results are in line with other genotoxic information provided for these cell lines exposed to SiO2 
nanoparticles (15, 30, and 100 nm at doses <10 µg/mL) (Gong et al. 2012), which support the 
sensitivity of these keratinocytes as in vitro models for this type of NP assays. In addition, 
AgNPs were reported to induce DNA breakage in other cell lines using the comet assay 
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(AshaRani et al. 2009, Eom &Choi 2010, Hackenberg et al. 2011, Kawata et al. 2009, Liu et al. 
2011, Piao et al. 2011).  
The interference of AgNPs with signaling cascades in keratinocytes is a current matter of 
debate, especially given the relevance of skin as an entry portal for AgNPs. Comfort et al (2014) 
demonstrated that 50 nm AgNPs affected the epidermal growth factor (EGF) signal transduction 
in HaCaT cell line (initially obstructed due to the dissolution of particles into silver ions). It was 
demonstrated that human keratinocytes undergo apoptosis when incubated with the blocking 
EGFR agents (Stoll et al. 1998), and that this receptor provides protection to normal human 
keratinocytes against apoptosis. It’s over activation has also been reported as involved in 
modulating DNA repair after radiation-induced damage (Liccardi et al. 2011). Kuroda et al 
(2014) also demonstrated that epidermal growth factor receptor (EGFR)-targeted hybrid 
plasmatic magnetic nanoparticles (225-NP) – with a gold layer-, induced DNA damage and 
abrogates G2/M phase of the cell cycle, leading to cellular apoptosis in a EGFR-mutant 
HCC827 cell line. It has been proposed that some metal NP may drastically affect the redox 
regulation of protein tyrosine phosphatases (involved in transduction pathways of cell cycle 
regulation and differentiation) via the inhibition of MAPK and EGFR. Here, we hypothesise 
that pathways mediated by these phosphatases may be at least partially involved in the increased 
DNA damage observed in the AgNPs exposed HaCaT cells. It was demonstrated elsewhere that 
the highly reactive cysteine residues of protein tyrosine phosphatases are predisposed to 
oxidative stress in the form of H2O2, free radicals or changes in intracellular thiol/dissulfide 
redox state (Manke et al. 2013). Indeed, we have recently demonstrated by Nuclear Magnetic 
Resonance (NMR) metabolomics that AgNPs-exposed HaCaT cells displayed upregulated 
glutathione-based antioxidant protection, increased glutaminolysis, downregulated tricarboxylic 
acid (TCA) cycle activity, energy depletion and cell membrane modification (Carrola et al. 
2016). The upregulation of the antioxidant battery was also supported by increased oxidative 
stress through ROS production (Chapter 2), pointing to their involvement on redox regulation of 
protein tyrosine phosphatases, which could be related to the DNA damage observed in the 
HaCaT exposed to AgNPs. 
Concerning the micronucleus assay, there was a significant increase of cells with MNi, a 
biomarker of chromosome breakage and/or whole chromosome loss (Fenech 2007). We could 
also observe a significant increase of mononucleated cells and a significant decrease of 
binucleated cells, meaning that citrate-coated AgNPs had a cytostatic effect. This result was 
confirmed by the decrease of the nuclear division observed in the cells exposed to both AgNPs 
concentrations, for 24 and 48h. Using other type of AgNPs (Ag–ginger and Ag–coffee NPs), 
Chunyan and Valiyaveettil (2013) showed an arrest at G2/M in HepG2 cells, rather than 
induction of apoptosis or necrosis. In agreement with those authors, we suggest that these delays 
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and cell proliferation decreases act as a mechanism to allow cells to repair DNA damage prior 
the chromosomes segregation. Despite the observed MNi increase and nuclear division index 
(NDI) decrease, changes in nucleoplasmatic bridges (NPBs) were not apparent from the results 
hereby presented. According to Fenech (2007), NPB may be used as a biomarker of DNA 
misrepair and/or telomere end-fusions. On other hand, we found a non-significant trend for 
nuclear buds (NBUDs) to increase with AgNP exposure. This putative increase deserves further 
attention as NBUDs are used to evaluate the elimination of amplified DNA and/or DNA repair 
complexes. Finally, it is evident by this assay that the tested doses induced cytostatic effects in 
HaCaT cells, which were measured via the proportion of mono-, bi- and multinucleated cells 
and by cytotoxicity via necrotic and/or apoptotic cell ratios, confirmed elsewhere to be mainly 
due to an arrest at G2/M transition (Chapter 2). 
 
Conclusions 
In sum, our study demonstrates that the largely used citrate-coated AgNPs decreased cellular 
viability and induced DNA damage in HaCaT cells. Furthermore, these particles induced MNi 
formation, increased mononucleated cells and decreased binucleated cells and the nuclear 
division index, thus pointing to clear cytostatic effects. Thus, we conclude that 30 nm citrate-
coated AgNPs have marked genotoxicity on HaCaT cells, even at a low dose (~IC20) and after 
a short period of exposure (24h). Overall, we demonstrate the validity of performing pre-clinical 
tests using HaCat cells as a model for skin toxicity evaluation, and we show that both Comet 
and CBMN assays are sensitive means for assessing genotoxicity. Considering that AgNPs are 
present in a vast number of consumer products and also in nanomedicine skin applications, this 
study highlights the need to investigate possible ways to reduce the genotoxic potential of 
AgNPs.   
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Abstract 
The antibacterial potential of silver nanoparticles (AgNPs) resulted in their increasing 
incorporation into consumer, industrial and biomedical products. Therefore, human and 
environmental exposure to AgNPs (either as an engineered product or a contaminant) supports 
the emergent research on the features conferring them different toxicity profiles. In this study, 
30 nm AgNPs coated with citrate or poly(ethylene glycol) (PEG) were used to assess the 
influence of coating on the effects produced on a human hepatoma cell line (HepG2), namely in 
terms of viability, apoptosis, apoptotic related genes, cell cycle and cyclins gene expression. 
Both types of coated AgNPs decreased cell proliferation and viability with a similar toxicity 
profile. At the concentrations used (11 µg/mL and 5 µg/mL corresponding to IC50 and ~ IC10 
levels, respectively) the amount of cells undergoing apoptosis was not significant and the 
apoptotic related genes BCL2 and BAX were both downregulated. Moreover, both AgNPs 
affected HepG2 cell cycle progression at the higher concentration (11 µg/mL) by increasing the 
% of cells in S and G2 phases. Considering the cell-cycle related genes, the expression of 
CCNB1 (cyclin B1) and CCNE1 (cyclin E1) was decreased. Thus, this work has shown that 
citrate- and PEG-coated AgNPs impact on HepG2 apoptotic gene expression, cell cycle 
dynamics and cyclin regulation in a similar way. More research is needed to determine the 
properties that confer AgNPs a lower toxicity, since their use has proved helpful in several 
industrial and biomedical contexts. 
 
Keywords: Silver nanoparticles (AgNPs), Citrate, Poly(ethylene glycol) (PEG), Cytotoxicity, 
Apoptosis, Cell cycle, Cyclins, Gene expression, HepG2 cells, Nanotoxicology. 
 
Introduction 
AgNPs are being extensively used in a wide range of applications, from medicine and industry 
to the most common consumer products (Behra et al., 2013; Eckhardt et al., 2013; EPA, 2010; 
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Franci et al., 2015; Rai et al., 2015). Consequently, the possible risks associated with their 
release into the environment and human exposure has also increased. Indeed, while researchers 
have stressed the need to establish whether the presence of nanosilver in those products is 
essential (Nowack and Bucheli, 2007), and several studies showed the toxic potential of AgNPs, 
their usage remains widespread (Chen et al., 2015; Dusinska et al., 2013; McShan et al., 2014).  
Previous studies have shown that the physico-chemical characteristics of  AgNPs will influence 
cellular uptake, intracellular fate and, consequently, the toxicity of these NPs (Caballero-Díaz et 
al., 2013; Gliga et al., 2014; Wang et al., 2014b; Zhang et al., 2015; Zhang et al., 2014). In 
particular, the size (Gliga et al., 2014; Kim et al., 2012; Park et al., 2011) and surface chemistry 
(Lu et al., 2010), as well as the type of formulation (Boonkaew et al., 2014), period of exposure 
(Comfort et al., 2014) and storage conditions (Ahlberg et al., 2014) have all been shown to play 
a determinant role in AgNPs toxicity. 
AgNPs are often coated to promote stability and avoid aggregation. Citrate is the most common 
reducing agent used to stabilize AgNPs, providing the particles a negative surface charge 
(Gutierrez et al., 2015; Pillai and Kamat, 2004; Sharma et al., 2009). Several other agents have 
also been employed to coat AgNPs, such as polyvinyl pyrrolidone (PVP) (Haberl et al., 2013; 
Nymark et al., 2013; Wang et al., 2014a), polyacrylates (Panacek et al., 2014), 
poly(vinyl)alcohol (PVA), polyacrylamide, poly(oxyethylene)-segmented imide (POEM), 
poly(styrene-co-maleic anhydride)-grafting poly(oxyalkylene) (SMA), poly(ethylene glycol) 
(PEG) (Fernández-López et al., 2009; Xu et al., 2007), and peptides (Haase et al., 2012; Nair 
and Laurencin, 2007). Polyethylene glycol (PEG) is another popular coating, especially 
concerning biomedical applications, due to its biocompatible nature and the high stability 
conferred to the particles (Ryan et al., 2008). Ginn and co-workers (2014) refer that in the years 
to come we will see an increase in the number of novel site-directed PEGylation chemistries and 
a shift in its application to a wider range of therapeutic molecules, including NPs for therapeutic 
and diagnostic purposes, becoming increasingly essential more studies with this coating. PEG 
coating improved the biopharmaceutical properties of drugs, increased stability and resistance to 
proteolytic inactivation, increased circulatory lives, and showed low toxicity (Ginn et al., 2014; 
Jain and Jain, 2008; Ryan et al., 2008). Moreover, it has been argued that PEG coating 
decreases AgNPs toxicity by reducing their cellular uptake (Brandenberger et al., 2010; 
Caballero-Díaz et al., 2013; Pang et al., 2015).  
As liver is the most important organ for xenobiotic metabolism (Roberts et al., 2014), liver cell 
lines have been amply used in biomedical research involving the testing of drugs or other 
toxicants. The cytotoxicity of AgNPs towards liver cells has also been demonstrated in a few 
previous studies. Faedmaleki and collegues (2014) showed that 20-40nm AgNPs decreased 
HepG2 viability in a concentration-dependent manner. Also, Nowrouzi and co-workers (2010) 
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studied the cytotoxicity of AgNPs on HepG2 and obtained IC50 value of 2.75-3 µg/mL for 
HepG2 after exposure to 5-10 nm AgNPs. Moreover, by determining changes in the activity of 
lactate dehydrogenase, alanine aminotransferase, aspartate aminotransferase, glutathione 
peroxidase, superoxide dismutase, lipid peroxidation and cytochrome c content, that same work 
provided evidence for  the involvement of oxidative alterations upon exposure to low doses of 
AgNPs. Recently, Xin and co-workers (2015) also found dose-dependent cytotoxicity of AgNPs 
in HepG2 cells, which was attributed to the interplay of oxidative stress, DNA damage and 
mitochondrial injury. Consistently, Xue et al. (2015), suggested the cellular toxicological 
mechanism of AgNPs to be related with oxidative stress induced by the generation of ROS, 
leading to mitochondria injury and induction of apoptosis. However, there are few studies 
comparing the coating influence on AgNPs cytotoxicity to liver cells. Kennedy et al (2014) 
studied the cytotoxicity potential of carbohydrate functionalization of ~54 nm AgNPs to HepG2 
and neuronal-line Neuro 2A cells and found that particles functionalized with ethylenglycol, 
glucose and citrate coated nanoparticles show a similar toxicity, while galactose and mannose 
functionalized AgNPs were significant less toxic to HepG2 cell line. Other studies comparing 
the influence of coating on AgNPs cytotoxicity have been addressed to other cell lines. Gliga et 
al. (2014) compared the cytoxicity of uncoated, PVP- and citrate-coated AgNPs in bronchial 
BEAS-2B cells and found no coating-dependent differences in cytotoxicity. Caballero-Díaz et 
al. (2013) reported that pegylation of AgNPs reduced cellular uptake and their toxicity in 
NIH/3T3 (mouse embryonic fibroblasts), compared to AgNPs coated with other polymers. The 
conflicting existing information addressed the need to deeply study surface coating AgNPs 
cytotoxicity, in order to aware if or which NPs are more cytotoxic to the different cell lines. 
Thus, in this study we aimed to compare the influence of coating (citrate vs PEG) on the 
cytotoxicity of AgNPs in liver cells, using the human hepatoma cell line HepG2 as an in vitro 
model. HepG2 cells were exposed to citrate- and PEG-coated AgNPs of 30 nm diameter and the 
effects on cell viability, apoptosis induction, apoptotic expression genes, cell cycle profile and 
cyclins gene expression were assessed. 
 
Material and methods 
Chemicals 
Sterile, purified and endotoxin-free AgNPs (Biopure AgNPs 1.0 mg/mL), with 30-nm diameter 
and a citrate or polyethyleneglycol (PEG) surface, designated from now on as Cit30 and PEG30 
NPs, were purchased from Nanocomposix Europe (Prague, Czech Republic). Dulbecco’s 
modified Eagle’s medium (DMEM), fetal bovine serum (FBS), antibiotics and phosphate buffer 
saline (PBS, pH 7.4) were purchased from Life Technologies (Carlsbad, CA, USA). 3-(4,5-
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dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and dimethyl sulfoxide (DMSO) 
were obtained from Sigma-Aldrich (St. Louis, MO, USA). RNase and propidium iodide (PI) 
were both from Sigma-Aldrich, St. Louis, MO-USA. 
 
Physicochemical characterization of AgNPs  
The morphology and size of AgNPs was assessed by scanning transmission electron microscopy 
(STEM) using a scanning electron microscope Hitachi SU-70 (Hitachi High-Technologies 
Europe GmbH, Germany) operating at 30 kV. Samples for STEM analysis were prepared by 
evaporating dilute suspensions of the nanoparticles on a copper grid coated with an amorphous 
carbon film. The hydrodynamic diameter and polydispersity index (PDI) of the nanoparticles 
were measured by dynamic light scattering (DLS) and the zeta potential was assessed by 
electrophoretic mobility, both measurements using a Zetasizer Nano ZS (Malvern Instruments, 
UK).  
Silver quantification measurements were performed by inductively coupled plasma optical 
emission spectrometry (ICP-OES) in an Activa M Radial spectrometer (Horiba Jobin Yvon), 
employing a charge coupled device (CCD) array detector, with a wavelength range of 166–847 
nm and radial plasma view. Samples were introduced into the ICP plasma using an HF resistant 
sample introduction system including a Burgener nebulizer, a cyclonic spray chamber and a 
quartz torch with aluminum injector. Samples for ICP-OES were prepared by addition of 10 µL 
AgNPs (1.0 mg/mL) to 990 µL of either ultrapure water or complete culture medium, 
incubation for variable periods (0, 4, 24 or 48h), followed by centrifugation at 40000 rcf for 120 
min at 4ºC (in accordance with the manufacturer’s recommendations) to deposit the 
nanoparticles and separate the supernatant (with dissolved ionic silver). Acid digestion of the 
supernatant was then performed by mixing 500 µL with 100 µL of acids (HCl:HNO3 2:1 v/v) 
and 400 µL of ultrapure water. The % dissolution of AgNPs to ionic silver was calculated as 
100×F×[Ag]/Ci, where F is the dilution factor, Ci the initial concentration of AgNPs and [Ag] 
the concentration of silver determined by ICP-OES. 
 
Cell Culture 
The HepG2 cell line, a liver hepatocellular carcinoma cell line, was obtained from European 
Collection of Authenticated Cell Cultures (ECACC) and supplied by Sigma. Cell culture 
reagents were purchased from Life Technologies (Carlsbad, CA, USA). The cells were grown in 
complete medium, i.e., Dulbecco’s modified Eagle’s medium, supplemented with 10% fetal 
bovine serum (FBS), 2 mM L-glutamine, 100 U/mL penicillin, 100 µg/mL streptomycin, 250 
µg/mL fungizone and 1 mM sodium pyruvate at 37°C in 5% CO2 humidified atmosphere. Cells 
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were daily observed under an inverted phase-contrast Eclipse TS100 microscope (Nikon, 
Tokyo, Japan). For each experiment, cells were allowed to adhere for 24h and then medium was 
replaced with fresh medium containing Cit30 or PEG30 AgNPs. The effects were measured 
after 24 and 48h. Throughout the experiments, cultures were routinely visualized for confluence 
and cell morphology. 
 
Exposure and Viability assay 
Cell viability was determined by the colorimetric 3-(4,5- dimethyl-2-thiazolyl)-2,5-diphenyl 
tetrazolium bromide (MTT) assay, which measures the formation of purple formazan in viable 
cells (Twentyman and Luscombe, 1987). Cells were seeded in 96-well plates and after 24h, 
medium was replaced with fresh medium containing coated AgNPs. 
Cells were exposed to Cit30 or PEG30AgNPs at 0, 1, 5, 10, 15, 25 and 50 µg/mL AgNPs. Cell 
viability was measured after 24h and 48h. Fifty microliters of MTT reagent (1 mg/mL) in 
phosphate buffered saline (PBS) were added to each well, and incubated for 4h at 37 °C, 5% 
CO2. Medium was then removed, and 150 µL of DMSO were added to each well for crystal 
solubilization. The optical density of reduced MTT was measured at 570 nm in a microtiter 
plate reader (Synergy HT Multi-Mode, BioTeK, Winooski, VT), and the cell metabolic activity 
(MA, a usual marker for cell viability) was calculated as: MA = [(Sample Abs –DMSO Abs) / 
(Control Abs – DMSO Abs)]*100. Three independent assays were performed with at least 2 
technical replicates each and the results compared with the control (no exposure). From the 
MTT results, the IC50 values were similar for cells exposed to Cit30 and to PEG30, around 11 
µg/mL at 24h. Therefore, 11 µg/mL was selected as the higher dose, and a lower dose 
corresponding to minimal loss of viability (~IC10 ~ 5 µg/mL) was also selected. The following 
studies were then performed with cell exposure during 24h to 5 µg/mL and 11 µg/mL of Cit30 
and PEG30 AgNPs. 
 
Uptake potential by flow cytometry 
Uptake potential of Cit30 and PEG30 AgNPs by HepG2 cells was assessed by flow cytometery 
(FCM), as previously described by Suzuki et al (2007). Briefly, cells were seeded in 6-well 
plates and after AgNPs exposure they were trypsinized, collected to FCM tubes and analyzed by 
FCM. Both parameters, forward scatter (FS), which give information on the particle’s size, and 
side scatter (SS), information on complexity of particles, were measured in a Coulter XL Flow 
Cytometer (Beckman Coulter, Hialeah, FL-USA) equipped with an argon laser (15 mW, 488 
nm). Acquisitions were made using SYSTEM II software v. 3.0 (Beckman Coulter, Hialeah, 
FL). For each sample, 5000–20000 cells were analyzed at a flow rate of about 1000 cells/s. 
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Annexin V 
Apoptosis and cell viability were measured by flow cytometry (FCM) in a Coulter XL Flow 
Cytometer (Beckman Coulter, Hialeah, FL-USA), with the FITC Annexin V Apoptosis 
Detection Kit (BD Pharmingen, San Diego, CA-USA) according to manufacturer. Briefly, cells 
were detached and washed with PBS, then cells were resuspended in diluted binding buffer 
provided with the kit (1:10 in distilled water) at 1×10
6 
cells/ml. To stain cell suspension, 5µL of 
FITC-Annexin V and 5µL of propidium iodide were added for 15 min at room temperature in 
the dark, after which each sample was diluted in 400µL binding buffer. For each sample, 10000 
events were analyzed using the SYSTEM II (v. 2.5) software (Beckman Coulter, Hialeah, FL-
USA). The cytogram of FITC florescence versus PI florescence allows the identification of live 
intact cells (Annexin V-FITC negative, PI negative), exclusively early apoptotic cells (Annexin 
V-FITC positive, PI negative), predominantly late apoptotic/necrotic cells (Annexin V-FITC 
positive, PI positive), and predominantly dead cells (Annexin V-FITC negative, PI positive). 
FCM data were analyzed by FlowJo software (Tree Star Inc., Ashland, OR). 
 
Cell cycle and clastogenicity analysis 
Cell cycle and putative clastogenic effects were analyzed by flow cytometry according to the 
method previously described (Oliveira et al., 2014). Briefly, cells were seeded in 6-well plates 
and after exposure they were washed with PBS, harvested using Trypsin-EDTA and centrifuged 
twice at 300 xg for 5 min. Cells were then fixed with 85% cold ethanol and kept at -20 ºC until 
analysis. At the time of analysis cells were centrifuged at 300 g for 5 min, resuspended in PBS 
and filtered through a 35-µm nylon mesh to separate aggregates. Then, 50 μL RNase (1mg/mL) 
and 50 μL PI (1mg/mL) were added to each sample which were then incubated for 20 min in 
darkness at room temperature until analysis. The relative fluorescence intensity of the stained 
nuclei was measured in a Coulter XL Flow Cytometer (Beckman Coulter, Hialeah, FL-USA) 
equipped with an argon laser (15 mW, 488 nm). Acquisitions were made using SYSTEM II 
software v. 3.0 (Beckman Coulter, Hialeah, FL). For each sample, the number of nuclei 
analyzed was approximately 5,000. The percentage of nuclei in each phase of the cell cycle 
(G0/G1, S and G2 phases) was analyzed using the FlowJo software (Tree Star Inc., Ashland, 
Oregon, USA). In order to assess the putative clastogenic effects of the two coated AgNPs and 
the silver ion, as described by (Misra and Easton, 1999), the coefficient of variation (CV) of the 
G0/G1 peak was determined. 
 
Apoptosis and Cyclin Gene Expression 
Gene-specific primer pairs (Table 5.1) were designed using the program Primer3 (REF) and 
confirmed for specificity by the UCSC In-Silico PCR Genome Browser (http://genome. 
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ucsc.edu/cgi-bin/hgPcr). 
Total RNA of control and exposed cells was extracted using the TRIzol method. Organic phase 
separation was achieved in Phase-Lock Gel Heavy tubes (5 Prime 3 Prime, Inc., Boulder, CO). 
The aqueous phase was mixed with 1 vol 70% ethanol and RNA was purified using RNeasy 
Mini Kit columns (Qiagen, Hilden, Germany). Synthesis of cDNAs was performed by a reverse 
transcriptase (RT) reaction: 2 μg total RNA were pre-incubated with DNase I (Sigma Aldrich, 
St. Louis, MO) and reverse-transcribed with 1 μM Oligo dT18, using the Omniscript RT Kit 
(Qiagen, Hilden, Germany). The cDNA samples were prediluted in ultrapure MilliQ water 
(1:20). The final individual qPCR reactions contained iQ SYBR Green Supermix (BioRad, 
Hercules, CA-USA), 0.15 µM each gene-specific primer and 1:4 (v/v) prediluted cDNA (1:20). 
Primers were designed using the program Primer3 (Rozen and Skaletsky 2000) and confirmed 
for specificity by the UCSC In-Silico PCR Genome Browser (http://genome.ucsc.edu/cgi-
bin/hgPcr). The qPCR program included 1 min denaturation at 95 °C, followed by 40 cycles at 
94 °C for 5 s, 58 °C for 15 s, and 72 °C for 15 s. After qPCR, a melting temperature program 
was performed. At least two technical replicates per sample of qPCR were performed from each 
of three independent biological replicates. Average PCR and cycle thresholds were determined 
from the fluorescence data using the algorithm Real-Time PCR Miner (Zhao and Fernald 2005). 
Gene expression of BAX and BCL2 and cyclins B1 (CCNB1), and E1 (CCNE1) were normalized 
with the GAPDH reference gene and expressed relative to control cells, calculated from the 
average efficiencies and cycle thresholds using the Pfaffl method (Pfaffl 2001). 
 
 
Table 5.1: Oligonucleotide primer sequences used for qPCR. 
 
 
 
Gene Forward primer  (5’ – 3’) Reverse primer  (5’ – 3’) 
BAX GACGGCCTCCTCTCCTACTT CAGCCCATCTTCTTCCAGAT 
BCL2 GGAGGATTGTGGCCTTCTTT GCCGGTTCAGGTACTCAGTC 
CCNB1 GCTGAAAATAAGGCGAAGATCAA ACCAATGTCCCCAAGAGCTG 
CCNE1 CAGCCTTGGGACAATAATGC GAGGCTTGCACGTTGAGTTT 
GAPDH ACACCCACTCCTCCACCTTT TACTCCTTGGAGGCCATGTG 
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Statistical analysis 
The results are reported as mean ± standard deviation (SD) of 2 technical replicates in each of 
the 3 independent experiments. For MTT assay, the statistical significance between control and 
exposed cells was performed by one way ANOVA, followed by Dunnet and Dunn’s method (as 
parametric and non-parametric test, respectively), using Sigma Plot 12.5 software (Systat 
Software Inc.). For the other assays, the results were compared using two-way ANOVA, 
followed by Holm-Sidak method, using also Sigma Plot 12.5 software (Systat Software Inc.). 
The differences were considered statistically significant for p < 0.05. 
 
Results 
Physicochemical characterization of AgNPs dispersed in water and in cell culture 
medium 
The characteristics of Cit30 and PEG30 AgNPs dispersed in water or in culture medium are 
summarized in Table 5.2, including hydrodynamic diameter of 43.3 ± 0.5 for Cit30 and 
62.1±0.5 for PEG30; polydispersity index (PdI) of 0.25-0.26 for Cit30 and 0.15-0.16 for 
PEG30; zeta potential () -42.7 ± 2.7 for Cit30 and -12.1±0.5 for PEG30; ionic silver 
dissolution in ultrapure water at 0h of Cit30 3.3±0.04% and PEG30 0.63±0.01%; and also ionic 
silver dissolution in DMEM at 0, 4, 24 and 48h of Cit30 3.8±0.04%, 5.5±0.07%, 5.7±0.03%, 
7.6±0.1%, respectively and PEG30 3.2±0.03%, 6.0±0.06%, 7.0±0.07%, 7.2±0.06%, 
respectively. 
 
Effects on cell growth, morphology and viability 
In control conditions, HepG2 cells showed typical morphology (Fig. 5.1a, and 5.2a). When they 
were exposed to Cit30 and PEG30 AgNPs, their confluence decreased, especially for the higher 
concentration (11 µg/mL) (Fig. 5.1c and 5.2c). No morphological alterations were observed in 
AgNP-exposed cells, independently of the coating and concentration. The viability of exposed 
cells was significantly reduced (p < 0.05) upon exposure to Cit30 and PEG30 at concentrations 
higher than 5 µg/mL after 48h and 10 µg/mL after 24h for Cit30; and concentrations higher than 
5 µg/mL after 24 and 48h for PEG30 (Fig. 5.3a-b). 
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Table 5.2: Physicochemical properties of AgNPs.  
 Citrate- AgNPs PEG- AgNPs 
D (nm)
a
 32.7±4.8 31.8±3.2 
D (nm)
b
 29.1±3.9 26.8±5.3 
Dh (nm)
c
 43.3±0.5 62.1±0.5 
PdI
c
 0.25-0.26 0.15-0.16 
ζ (mV)d -42.7±2.7 -12.1±0.5 
λmax
e
 (nm) 408 411 
%Ag
+
 in water 0h
f 
3.3±0.04 0.63±0.01 
%Ag
+
 in DMEM 0h
f
 3.8±0.04 3.2±0.03 
%Ag
+
 in DMEM 4h
f
 5.5±0.07 6.0±0.06 
%Ag
+
 in DMEM 24h
f
 5.7±0.03 7.0±0.07 
%Ag
+
 in DMEM 48h
f
 7.6±0.1 7.2±0.06 
a
Diameter indicated by the manufacturer; 
b
Diameter measured by TEM; 
c
Hydrodynamic diameter and 
polydispersity index (PdI) measured by DLS; 
d
Zeta potential assessed by electrophoretic mobility (in cell 
culture medium); 
e
Wavelength of maximum absorbance peak in the UV-Vis spectrum; 
f
Percentage of 
ionic silver in the AgNP suspension (10 µg/mL). Standard deviations calculated for Dh, ζ and %Ag+ 
correspond to 3 replicate measurements.  
 
 
 
 
 
 
 
 
 
 
Figure 5.1: Light microscopy images (100X) of HepG2 cells exposed to citrate- AgNPs for: 24h - a) 0, b) 
5 µg/mL and c) 11 µg/mL. Bar corresponds to 100 µm. 
 
 
 
 
 
a b c 
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Figure 5.2: Light microscopy images (100X) of HepG2 cells exposed to PEG- AgNPs for: 24h - a) 0, b) 5 
µg/mL and c) 11 µg/mL. Bar corresponds to 100 µm. 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.3: Relative cell viability of HepG2 (%), measured by MTT assay, for 24h and 48h. a) 30 nm 
citrate-coated AgNPs; b) 30 nm PEG coated AgNPs. Data expressed as mean and standard deviation. * 
indicate significant differences between control at p < 0.05 and ** at p < 0.01 for 24h; and # indicate 
significant differences between control at p < 0.05 and ## at p < 0.01 for 48h. 
 
 
Nanoparticle uptake measured by flow cytometry 
The uptake of both Cit30 and PEG30 AgNPs by HepG2 cells is shown in Figure 5.4. Both 
concentrations (5 and 11 µg/mL) of both AgNPs induce an increase in side scatter intensity 
without change of forward scatter intensity of HepG2 cells, which means particles taken up by 
cells. The uptake potential was significant only for the highest concentration (11 µg/mL) and no 
significant difference was observed when comparing cells exposed to Cit30 vs PEG30 AgNPs. 
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Figure 5.4: Uptake of AgNP by HepG2 cells after 24h exposure to 5 and 11 µg/mL of citrate- AgNPs and 
PEG- AgNPs assessed by the side scattered light by flow cytometry. The results were expressed as the 
mean +/- SD versus control. ** indicate significant differences between control at p < 0.01. 
 
 
Apoptotic markers 
The Annexin V assay was performed in order to evaluate the potential of AgNPs to induce 
apoptosis in HepG2 cells. Although exposure to Cit30 NPs at the IC50 concentration caused a 
small non-significant increase in the % late apoptotic cells (Fig. 5.5), there were no statistically 
significant differences in relation to controls. Both concentration of Cit30 and PEG30 AgNPs 
decreased the expression levels of selected genes involved in the apoptotic cascade, BCL2 and 
BAX, after 24h (Fig. 5.6). Cit30 induced a significant decrease of antiapoptotic BCL2 
expression levels for the higher concentration tested and of BAX expression levels for 5 µg/mL. 
PEG30 induced a significant decrease of BCL2 expression levels for both concentrations used. 
 
Cell cycle analysis 
Figure 5.7 shows the effect of Cit30 and PEG30 AgNPs on the cell cycle of HepG2 cells. Cit30 
in both doses decreased the percentage of cells in G0/G1 (significant at the higher 
concentration) and increased the percentage of cells in G2, this effect being visible for both 
concentrations, but more pronounced for 11 µg/mL (p < 0.01) (Fig. 5.7a). An increase in the 
percentage of cells in the S phase was also observed for the higher concentration. 
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Figure 5.5: Citrate- and PEG- AgNPs effects on HepG2 cells exposed to 5 and 11 µg/mL after 24h, 
measured by annexin V assay. Intact cells are represented by “A-P-“, dead cells “A-P+”, early apoptotic 
cells “A+P-“ and late apoptotic/necrotic cells “A+P+”. The results were expressed as the mean +/- SD 
versus control. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.6: HepG2 gene expression of apoptotic genes, for 24h: a) Citrate-coated AgNPs; and b) PEG-
coated AgNPs The results were expressed as mean relative to control cells (normalized with the GAPDH 
reference gene) and standard deviation. ** indicate significant differences between control at p < 0.01. 
 
  
 PEG30 showed a similar trend, but decreased the percentage of cells at G0/G1 only at the 
higher concentration (11 µg/mL). The increase of the percentage of cells at G2 and S phases 
was pronounced at the higher concentration; for the lower concentration, only the populations at 
G2 increased. The coefficient of variation (CV) of the G0/G1 peak did not change significantly 
with exposure to AgNPs, comparatively to their counterparts in the control (Fig. 5.8). When 
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comparing cell cycle profiles upon exposure to both types of AgNPs, significant differences 
were found for the lowest concentration (5 µg/mL) at G0/G1 and S phases: the percentage of 
cells in G0/G1 phase was higher for PEG-AgNPs exposed cells; and the percentage of cells in S 
phase was higher for the Cit30 AgNPs. 
Finally, it should also be stressed that both exposures increased the percentage of 
subpopulations at channel >600 and channel >800 corresponding to superG2 subpopulations 
(Fig. 5.8). 
In addition to changing the cell cycle distribution, exposure to AgNPs downregulated the 
expression of genes involved in G1/S (cyclin E1) and G2/M (cyclin B1) phase transitions (Fig. 
5.9). Both concentrations of Cit30 AgNPs downregulated the expression of cyclin B1 gene 
(CCNB1), though only significantly for 11 µg/mL (p < 0.01). HepG2 cells exposed to PEG30 
AgNPs showed a similar profile of CCNB1, where the expression was significantly decreased 
for 11 µg/mL (p < 0.01). In HepG2 exposed to Cit30 the expression of CCNE1 gene was 
decreased for both concentrations, while cells exposed to PEG30 did not show differences for 
the higher concentration, showing a significant decrease of CCNE1 expression levels after 
exposure to 5 µg/mL (p < 0.05). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.7: Effects of AgNPs on cell cycle dynamics, measured by flow cytometry: a) citrate-coated 
AgNPs; and b) PEG-coated AgNPs. The results were expressed as mean and standard deviation. * 
indicate significant differences between control at p < 0.05 and ** at p < 0.01. 
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Figure 5.8: Examples of HepG2 cell cycle histograms obtained after 24h of AgNPs exposure, measured 
by flow cytometry. a) Control; b) 11 μg/mL of citrate- AgNPs; and c) 11 μg/mL of PEG- AgNPs. In each 
histogram are represented the coefficient of variation (CV) values of the respective conditions. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.9: HepG2 gene expression of cell cycle genes, for 24h: a) Citrate-coated AgNPs; and b) PEG-
coated AgNPs The results were expressed as mean relative to control cells (normalized with the GAPDH 
reference gene) and standard deviation. ** indicate significant differences between control at p < 0.01 and 
* p < 0.05. 
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supporting some cytotoxic effects of AgNPs on different cell lines have been reported, these 
effects are dependent on multiple aspects such as external factors (e.g. storage conditions, 
dispersion medium) and NP characteristics (e.g. size and coating). In particular, research on the 
coating properties that may confer AgNPs less toxicity is essential, namely the evaluation of 
cyto- and genotoxic potential.  
This study focused on the comparison between citrate- and PEG- coated AgNPs cytotoxicity 
to human liver cells. As discussed elsewhere (Chapter 2) coating deeply influences AgNPs 
physicochemical properties, with citrate coating providing a more negative and, hence, 
potentially more reactive surface. It has been reported that nanoparticle coating, media 
composition and ionic strength influences the surface chemistry, shape, aggregation state and 
dissolution, which can impact toxicological determinations by altering concentration, dissolved 
ionic silver, aggregation and shape, consequently affecting NP uptake (Tejamaya et al., 2012). 
The same authors reported that charge-stabilized particles (e.g. by citrate) were more unstable 
and aggregated more than sterically stabilized particles (e.g. by PEG); which could induce 
different levels of cytotoxicity (Wang et al., 2014b).  
In this study, citrate-coated AgNPs and PEG-coated AgNPs (both 30 nm nanospheres) 
yielded approximately the same viability profile, up to IC50 concentrations, indicating that 
particle coating did not greatly influence the AgNPs cytotoxicity potential on HepG2 cell line. 
Considering the literature (Caballero-Díaz et al., 2013), it was expected that citrate- AgNPs 
would induce higher cell death compared to PEG-AgNPs. For example, our previous results on 
human keratinocytes HaCaT cell line showed that citrate-AgNPs had higher cytotoxicity than 
PEG- AgNPs (Chapter 2). Lu and colleagues (2010) found that citrate-coated silver nanopowder 
was cytotoxic, whereas PVP-coated silver nanoprisms or NPs were not. The authors also 
highlighted the importance of replacing, in daily life applications, citrate-coating with other 
biocompatible and functionalized formulations such as PVP. Pang and co-workers (2015) 
demonstrated that the toxicity of AgNPs on murine hepatoma cells (Hepa1c1c7) depended on 
the surface chemistry of NPs. They suggested that PEG-AgNPs have better biocompatibility, 
with an optimal biological inertia, and could effectively resist opsonization or non-specific 
binding to protein in mice. Also, Caballero-Díaz et al (2013) reported that pegylation of AgNPs 
reduced cellular uptake and their toxicity to NIH/3T3 (mouse embryonic fibroblasts). Also, 
when evaluating the uptake rates of gold NPs on human alveolar epithelial cells (A549), 
Brandenberger et al (2010) observed that significantly more plain NPs (i.e., stabilized with 
citrate buffer) could enter the cells than PEG-coated gold NPs. However, from our uptake 
results there was not a statistical difference between cells exposed to Cit30 AgNPs and cells 
exposed to PEG30 AgNPs. 
We have previously tested these AgNPs in other cell lines and demonstrated that the IC50 
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for keratinocytes (HaCaT) was 40 µg/mL, above the values herein found for the HepG2 cells. 
The cytotoxicity of these AgNPs is thus dependent on the cell type, with keratinocytes 
demonstrating higher tolerance than liver cells. PEG-coated AgNPs induced a similarly decrease 
on the viability of liver cells (HL-7702) in a dose- and time-dependent manner at doses from 
6.25 μg/mL (Song et al., 2012). Faedmaleki and collegues (2014) obtained IC50 value of 2.764 
µg/mL for HepG2 when exposed to 20-40 nm AgNPs. Similarly, Nowrouzi and co-workers 
(2010) obtained IC50 value of 2.75-3 µg/mL for HepG2 after exposure to 5-10 nm AgNPs. 
However, Xin and co-workers (2015) observed lower cytotoxicity of 20-50 nm AgNPs to 
HepG2 cells, where viability decreased with concentrations ranging from 25 to 200 µg/mL. The 
same authors found a viability decrease of A549 cells after exposure to 20-50 nm AgNPs within 
concentrations ranging from 12.5 to 200 µg/mL. 
Regarding apoptosis, our results did not show significant differences between control and 
exposed cells after 24h. Urbańska and co-workers (2015) determined the occurrence of 
apoptosis on glioblastoma multiforme (GBM) cells cultured in an in ovo model (tumor cell 
implantation of GBM cells, line U-87, placed on chicken embryo membrane on fertilized 
chicken eggs in order to study tumors growth rate, angiogenic potential, and metastatic 
capability) treated with colloidal 70 nm AgNPs (40 μg/ml). Through TUNEL assay, the authors 
observed no induction of apoptosis as well, despite the increased level of immunohistochemical 
caspase 3 and 9. The authors suggested that malignant tumor cells, such as GBM, are extremely 
resistant to apoptosis and particularly resistant to radiation and chemotherapy (Kuriyama et al., 
2002). Also, Xue et al (2015) determined the apoptotic potential of 15 nm AgNPs in HepG2 
cells and did not find significant differences between control and 40 µg/mL exposed cells after 
24h. However, a study using 1 and 50 µM of PVA- AgNPs obtained significant apoptotic 
effects on HepG2 after 24h (Paino and Zucolotto, 2015). In terms of apoptotic gene expression, 
we have found that both AgNPs downregulated BAX and BCL2 gene expression. Cit30 AgNPs 
significantly decreased BAX (pro-apoptotic) gene expression for the lowest concentration (5 
µg/mL) and BCL2 (anti-apoptotic) gene expression for the higher concentration (11 µg/mL). On 
the other hand, PEG30 decreased significantly BCL2 gene expression for both concentrations. 
BCL2 is an anti-apoptotic protein coding gene that prevents the opening of the mitochondrial 
membrane pore, while BAX – pro-apoptotic coding gene - accelerates it. Mitochondrial 
membrane pore opening induces the release of cytochrome c from mitochondria. Piao and co-
workers (2011), observed that AgNPs downregulated BCL2 expression and upregulated BAX 
expression in Human Chang liver cells, resulting in the disruption of mitochondrial membrane 
potential, followed by cytochrome c release from the mitochondria, resulting in mitochondria-
dependent apoptotic pathway. Furthermore, Jeyaraj and co-workers (2015) found an 
upregulation of BAX, caspases-6 and -9 and downregulation of BCL2 on HeLa cells after 
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exposure to AgNPs. 
Cell cycle dynamics was evaluated in HepG2 cells exposed to Cit30 and PEG30 AgNPs. For 
both AgNPs, there were changes on the cell cycle of HepG2 cells. Cit30 and PEG30 induced an 
increase in the percentage of cells in G2, indicating an arrest at this phase, visible for both 
concentrations. Also, both AgNPs significantly increased the percentage of cells at S phase for 
the higher concentration used (11 µg/mL) pointing to an S-phase delay. An S phase delay was 
also observed by Liu et al. (2010) in HepG2 cells exposed to PVP-coated AgNPs. However, 
Song et al. (2012) found an increase in the percentage of cells at G2/M phase on HL-7702 cells 
(human liver cell line) exposed to 100 µg/mL mPEG-SH coated AgNPs after 24h. Indeed, cell 
cycle arrest at G2 was also previously observed as a result of AgNP exposure (AshaRani et al., 
2009; Kang et al., 2012; Lee et al., 2011; Wei et al., 2010). Xue and colleagues (2015) found 
that no significant changes were observed on HepG2 after exposure to 40 and 80 µg/mL AgNPs 
for 24h. In our study, both exposures promoted the appearance of superG2 subpopulations. This 
suggests that exposure to AgNPs stimulates the proliferation of the hyperdiploid karyotype 
subpopulations (ATCC 2015; http://www.hepg2.com/) over the typical diploid profile, meaning 
an increase of the heterogeneity of this culture, and the consequences of this increase remain 
unknown, as well as the behavior of each subpopulation individually.  
Expression of two selected cell cycle regulator genes was also assessed in this study. Cyclin 
B1, encoded by the CCNB1 gene, is a regulatory protein which complexes with Cdk1 and both 
play a determinant role in G2/M phase transition of the cell cycle. Cyclin E1, encoded by the 
CCNE1 gene, forms a complex with Cdk2, which accumulates at the G1-S phase and is 
degraded as cells progress through the S phase. From our results, both AgNPs decreased the 
CCNB1 and CCNE1 gene expression for both concentrations used. CCNE1 gene expression was 
decreased after exposure to both AgNPs, especially at the lowest concentration (5 µg/mL), 
although it was significantly decreased only for PEG- AgNPs. This agrees with the increase in 
the percentage of cells in S-phase observed for both AgNPs. There are other studies on AgNPs 
cytotoxicity in agreement with our results: Foldbjerg et al (2012) found a downregulation of 
CCNB1 and Cdk1 for A549 cell line; and also AshaRani et al (2012) reported a downregulation 
of CCNB1 and also of CCNE1 in normal human lung cells IMR-90 and human brain cancer 
cells. 
 
Conclusions 
In sum, our study demonstrates that citrate-coated and PEG- coated AgNPs have similar profiles 
in decreasing the viability of HepG2 cells. Thus, and contrarily to what we have found in other 
cell lines such as keratinocytes where citrate coating was generally more toxic, in HepG2 cells 
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the cytotoxicity of AgNPs was independent of the studied coatings. Despite leading to low 
proliferation, AgNPs did not induced apoptosis for the studied concentrations and the apoptotic 
related genes BCL2 and BAX were downregulated, supporting that the decrease of proliferation 
may be due to both cytostatic effects and/or necrotic events. HepG2 showed the same profile of 
cell cycle dynamics after exposure to both AgNPs, where, for the higher concentration, there 
was an increase of the percentage of cells at S and G2 phases. Cyclins gene expressions CCNB1 
and CCNE1 were also downregulated, which supports cytostatic effects of these coated AgNPs 
on this cell line. Also, both type of nanoparticles induced higher heterogeneity of the population 
(increase % of cells at super G2). 
This study supports the claim for more thorough studies on different cell lines before a decision 
can be reached on the toxicity of each type of nanoparticles on humans. For this reason, more 
research is needed to complement the existing information about the cell lines response to 
different physicochemical features of AgNPs currently used in industrial, consumer products 
and nanomedicines. 
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Abstract 
The influence of coating on the induced toxicity of nanoparticles (NPs) has emerged in the last 
year among the scientific community. Citrate coated silver nanoparticles (citrate-AgNPs) are 
among the most commonly used nanomaterials, widely present in industrial and biomedical 
products. In this study, the cytotoxicity of 30 nm AgNPs, coated with citrate, on the macrophage 
cell line RAW 264.7 was evaluated, using a battery of cytotoxicity endpoints (viability, 
oxidative stress and cytostaticity/clastogenicity). After 24 and 48h, viability, oxidative stress 
and cell cycle dynamics were assessed. Citrate-AgNPs decreased cell proliferation and viability 
only at 75 µg/mL, suggesting a low sensitivity of RAW cells to lower doses of these AgNPs. 
After 24h exposure, ROS content decreased in cells exposed to 60 µg/mL AgNPs (IC20 value), 
and the putative involvement with the high tolerance of these cells to citrate- AgNPs is 
discussed here. However, these cells suffered an impairment of the cell cycle, while an increase 
of cells at Sub-G1 phase is observed. This increase of the subG1 population is correlated with 
an increase of DNA fragmentation which suggests an increase of apoptosis in these cells. 
Regarding literature, these cells present a high IC20 for these AgNPs when compared with other 
cells, which may be related with the function of these cells in vivo. 
 
Keywords: Cell cycle, Citrate- silver nanoparticles, Nanotoxicology, RAW 264.7, ROS, 
Viability. 
 
Introduction 
Nanotechnology revolution poses advantages in many fields as engineering, information 
technology and diagnostics. The antibacterial effects of silver nanoparticles (AgNPs) are well 
known rendering wide range of applications from medicine and industry to household and 
personal care products or clothing (Abdelhalim and Jarrar, 2011; Behra et al., 2013; Benn and 
Westerhoff, 2008; Eckhardt et al., 2013; EPA, 2010; Nowack et al., 2011).This extensive use of 
AgNPs raises the concern about safety and their possible impacts on the environment and 
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human health (Nowack and Bucheli, 2007; Oberdorster et al., 2005). Thus, their toxic effects on 
biological system should be investigated in order to monitor putative influence on health caused 
by chronic or acute exposure (Pumera, 2011). The widespread use of silver nanoparticles makes 
human exposure inevitable. It is therefore important to understand the mechanisms of toxicity of 
these nanoparticles, in particular in to mammalian cells. Several in vitro studies have reported 
toxic effects of AgNPs towards different types of human cells (Li et al., 2014; Smita et al., 
2012; Zhang et al., 2014), but the mechanisms of AgNPs-induced toxicity are not completely 
understood (Browning et al., 2013). Also, the susceptibility of different cell types to AgNPs 
should be more deeply investigated (Zhang et al., 2015). The cell dependent toxicity could 
reflect, besides inherent characteristics of the cells, differences in the Ag
+
 dissolution from the 
AgNP, cellular uptake, bioavailability or the generation of oxidative stress (AshaRani et al., 
2009; Avalos et al., 2014; Wang et al., 2014). 
As often reported, AgNPs are coated to promote stability and avoid aggregation, being citrate 
the most commonly used reducing agent and stabilizer conferring the NPs a negative charge 
(Sharma et al., 2009). Zhang and co-workers (2014) reported that citrate coating improves the 
stability of AgNPs while decreasing their toxicity. Nevertheless, other studies found that after 
24h, citrate-coated AgNPs (20 and 10 nm) can be cytotoxic to human bronchial epithelial cells 
at concentrations ≥ 6.25 µg/mL (Wang et al., 2014) and to rat brain endothelial cells at 
concentrations ≥ 10 µg/mL (Grosse et al., 2013). However, more research on this field is needed 
to determine the cytotoxic potential of AgNPs with different physico-chemical characteristics in 
different cell types. 
The response of macrophages to nanoparticles is an important area of investigation since these 
cells represent the major pathway by which early-stage defense barriers are established in skin, 
lungs, and mucosal systems to counteract foreign molecules (Park et al., 2011). Macrophages 
among the most phagocytic cell lines in the human body constitute the first line of defense upon 
nanosilver intake by humans and other mammals. 
 In this report we aimed to evaluate the effects of well characterized and sized defined citrate 
coated AgNPs on macrophage’s viability, intracellular ROS production and cell cycle profile. 
For that, the RAW 264.7 cell line was exposed to 30 nm citrate-coated AgNPs. The mouse 
macrophage RAW 264.7 cell line is a model macrophage cell type, which is commonly used for 
hazard assessment and mechanistic studies in nanotoxicology (Munusamy et al., 2015; Orr et 
al., 2011). 
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Material and methods 
Chemicals 
Sterile, purified and endotoxin-free silver nanoparticles (Biopure AgNPs 1.0 mg/mL), with a 
diameter of 30 nm and a citrate surface, Cit30, were purchased from Nanocomposix Europe 
(Prague, Czech Republic). Dulbecco’s modified Eagle’s medium (DMEM), fetal bovine serum 
(FBS), antibiotics and phosphate buffer saline (PBS, pH 7.4) were purchased from Life 
Technologies (Carlsbad, CA, USA). 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT) and dimethyl sulfoxide (DMSO) were obtained from Sigma-Aldrich (St. Louis, 
MO, USA). Dichlorodihydrofluorescein diacetate (DCFH2-DA) was purchased from Sigma-
Aldrich, St. Louis, MO-USA. RNase and propidium iodide (PI) used in cell cycle assay was 
purchased from Sigma-Aldrich, St. Louis, MO-USA. 
 
Cell Culture 
The RAW 264.7 cell line, a macrophage-like cell line, was obtained from European Collection 
of Authenticated Cell Cultures (ECACC) and supplied by Sigma. Cell culture reagents were 
purchased from Life Technologies (Carlsbad, CA, USA). The cells were grown in complete 
medium, i.e., Dulbecco’s modified Eagle’s medium, supplemented with 10% fetal bovine serum 
(FBS), 2 mM L-glutamine, 100 U/mL penicillin, 100 µg/mL streptomycin and 250 µg/mL 
fungizone at 37°C in 5% CO2 humidified atmosphere. Cells were daily observed under an 
inverted phase-contrast Eclipse TS100 microscope (Nikon, Tokyo, Japan). For each experiment, 
cells were allowed to adhere for 24h and then medium was replaced with fresh new medium 
containing citrate- AgNPs. The effects were measured after 24 and 48h. Throughout the 
experiments, cultures were routinely visualized for confluence and cell morphology. 
 
Viability assay 
Cell viability was determined by the colorimetric 3-(4,5- dimethyl-2-thiazolyl)-2,5-diphenyl 
tetrazolium bromide (MTT) assay (Twentyman and Luscombe, 1987). Cells were seeded in 96-
well plates and cultured as described above. Cell viability was measured after 24h and 48h of 
citrate- AgNPs exposure at the concentrations 0, 0.5, 5, 10, 25, 50, and 75 µg/mL. Fifty 
microliters of MTT (1 mg/mL) in phosphate buffered saline (PBS) were then added to each 
well, and incubated for 4h at 37°C, 5% CO2. Medium was then removed and 150 µL of DMSO 
were added to each well for solubilization of formazan crystals. The optical density of reduced 
MTT was measured at 570 nm in a microtiter plate reader (Synergy HT Multi-Mode, BioTeK, 
Winooski, VT). Three independent assays were performed with at least 2 technical replicates 
each and the results compared with the control (no exposure). From the MTT results, the IC50 
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(calculated through SigmaPlot) and IC20 was 87 µg/mL and 60 µg/mL at 24h of exposure and 
79.8 µg/mL and 61.4 µg/mL at 48h of exposure, respectively. Therefore, the 24h exposure and 
the concentration of citrate- AgNPs corresponding IC20 was selected for the following assays. 
 
Intracellular ROS Formation  
Intracellular ROS production was assessed by flow cytometry (FCM) with the use of 
dichlorodihydrofluorescein diacetate (DCFH2-DA) fluorescent probe, as described previously 
(Ferreira de Oliveira et al., 2014). This probe enters the cells and is deacetylated by cellular 
esterases producing non-fluorescent DCFH2 and diacetate. In the cytosol DCFH2 is quickly 
oxidized to fluorescent DCF by intracellular ROS. Cells were plated in 6-well plates and after 
AgNPs exposure, medium was discarded and cells were incubated for 30 min, at 37ºC, in the 
dark with serum-free DMEM containing 10 mM DCFH2-DA. Cells were washed with PBS, 
trypsinised and collected for analysis. Acquisitions were made using a Coulter EPICS XL flow 
cytometer (Coulter Electronics, Hialeah, Florida, USA) equipped with an argon laser (15 mW, 
488 nm). Acquisitions were made using SYSTEM II software v. 3.0 (Beckman Coulter, 
Hialeah, FL). ROS formation was estimated from the median fluorescence intensity (MFI) of 
DCF using the FlowJo software (Tree Star Inc., Ashland, OR-USA). For each sample, the 
number of events reached at least 10000. 
 
Cell cycle and clastogenicity analysis 
Cell cycle and putative clastogenic effects were analyzed by FCM according to the method 
previously described (Oliveira et al., 2014). Briefly, cells were seeded in 6-well plates and after 
exposure, they were harvested through scrapping and centrifuged twice at 300 xg for 5 min. 
Cells were then fixed with 85% cold ethanol and kept at -20 ºC until analysis. At the time of 
analysis cells were centrifuged at 300 g for 5 min, resuspended in PBS and filtered through a 
35-µm nylon mesh to separate aggregates. Then, 50 μL RNase (1mg/mL) and 50 μL propidium 
iodide (PI) (1mg/mL) were added to each sample which were then incubated for 20 min in 
darkness at room temperature until analysis. The relative fluorescence intensity of the stained 
nuclei was measured in a Coulter XL Flow Cytometer (Beckman Coulter, Hialeah, FL-USA) 
equipped with an argon laser (15 mW, 488 nm). Acquisitions were made using SYSTEM II 
software v. 3.0 (Beckman Coulter, Hialeah, FL). For each sample, the number of nuclei 
analyzed was approximately 5,000. The percentage of nuclei in each phase of the cell cycle 
(G0/G1, S and G2 phases) was analyzed using the FlowJo software (Tree Star Inc., Ashland, 
Oregon, USA). In order to assess the putative clastogenic effects of Cit30 AgNPs, as described 
by (Misra and Easton, 1999), the coefficient of variation (CV) of the G0/G1 peak was 
determined. 
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Statistical analysis 
The results are reported as mean ± standard deviation (SD) of 2 technical replicates in each of 
the 3 independent experiments. For all the assays, the statistical significance between control 
and exposed cells was performed by one-way ANOVA, followed by Dunnet and Dunn’s 
method (as parametric and non-parametric test, respectively), using Sigma Plot 12.5 software 
(Systat Software Inc.). The differences were considered statistically significant from p < 0.05. 
 
Results 
Physicochemical characterization of AgNPs 
The characteristics of water or medium solubilized citrate-AgNPs are summarized in Table 6.1, 
including hydrodynamic diameter (Dh), polydispersity index (PDI) and zeta potential (. The 
three parameters increase when AgNPs were solubilized in DMEM: hydrodynamic diameter 
from 43.3 to 64.8 nm; polydispersity index from 0.25 to 0.4; and zeta potential from -42.7 to –
8.5 mV. 
 
Table 6.1: Hydrodynamic diameter Dh (with respective polydispersity index PdI), and zeta potential ( of 
citrate- AgNPs (30 nm nominal diameter) dispersed in ultrapure water or in DMEM culture medium (10 
µg/ml). Standard deviations calculated from 3 replicate measurements. 
 
 
 
 
Effects on cell growth, viability and ROS 
RAW 264.7 cells in control conditions showed typical confluence profile and morphology (Fig. 
6.1a and 6.1c). When cells were exposed to 60 µg/mL citrate-coated AgNPs, their confluence 
decreased (Fig. 6.1b and 6.1d), especially after 48h of exposure (Fig. 6.1d). In exposed cells, 
some alterations on cells morphology, semblance of phagosomes, after exposure to AgNPs were 
noticed, including an increase of granularity and darker aspect (Fig. 6.1b and 6.1d). 
The viability of RAW cells was negatively affected by citrate- AgNPs (Fig. 6.2). Relatively to 
controls, the viability of exposed cells was significantly reduced (p < 0.05) upon exposure to 
citrate- AgNPs at 75 µg/mL after both time exposures.  
The intracellular ROS production is shown in Fig 6.3. Citrate- AgNPs significantly decrease 
ROS production in RAW 264.7 cells at the concentration of 60 µg/mL after 24h exposure. 
 Dh (nm) PdI  (mV) 
In water 43.3 ± 0.5 0.25-0.26 -42.7 ± 2.7 
In DMEM 64.8 ± 0.4 0.40-0.41 -8.5 ± 0.4 
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Figure 6.1: Light microscopy images (100X) of RAW 264.7 cells exposed to citrate- AgNPs for: 24h - a) 
0, b) 75 µg/mL of citrate- AgNPs; and for 48h – c) 0, d) 75 µg/mL of citrate- AgNPs. Bar corresponds to 
100 µm. 
 
 
 
Figure 6.2: Relative cell viability (%) of RAW 264.7 after exposure to 30 nm citrate- AgNPs for 24h and 
48h, measured by MTT assay. Data expressed as mean and standard deviation. * indicate significant 
differences between control at p < 0.05 for 24h and # indicate significant differences between control at p 
< 0.05 for 48h. 
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Figure 6.3: Characterization of intracellular ROS production of RAW 264.7 after exposure to citrate- 
AgNPs for 24h, using the DCFDA assay. The results were expressed as the mean +/- SD versus control. 
** indicate significant differences between control at p < 0.01. 
 
 
Cell cycle and clastogenicity 
Figure 6.4 shows the effect of IC20 citrate- AgNPs on the cell cycle of RAW 264.7 cells. 
Citrate- AgNPs induced a significant increase in the percentage of cells in Sub G1 phase and a 
significant decrease in the percentage of cells in S and G2 (p < 0.05). Beyond, there is a 
significant increase of the coefficient of variation (CV) corresponding to G1 peak after exposure 
to citrate- AgNPs (p < 0.01). An example of histograms obtained for control cells and after 24h 
of exposure to 60 µg/mL citrate- AgNPs are represent in figure 6.5. 
 
 
Discussion 
The influence of coating has to be considered in studies of AgNPs cytoxicity, despite several 
publications still omit the description of coating used. Citrate-coated AgNPs have been 
demonstrated to exert some cytotoxic effects in some cells/tissues such as keratinocytes and 
liver cells (Chapter 2 and 5). This toxicity has been poorly explored in macrophages with few 
exceptions (eg Hamilton et al., (2014), Shannahan and Sowrirajan (2015)). 
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Figure 6.4: Effects of AgNPs on cell cycle dynamics, Sub G1 population and coefficient of variation 
(CV), measured by flow cytometry, exposed during 24h. The results were expressed as mean and 
standard deviation. * indicate significant differences between control at p < 0.05. 
 
 
 
 
 
 
 
 
 
 
Figure 6.5: Examples of RAW 264.7 cell cycle histograms obtained after 24h of Cit30 AgNPs exposure, 
measured by flow cytometry. 
 
 
Hamilton et al (2014) showed that smaller AgNPs (20 nm) were, regardless of coating (citrate-
coated or PVP-coated) more toxic and most active in THP-1 macrophages than larger AgNPs. It 
was also demonstrated that macrophages internalize AgNPs agglomerates via actin-dependent 
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endocytosis mediated by scavenger receptors (Wang et al., 2012), but the influence of the 
coating on this process remains unknown. For mouse macrophage cell line RAW 264.7 and 
bone marrow-derived macrophages (BMDM) exposed to 20 nm citrate-coated AgNPs it was 
demonstrated an up-regulation expression of some inflammatory related transcripts (Aldossari 
et al., 2015). 
Our data contributes to clarify the influence of AgNPs coated with citrate on macrophages cells, 
where a toolbox of cellular function endpoints were employed to determine if low citrate-
AgNPs toxic concentrations (IC20) have effects on vital macrophage functions in vitro. 
Different cells have different roles in our body and thus it is expectable that they behave 
differently to AgNPs exposure. White blood cells have greater capacity to destroy or remove 
foreign matter from the body since they are the cells of the immune system. More specifically 
macrophages actively perform phagocytic functions engulfing the particles creating phagosomes 
where enzymes are released into it by lysosomes. The acidic environment in the lysosomes can 
further contribute to dissolve the Ag ions from the AgNP. Our results showed that RAW 264.7 
cells only reduced 20% of viability after exposure of 60 µg/mL Cit30 AgNPs, supporting that 
macrophage cells may present higher tolerance towards AgNP mediated toxicity than other cell 
lines. This hypothesis is in agreement with Kaur et al (2013) who found that RAW macrophages 
presented the least cell viability reduction (21% cell death) at 100 µg/ml of TSNPs (AgNPs 
synthesized by reduction with tannic acid) compared with A431 (skin epithelial) and A549 
(lung epithelial). They also concluded that RAW cells “engulf” silver nanoparticles and thus 
resist any toxic response. Zhang et al (2015) exposed RAW 264.7 cells to a range of citrate- 
AgNPs concentrations (0.1-50 µg/mL) and also obtained less than 20% of viability reduction. 
Otherwise, a study on the cytotoxic potential of tannic acid modified AgNPs (13, 33 and 46 nm) 
reported a significantly decrease on RAW 264.7 cells viability after exposure to 2.5 µg/mL 
AgNPs (Orlowski et al., 2013). Other study on toxicity of Ag/SiO2 particles in murine 
macrophage RAW 264.7 highlighted the influence of size and their release of Ag
+
 ions on their 
toxicity potential (Pratsinis et al., 2013). The authors obtained significant viability decrease after 
exposure to ~ 20 nm Ag/SiO2 particles for concentrations ≥ 20 µg/mL, while for ~ 10 nm 
Ag/SiO2 particles significant decrease begins at concentrations ≥ 10 µg/mL. On the other hand, 
a study on the cytotoxic effects of AgNPs coated with a peptide layer on a human macrophage 
cell line (THP-1) obtained IC50 values of 110 µg/mL for 20nm AgNPs and 140 µg/mL for 40 
nm AgNPs after 24h of exposure, while after 48h was 18 µg/mL for 20 nm AgNPs and 30 
µg/mL for 40 nm AgNPs, stressing the size and time dependent toxicity (Hasse et al., 2011).  
Although the induction of ROS is a common in vitro response to AgNPs exposure (Arora et al., 
2008; Hussain et al., 2005), in our work we could not find evidences of ROS induction, and on 
the contrary, a 50% decrease in the ROS levels was detected for Raw cells exposed to AgNPs at 
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IC20. Other studies also failed to present evidences of ROS increase upon AgNPs exposure. For 
instance, Gliga et al (2014) investigated the ROS formation upon exposure to AgNPs of 10-75 
nm uncoated or coated with PVP or citrate and  found no changes in ROS generation in BEAS-
2B cells. In another study Kaur et al (2013) found that TSNPs (AgNPs synthesized by reduction 
with tannic acid) at 50 µg/mL did not induce significant ROS generation in RAW macrophages 
while increasing in more sensitive cells (lung cell line A549 and epidermoid carcinoma cell line 
A431). 
Also, the observed decrease of ROS levels in macrophages exposed to such low levels of 
AgNPs supports the hypothesis that these cells present a good adaptive mechanism to cope with 
AgNPs inside the cell. This may involve an induction of the total antioxidant battery in response 
to exposure this low dose of AgNPs, reducing the ROS intracellular content.  
A significant increase in the sub-G0/G1 population was observed in RAW cell exposed to 
AgNPs. The increase in Sub G1 population may be related to DNA fragmentation often 
associated with apoptosis (Kajstura et al., 2007). Park et al (2010) after exposure RAW 264.7 
cells to 1.6 µg/mL AgNPs also obtained a significant increase of cells at Sub G1 phase 
suggesting, as in our results, the occurrence of apoptosis. Concerning cell cycle dynamics, 
RAW 264.7 cells were extremely affected by AgNPs exposure. Moreover, the significant 
increase of the coefficient of variation could be related to clastogenic potential of citrate- 
AgNPs on RAW 264.7 cells (Misra and Easton 1999). On other hand, the arrest at G0/G1 phase 
may support the observed decreases of cells in both S and G2 phases. Sasidharan et al (2011) 
obtained similar histograms for nasopharyngeal carcinoma cell line (KB) cells after 24h 
exposure of 200 and 300 µM ZnO nanocrystals (NCs). Similarly, RAW 264.7 cells showed a 
decrease in S phase and increases of cells in G0/G1 and sub G1 after exposure to 0.01 µg/mL of 
SiO2 NPs (10 nm). The authors indicated that although there was no decrease in cell viability, a 
subpopulation of cells (between 12% and 15% at sub G1) underwent apoptosis (Bancos et al., 
2015). 
Comparing to our previous studies on cytotoxic potential of the same citrate- AgNPs on human 
keratinocyte cell line (HaCaT) and hepatocellular carcinoma cell line (HepG2), RAW 264.7 cell 
line was, undoubtable the less sensible, with the higher IC20 value (60 µg/mL) (Chapter 2 and 
5), which demonstrates that different cell types have different susceptibility to AgNPs and that 
the toxicological profile of AgNPs must not be generalized for individual nanoparticles.  
In conclusion, our study demonstrates that the widely used citrate-coated AgNPs only induced a 
significant decrease on viability of RAW at higher concentrations (75 µg/mL). In addiction 
citrate-AgNPs did not induce ROS production, in opposition, decreased ROS production on 
RAW 264.7 cell line. However, AgNPs have a great impact on cell cycle progression of RAW 
cells. Beyond the apparent cytostatic effect, AgNPs induced a population at Sub G1 phase, 
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associated with apoptosis/necrosis. Thus, and reporting our previous works, we can conclude 
that toxicity of AgNPs varies with the cell type and their toxicological profile could not be 
generalized for individual nanoparticles. Instead, a long data based should be done to determine 
the toxicity profile of the different sized and coated AgNPs in each cell type. 
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General Conclusions 
At the beginning of this study, we assessed size dependent cytotoxicity of citrate- AgNPs (10 
nm, 30 nm and 60 nm AgNPs) to HaCaT cells, through MTT assay (Fig. A1 and A2; Annex). 
We found that the decrease of viability was higher for 30 nm AgNPs exposed cells, thus we 
preceded the studies using 30 nm AgNPs. AgNPs with 10 nm was only used at inflammatory 
responses study in order to determine the influence of the size. 
In this work, we have investigated the cellular effects of well-characterized AgNPs with 
different coatings (citrate and PEG) and the same nominal diameter (30 nm or 10 nm), in order 
to address the influence of NP surface on biological outcomes, assessing cell proliferation and 
viability, oxidative stress, inflammatory responses, apoptosis, cytostaticity, DNA damage, 
micronuclei (MNi) induction, and the less commonly reported changes in cell cycle dynamics. 
Further motivation arose from the growing interest in using PEG-coated NPs in nanomedicine 
applications (Povoski et al., 2013; Thorley and Tetley, 2013), thus making it timely and useful 
to report on the cytotoxic effects of such particles.  
Our study has shown that largely used citrate-coated AgNPs decreased the viability of the 
keratinocytes cells (HaCaT) more severely than the emerging PEG-coated AgNPs. This 
difference was not due to putative effects of the coating molecules per se (as they produced no 
cytotoxicity), neither to the extent of extracellular release of ionic silver. However, our study 
demonstrates that citrate-coated and PEG- coated AgNPs decrease viability of hepatoma cells 
(HepG2) in a similar way. Thus, for HepG2 cells the cytotoxicity of AgNPs is independent of 
the studied coatings.  
The differently coated AgNPs produced in HaCaT distinct effects regarding the mode of cell 
death and cell cycle progression. While Cit30 AgNPs clearly induced apoptotic death, cells 
exposed to PEG30 AgNPs appeared to be at an earlier phase of apoptosis mechanisms, as 
supported by gene expression analysis. Concerning the impact on cell cycle progression, both 
Cit30 and PEG30 AgNPs affected cell cycle regulation of HaCaT cells, but, again, citrate-
coating induced more drastic effects, showing earlier downregulation of cyclin B1 gene and 
blockage of cells at G2. However, both AgNPs increased similarly the amount of ROS produced 
by HaCaT cells.  
Concerning the effects of citrate- and PEG- AgNPs on HepG2, both AgNPs did not induced 
apoptosis for the studied concentrations and the apoptotic related genes BCL2 and BAX were 
downregulated. HepG2 showed the same profile of cell cycle dynamics after exposure to both 
AgNPs, where, for the higher concentration, there was an increase of the percentage of cells at S 
and G2 phases. Gene expressions of cyclins CCNB1 and CCNE1 were also downregulated. 
PEG10 AgNPs at high concentrations inactivate the transcription factor, NF-kB, in HaCaT cells 
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and putative correlation with anti-inflammatory and antiapoptotic homeostasis should be further 
explored. It was demonstrated that, independently of the coating, 10 nm and 30 nm AgNPs do 
maintain cytokins release at undetectable levels, and decreases MCP-1 release, which is in line 
with part of the literature, though this remains a controversial topic, most probably due to the 
complex varieties involved.  
Our study also demonstrates that citrate- AgNPs induced DNA damage to HaCaT cells 
increasing their genetic damage. Also, these NPs induced MNi, increased mononucleated cells 
and decreased binucleated cells, being, thus, cytostatic for HaCaT cells by decreasing their 
nuclear division index. 
However, our study showed that the widely used citrate-coated AgNPs only induced a 
significant decrease on viability of mouse monocyte/macrophage cells (RAW 264.7) at higher 
concentrations (75 µg/mL). In addition citrate- AgNPs did not induce ROS production, in 
opposition, decreased ROS production on RAW 264.7 cell line. However, AgNPs have a great 
impact on cell cycle progression of RAW cells. Beyond the apparent cytostatic effect, AgNPs 
induced a population at Sub G1 phase, commonly associated to apoptosis/necrosis.  
Therefore, we can conclude that toxicity of AgNPs varies within the cell type, since, HepG2 
was more sensitive to AgNPs, followed by HaCaT cells and finally RAW 264.7 cells. These last 
ones have the greatest IC20 value comparing to HaCaT and HepG2 cells, and this fact could be 
due to a good adaptative mechanism to cope with AgNPs inside the cell by macrophages, since 
it has been proposed elsewhere that they may “engulf” silver nanoparticles and thus resist any 
toxic response. 
Thus, we can conclude that AgNPs toxicological profile could not be generalized for individual 
nanoparticles. Instead, a long data based should be done to determine the toxicity profile of the 
different sized and coated AgNPs in each cell type. 
Considering that AgNPs are present in a vast number of consumer products, it is important to 
determine if or which NPs are more cytotoxic. Our study suggests that PEG-coating can be 
regarded as a good alternative to citrate stabilization of AgNPs used in industrial and medical 
applications towards human skin cells. However, for hepatocyte cells, AgNPs cytotoxic 
potential was coating independent for these studied conditions. 
 
As future work, additional cytotoxic studies, including metabolomics and other –omics 
approaches, could be performed to better understand the mechanisms of AgNPs toxicity and 
their underlying pathways of toxicity/cell resistance.  
In order to get a better knowledge on what might be happening in all the human body, other cell 
lines should be used to determine the cytotoxic potential of AgNPs representing other human 
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organs, supporting laboratory in vivo assays. Also, the characterization of AgNPs effects in 
inflammatory responses is at its infancy and deserves further studies, combining multiple 
analyses, omics and in vitro vs in vivo assays. 
Finally, a major conclusion from our work points that the largely used citrate AgNPs are 
cytotoxic, and further studies to find effective coating alternatives for health/cosmetic industry 
must be performed to search for AgNPs less toxic to human health (as PEG has demonstrated to 
be in vitro). 
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Annex 
Results from a preliminary assay where 10 nm citrate- AgNPs and 60 nm citrate- AgNPs were 
used, together with 30 nm citrate- AgNPs (Fig. 2.4a, Chapter 2), to assess the size dependent 
cytotoxicity in HaCaT cells in order to continue the other assays using the size that induced the 
higher reduction on viability (30 nm). 
 
 
 
Figure A1: Relative cell viability (%) of HaCaT after exposure to 10 nm citrate- AgNPs for 24h and 48h, 
measured by MTT assay. Data expressed as mean and standard deviation. ** indicate significant 
differences between control at p < 0.01. 
 
 
 
  
Figure A2: Relative cell viability (%) of HaCaT after exposure to 60 nm citrate- AgNPs for 24h and 48h, 
measured by MTT assay. Data expressed as mean and standard deviation. ** indicate significant 
differences between control at p < 0.01 
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